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Abstract 
DYSPNEA: EFFECT OF AURICULAR ACUPRESSURE IN END STAGE LUNG 
CANCER PATIENTS, A PILOT FEASIBILITY STUDY 
Roger A. Strong, Ph.D., RN 
Hahn School of Nursing and Health Sciences 
University of San Diego, San Diego, C A 
Jane Georges, Ph.D. RN, Advisor 
Introduction: Dyspnea is a debilitating symptom, common in advanced lung cancer 
patients, and poorly controlled. The National Institutes of Health has promoted the need 
for research regarding end of life care symptom control. 
Purpose: Conduct a feasibility study evaluating auricular acupressure effects on dyspnea 
in hospice lung cancer patients. 
Theoretical Framework: The UCSF School of Nursing Symptom Management Faculty 
Group's Model for Symptom Management was used for the conceptual framework. The 
model includes three dimensions: symptom experience, symptom management strategies, 
and symptom outcomes. The Human Energy Field Theory provided context for using 
auricular acupressure. 
Aim: Conduct a pilot study evaluating feasibility and effects of auricular acupressure on 
dyspnea. Hypotheses: auricular-acupressure seed adhesive use on appropriate points plus 
standard care (SC) would be more effective than usual care or usual care plus placebo in 
(1) reducing dyspnea and (2) increasing oxygen saturation. 
Methods: Both quantitative and qualitative methods. Sample -11 hospice patients with 
lung cancer and dyspnea. Procedure - 8 times (Day 1 baseline and post intervention, 
Days 2 early-late, 3 early-late, 4 early-late follow-ups) dyspnea was measured by the 
Cancer Dyspnea Scale and oxygen saturation was measured by pulse-oximeter. 
Qualitative questions were asked on Days 1 and 4. A trained professional administered 
the acupressure intervention after baseline assessments. Design - The experimental 
design included 3 conditions with eight measurement points in time. Patients were 
randomly assigned to one of three treatment conditions: (1) Standard Care; (2) Standard 
Care with seed adhesive on inappropriate points (placebo); (3) Standard Care with seed 
adhesive Auricular acupressure on appropriate points. The results were analyzed using 
analysis of variance (ANOVA). 
Results: Both quantitative and qualitative analyses supported the presence of acupressure 
effects with medium to large effects and a significant effect for dyspnea effort. 
Conclusions: Although difficult to recruit patients to a trial of alternative therapy in 
advanced disease, it is possible to test such treatments that potentially can improve 
symptoms in palliative care. Auricular acupressure may help ameliorate dyspnea. There 
is a continued need for symptom control at end of the life. The role of nursing is central 
to end of life care. 
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Chapter 1 Introduction and Significance 
Dyspnea & Context 
Dyspnea Definition and Prevalence 
Dyspnea as a word is derived from ancient Greek; "dys," means disordered or 
abnormal and "pnoia" means breath. Hence, dyspnea is literally translated as meaning 
disordered breathing. Dyspnea, also often called breathlessness or shortness of breath, is 
a common and debilitating symptom of advanced lung cancer patients (Thomas & von 
Gunten, 2006; Bruera, Sweeney, Ripamonti, 2002; Ahmedzai, 1993; Cowcher & Hanks, 
1990). 
In advanced lung cancer patients, reports give a range of dyspnea occurrence of 
21% to 79% (Ripamonti, 1999) and Yoder (2006) reports on research showing that 60% 
of lung cancer patients develop dyspnea early and that about 65% experience dyspnea 
sometime during their illness. These prevalence estimates are also in line with Bruera, 
Schmitz, Pither, Neumann, and Hanson's (2000) report of a 55% incidence of dyspnea in 
ambulatory terminally ill cancer patients (not all of whom had lung cancer). Additional 
reports on dyspnea incidence rates are presented below in the section, 'Research Needed 
Regarding End-of-Life Symptom Management.' 
Nursing Mandate to Study Dyspnea 
A symptom of cardiopulmonary disorder, dyspnea is assessed and managed by 
nurses in both as an acute and a chronic problem. In a classic review of the sensation of 
dyspnea, Carrieri-Kohlman, Janson-Bjerklie, and Jacobs (1984) wrote: "In the recent 
social policy statement by American Nurses' Association [ANS, 1980], nursing was 
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defined as the diagnosis and treatment of human responses to health problems. 
Subsequently, the symptom of ineffective breathing patterns has been listed as an 
accepted nursing diagnosis at the Fifth National Conference on Nursing Diagnosis, April 
1982, St. Louis. [Kim & Moritz DA, 1982]. These documents provide a mandate for 
nurses to study the measurement and management of symptoms and responses to illness, 
dyspnea being an example." 
In her overview article on terminal dyspnea, LaDuke (2001) maintains, even in 
her title, "Patient deaths are inevitable. 'Bad deaths' - those accompanied by severe 
suffering ~ are not." She notes that dyspnea is characterized by subjective awareness of 
uncomfortable and difficult breathing. Many patients describe the experience as 
agonizing and even worse than pain. Terminal dyspnea, sometimes described as "air 
hunger" (Tarzian, 2000), is present in as many as 75% of those who are dying (Rousseau, 
1997). In fact, dyspnea should probably be expected in most dying patients (Berry, 
2002). Even though dyspnea is often thought of as characteristic of chronic obstructive 
pulmonary disease (COPD), pneumonia, heart failure, and pulmonary system 
malignances, it can and does appear in the absence of any cardiopulmonary pathology 
(Rousseau, 1999). Nursing professionals are those who most often respond to dyspnea's 
appearance. Inzeo and Tyson (2003) specifically identify the key role of nursing in the 
assessment and management of dyspneic patients with lung cancer and Indelicato (2007) 
provides both an overview of and 72 references for "The advanced practice nurse's role 
in palliative are and the management of dyspnea." 
Dyspnea is not always well assessed or well managed. Three nurses, Webb, 
Moody, and Mason (2000) note this and describe dyspnea assessment and management in 
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72 hospice patients using a retrospective, descriptive design with chart audits as the 
source of data. They conclude that dyspnea assessment needs to be frequently done 
employing standardized instruments to evaluate intensity of dyspnea and accompanying 
distress. Additionally, they recommend that these types of instruments be used in clinical 
trials to determine treatment effectiveness. 
Theoretical Models 
How does one begin to understand the phenomenon that is labeled dyspnea? 
Beyond attempting to develop some way to organize the information about dyspnea, 
Lenz, Suppe, Gift, Pugh, and Milligan (1995) make the case that use of middle-range 
theories as oppose to grand theories or broad-scope conceptual frameworks will enhance 
the generation of new knowledge. They argue that placing greater emphasis on such 
middle-range theories will more efficiently and quickly advance theory-research and 
theory-practice linkages. These authors cite Merton (1968) as describing middle-range 
theories as those falling between working hypotheses, an essential part of carrying out 
research and "the all-inclusive systematic efforts to develop a unified theory [of the 
discipline]." (p 39) 
Lenz et al. (1995) list some middle-range theories that have been developed by 
nurses and point out that these middle-range theories are now being used in an increasing 
number of clinical and research settings. These include such middle-range theories as 
Mishel's (1988, 1990) theory of uncertainty in illness, Cox's (1982) interaction model of 
client health behavior, Morse and Johnson's (1991) illness constellation model, and 
Pender's (1987) model of health promotion and illness prevention. 
Prominent among those in nursing scholarship that support the importance of 
middle-range theories is the UCSF School of Nursing Symptom Management Faculty 
Group (Dodd, Janson, Facioine, Faucett, Froelicher, Humphreys, Lee, Miaskowski, 
Puntillo, Rankin, & Taylor, 2001). They state, "The UCSF faculty members are 
committed to developing symptom management knowledge and middle range theories 
are useful for this purpose" (p 675). This UCSF group themselves have proposed a 
Symptom Management Conceptual Model (SMCM, Dodd, et al. 2001) updated and 
revised from their earlier model (Larson, Carrieri-Kohlman, Dodd, Douglas, Faucett, 
Froelicher, Gortner, Halliburton, Janson, Lee, Miaskowski, Savedra, Stotts, Taylor, 
Underwood, 1994a, 1994b). See figure 1 for a schematic presentation of the Revised 
Symptom Management Conceptual Model (RSMC Model). 
Person 
"Demographic, psychological, sociological," 
physiological, developmental 
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/ strategies . 
I Who? (Delivers) * 
1 What? How? * 
\ When? To Whom? * / 
\ Where? How much? y 
o'utcomes'NU. % ' ^ ' \ 
.^JV? •'—Adherence 
^Environment". V """* # Emononai oen-ca.e i - ^ Jf 
Physical '• ^ " - J s t a t us Symptom I ^^.^^'Health & Illness, 
N Social \ 1 status C o s l s J—""^ / Risk factors .• 
/ Heal 
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Figure 1. Revised Symptom Management Conceptual Model (RSMC Model). 
This is an evidence-based conceptual model for symptom management that has 
three basic dimensions: symptom experience, symptom management strategies, and 
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outcomes. Within the model, "a symptom is defined as a subjective experience reflecting 
changes in the biopsychosocial functioning, sensations, or cognition of an individual" 
(Dodd et al. 2001, p. 669). The model describes the interrelatedness of the three 
dimensions within three domains of nursing science (person domain, health & illness 
domain, and environmental domain). Within the symptom experience dimension, there 
are three sub-dimensions of perception of symptoms, evaluation of symptoms, and 
response to symptoms. It is based on five assumptions: (1) the gold standard for 
understanding and studying symptoms is the perception of the individual experiencing 
the symptom and the individual's report of the experience; (2) the symptom need not be 
experienced by an individual in order for the symptom management model to be applied 
since the individual can be at risk for symptom development from the impact of a context 
variable such as a work hazard and intervention strategies can be initiated before the 
symptom is experienced by the individual; (3) nonverbal patients such as infants or post-
stroke aphasic individuals may experience symptoms where the interpretation by a parent 
or caregiver is accepted as accurate for intervention purposes since all troublesome 
symptoms need to be managed; (4) the target of management strategy can be the level of 
the individual, group, family, or work environment; (5) symptom management is a 
dynamic process in that it is modified by individual outcomes and the influences of the 
three nursing domains of person, health/illness, and environment. Note should be made 
that the authors' statement of six assumptions in their 2000 article is incorrect. There are 
only five listed in that article and, indeed, Elfreida O'Neil reported to this researcher that 
the assumptions do number only five (O'Neil, personal communication, 2004). 
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Research Needed Regarding End-of-Life Symptom Management 
The National Institutes of Health has identified a need for research regarding 
symptom management and end of life care (Grady, 2005; National Institutes of Health, 
2005). In setting research priorities specifically in respiratory nursing, the American 
Thoracic Society (1998) included the need for research on specific interventions for 
ameliorating dyspnea. A common end of life diagnosis that comes with panoply of 
difficult to manage symptoms is lung cancer. More people die of lung cancer than of 
colon, breast, and prostate cancers combined. The American Cancer Society estimates 
that there were 170,000 people in 2006 that had lung cancer with an estimated 162,000 
deaths. For 2008, there are an estimated 215,020 cases of lung cancer in the United 
States (American Cancer Society, 2008). The numbers simply keep climbing. 
There are two major types of lung cancer: non-small cell and small cell. Non-
small cell lung cancer (NSCLC) is the most common type (Shepherd, 1994). Cooley 
(1998) reported that for both men and women in North American, lung cancer is the 
number one cause of cancer mortality (Parker, Tong, Bolden, & Wingo, 1997). In 2007 
this is apparently still the case and Arenberg (2007) points out that though lung cancer 
leads in cancer causing deaths, it does not lead in the amount of research funds. 
Many advanced cancer patients avail themselves of the services of hospices. 
Weitzner, Moody, and McMillan (1997) report that a retrospective review of charts from 
a large hospice in west-central Florida identified the most common physical problem 
among cancer patients was pain (87%), with dyspnea being the second most common 
physical problem (56%). These percentages are higher than those reported by Vainio and 
Auvinen (1996), although it should be noted that Vainio and Auvinen collected data on 
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admission to hospice care, while Witzner et al. collected data from patients closer to 
death. In a sample of ambulatory patients with advanced lung cancer, Tanaka, Akechi, 
Okuyama, Nishiwaki, & Uchitomi (2002) found that over half (55%) the sample 
experienced clinical dyspnea as measured by the Cancer Dyspnea Scale (CDS) and the 
Dyspnea Numeric Scale (DNS). Also, Dudgeon, Kristjanson, Sloan, Lertzman, and 
Clement (2001) found a similar prevalence (46%) in a very large (over 900) sample of 
ambulatory lung cancer patients. More agreement on this general prevalence rate finding 
is found in the Skaug, Eide, and Gulsvik (2007) Norwegian community study looking at 
lung cancer diagnosed cases within a defined hospital area from 1990 to 1996. Here, 
dyspnea was found in 54% of the cases. Finally, Doorenbos, Given, Given, and 
Verbitsky (2006) reported that, in their study of symptom experience in the last year of 
life for individuals with cancer, dyspnea was in the top five most prevalent symptoms. 
They also note that in their last year of life, patients with lung cancer experienced more 
symptoms than those with other solid tumor cancers. 
The World Health Organization (1990) defines palliative care as the provision of 
relief from pain and other distressing symptoms. Management of symptoms is a crucial 
part of the role of nursing in the hospice setting. Besides pain, a critically important 
symptom for those with impaired breathing is dyspnea. Yet research reveals that dyspnea 
is frequently inadequately assessed and reported (Moody, McCormick, & Williams, 
1990). Good symptom control is important generally, especially for common symptoms 
such as dyspnea (Vignaroli and Bruera, 2006), and is achieved for dyspnea less 
frequently than for other symptoms including pain and nausea (Higginson & McCarthy, 
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1989; Kazanowski, 2001). This may be due to dyspnea not being adequately assessed 
near end of life (Escalante, Martin, Eltin, Cantor, Harle, Price, and Kish, 1996). 
Manzullo, E.F. & Rubenstein, E.B. (1996).). Witzner et al. (1997) note: "Few 
intervention studies exist that have demonstrated which methods of treating dyspnea 
work best. Clinical guidelines for dyspnea are needed such as those developed for pain. 
Interestingly, the historical model of assessment of the experience of dyspnea is the 
assessment of pain (Matzo et al. 2001). 
This research addressed the symptom of dyspnea within advanced lung cancer 
patients in a hospice setting. For hospice care patients, symptom management is a central 
goal of treatment. Sadly, as noted above dyspnea is inadequately assessed at end of life 
and is less frequently controlled well than other symptoms including the symptom of pain 
(Higginson & McCarthy, 1989; Kazanowski, 2001). One option for ameliorating the 
experience of dyspnea in this patient population would be auricular acupressure, a 
complementary alternative intervention. 
Dyspnea Assessment 
In nursing science, theoretical models are utilized as a basis for the development 
of new instruments. Conversely, it is also the case that the new instruments of 
measurement lead to revised or new theoretical models. The following, then, is a brief 
description of the development of current dyspnea measures. 
Earlier definitions of dyspnea were based on objective symptoms, sometimes 
referred to as signs, such as "difficult or disordered breathing" (Williams, 1845). A 
hundred years later, there were still some confusing of symptoms and signs, e.g., Wright 
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and Branscomb's (1954) "difficult, labored, uncomfortable breathing." Today, the 
general consensus is that the dyspnea is a subjective symptom, experienced by the patient 
only, and reported by the patient (American Thoracic Society, 1999). Even in the 1950s 
and 60s when the research on dyspnea primarily dealt with the impact of mechanical 
loads on respiratory symptoms (Howell & Campbell, 1966), there was an awareness that 
dyspnea may come with several different qualities (hence, as experienced by the patient), 
and that the sense of effort (again, something experienced by the patient) was the primary 
component of breathing discomfort (American Thoracic Society, 1999). In their article 
on symptom control in palliative care, Fabbro, Dalai, and Bruera (2006) were careful to 
point out both that dyspnea is a subjective symptom and that objective assessments (e.g., 
tachypnea and oxygenation saturation levels) "may not adequately reflect the distress 
experience by patients with dyspnea." (p 423). 
There is an astonishing array of instruments for measuring dyspnea. Table 1 
provides an alphabetical listing of most of them. Researchers aiming at the development 
of dyspnea assessment tools have addressed the many different aspects of the 
phenomenon. These range from in-depth interviews to simple visual analogue scales, and 
include retrospective reports of impact of breathlessness, current descriptions of a 
symptom being immediately experienced, descriptors of breathlessness, 
psychophysiological magnitude estimation, and single factor and multi-factor scales. The 
range of attempts to describe dyspnea is immense. As with dyspnea itself, some 
approach to organizing the assessments of dyspnea is needed. In Chapter Two, four 
general schemes for accomplishing this are presented. McCord and Cronin-Stubb (1992) 
use four domains within a model of dyspnea: culture, environment, perception, and 
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psychological status. Carrieri-Kohlman and Janson (1999) use four descriptive 
categories for classification of degrees of dyspnea (qualitative descriptions, intensity, 
affective components, and activities of daily living). Sorenson (2000) presents three 
content groupings of dyspnea (activities of daily living, exercise, and health-related 
quality of life), while Cullen and Rodak (2002) use six clinical utility categories for 
grouping (exercise, activities of daily living, benchmark, outcome, responsiveness, and 
clinical trials) and two dimensions of assessment in evaluating the clinical utility of 
interventions (the discriminative versus the evaluative instruments). The choice of 
dyspnea measurement should be made keeping in mind the purpose of the study and 
populations of the studies within which a measurement was developed. 
Hospice and Palliative Care 
The unique population that seeks hospice and palliative care and the nature of the 
services in this area being prevention and relief of suffering are the sources of concerns 
and issues regarding research in this area (Ferrell and Grant, 2001; Addington-Hall, 
2007). Terminally ill patients are a vulnerable group, research participation can be 
burdensome, and the methods that best address the questions need to be carefully 
evaluated. Hence, there are both ethical and research methodological issues involved. A 
number of research approaches to the challenges involved have been proposed. In the 
current study, efforts were made to lessen the participation burden as much as possible, 
clear consent procedures were developed, and both quantitative and qualitative methods 
were used as part of the research design. Indeed, in spite of challenges in hospice and 
palliative care, research must be conducted in order to build an evolving knowledge base 
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that allows for the delivery of quality hospice and palliative care. As Ferrell (2004) 
asserts, "Improved care will not happen without inquiry." (p. 408) 
Traditional Chinese Medicine, Acupuncture, and Acupressure 
Acupuncture is an ancient Chinese procedure for alleviating many different types 
of medical complaints. It involves the use of needles that are inserted in specified points 
of the body. Such insertion is assumed to change the flow of energy along meridians in 
the human body. Acupressure is assumed to produce similar effects, but by applying 
pressure to specified points of the body. 
Some reviews of treatment for dyspnea already include sections on acupuncture 
and acupressure. Manning (2000), writing in the journal Respiratory Care, included 
these two procedures in his section on alternative medicine. His review concluded that 
traditional acupuncture produced greater improvement in breathlessness ratings and the 
6-min walk distance than did a placebo acupuncture procedure. Also, in a study that did 
not use a control condition, acupuncture generated "prompt and significant improvements 
in dyspnea, relaxation, and anxiety." (p 1348) Manning also reported that patients using 
auricular acupressure, a procedure related to Auricular acupressure, demonstrated 
significantly lower visual analog scale (VAS) ratings of breathlessness for real versus 
sham acupoints. See Chapter Two for details of these and other studies. 
Research Purpose and Hypotheses 
The focus of this research was on those individuals in a hospice program who 
have the diagnosis of lung cancer, a prognosis of less than six months, and the specific 
symptom of dyspnea. 
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The overall purpose of this research was to function as a pilot feasibility study on 
evaluating the effects of Auricular acupressure on dyspnea (shortness of breath) in 
terminal lung cancer patients. The general research question was to determine whether 
the dependent variable, dyspnea, would be differentially decreased in hospice lung cancer 
patients across three levels of the independent variable, treatment condition. The three 
levels of the independent variable consisted of Auricular acupressure plus standard of 
care, sham Auricular acupressure plus standard of care, and standard of care. 
Additionally, a simple thematic analysis qualitative method was used to place the 
quantitative results in a broader and richer context [Braun and Clarke, 2008]. 
It is important to collect qualitative data in symptom and palliative care research. 
Such data provide a source of richness regarding the experience of those individuals with 
the symptoms of interest and this information may not be captured by quantitative 
methods only. Additionally, qualitative data can compliment and reinforce the 
quantitative results. 
To address this specific aim and the general question, there were three basic 
hypotheses: 
Hypothesis 1. Over four days there would be a decrease in dyspnea for the 
standard care plus seed adhesive Auricular acupressure group compared to a standard 
care group and a standard care non-appropriate seed point adhesive placebo group. 
Hypothesis 2. Over four days there would be an increase in the levels of oxygen 
saturation for standard care plus seed adhesive Auricular acupressure group compared to 
a standard care group and a standard care non-appropriate seed point adhesive placebo 
group. 
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Chapter Two, the background and literature, presents detail regarding the 
theoretical framework, models of dyspnea, issues of dyspnea assessment, and a brief 
background on traditional Chinese medicine, acupuncture, and acupressure. Chapter 
Three, the methods section, presents the research design, the sample, data collection 
procedures, measurement, the experimental procedure, and data analysis. 
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Chapter 2 Background and Literature Review 
The purpose of this research was to conduct a pilot feasibility study regarding 
evaluating the effects of Auricular acupressure on dyspnea in hospice lung cancer 
patients. This literature review will provide a critique and synthesis of the current 
knowledge regarding dyspnea. The theoretical framework guiding this study will be 
described and critiqued along with a presentation of efforts to describe and understand 
dyspnea, followed by an analysis of alternative models of dyspnea. The instrument that 
was used to assess dyspnea in this study will be presented and placed within the context 
of a description of critiques of alternative instruments for measuring dyspnea. Finally, a 
description of the basis for Chinese medicine will be presented along with acupuncture 
and acupressure as medical treatments. 
Theoretical Framework 
Symptom Management Model (RSMC) 
The UCSF School of Nursing Symptom Management Faculty Group's Model for 
Symptom Management was used as the conceptual framework for this study (Larson, et 
al.l994a, 1994b; Dodd et al, 2001). Interestingly, after this model was proposed in 2005 
for this research, the researcher found that later another doctoral student adopted this 
same model for her study of dyspnea in patients with lung cancer under palliative care (I. 
Henoch, personal communication, February 11,2008; Henoch, 2007). The model's 
broad perspective of symptom management includes three dimensions: symptom 
experience, symptom management strategies, and symptom outcomes. See Figure 1 for a 
schematic diagram of the RSCM Model (Dodd et al, 2001). As Dodd et. al. (2001) state, 
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"Healthcare providers have difficulty developing symptom management strategies that 
can be applied across acute and home-care settings because few models of symptom 
management have been tested empirically" (p 669). The RSCM model is a generic 
symptom management model that can provide direction for "selecting clinical 
interventions, informing research, and bridging an array of symptoms associated with a 
variety of disease and conditions" (p. 669). The model also has as its base, the nature of 
the individual's experience of the symptom. 
Dyspnea as Symptom 
Many advanced cancer patients avail themselves of hospice services. For hospice 
care patients, symptom management is one of the central goals of treatment. Dyspnea is 
one of the most important symptoms. Dyspnea is also less frequently controlled well 
than other symptoms including the symptom of pain (Higginson & McCarthy, 1989). 
Interestingly the model of assessment of dyspnea is the assessment of pain (Matzo et al. 
2001). 
When asked what his experience of breathlessness was like, one patient reported 
that the dyspnea sensation was like "being at the bottom of a swimming pool, struggling 
but unable to reach the top to breathe" (Dudgeon & Rosenthal, 1996). Asking the patient 
what he or she experiences is crucial in evaluating dyspnea, since dyspnea is a sensory 
experience perceived and interpreted by the patient (Widimsky, 1979; Carriere-Kohlman, 
Janson-Bjerklie, & Jacobs, 1984; American Thoracic Society, 1999; Dodd et al., 2001). 
Indeed, symptom experience is one of the three dimensions in the RSMC Model (Dodd et 
al. 2001). Within the model, the person is viewed as central, with the person's symptom 
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experience itself having three components: (1) perception of the symptom (a change in 
sensation); (2) evaluation of the symptom (interpretation); (3) response to symptom. 
Researchers and clinicians have attempted to define dyspnea through various 
metaphors (American Thoracic Society, 1999). These include such descriptions as "an 
uncomfortable sensation of breathing" (Mahler & Schwartzstein, 1995); "the sensation of 
feeling breathless or experiencing air hunger" (Simon, Schwartzstein, Weiss, LaHive, 
Fencl, Teghtsoonian, & Weinberger, 1989); "difficult, labored, uncomfortable breathing" 
(Wright & Branscomb, 1954); and "awareness of respiratory distress" (Wasserman & 
Cassaburi, 1988). These attempts at descriptive definition mix symptoms (what patients 
report they are feeling) and physical signs (what a physician or nurse observes about the 
patient such as the patient exhibiting labored breathing). It is important to remember that 
only the person who is experiencing a symptom can describe it. 
Even though it is the patient who describes a symptom that is experienced, it is 
possible to generate a more general definition of dyspnea while preserving the necessary 
attribute of it being a subjective experience. The American Thoracic Society offered this 
broad definition (1999): "[W]e suggest that dyspnea is a term used to characterize a 
subjective experience of breathing discomfort that consists of qualitatively distinct 
sensations that vary in intensity. The experience derives from interactions among 
multiple physiological, psychological, social, and environmental factors, and may induce 
secondary physiological and behavioral responses." An examination of the Figure 1 
RSMC Model reveals how well the general model of symptom management and this 
broad definition of the specific symptom dyspnea agree regarding the symptom 
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experience. Both identify three components of the symptom experience: perception of, 
evaluation of, and response to symptoms. 
Given that the literature consistently presents dyspnea as a subjective symptom 
(Carrieri-Kohlman, Janson-Bjerklie, & Jacobs, 1984; Gift, 1987; Cockcroft, Adams, & 
Guz, 1989; Lenz et al, 1995; American Thoracic Society, 1999; Wilcock, Crosby, Hughs, 
Fielding, Corcoran, Tattersfield, 2002) and that it is detected only by the patient who 
reports the sensation of difficult or labored breathing, it may be helpful to examine the 
language of breathlessness. That is, how do patients describe breathlessness; what 
descriptors do they use? Importantly, in the development phase of their instrument, the 
Cancer Dyspnea Scale, Tanaka, Akechi, Okuyama, Nishiwaki, & Uchitomi (2000) 
interviewed dyspneic patients in a thoracic oncology division and palliative care unit. 
Additionally, they brainstormed with the staff of the same unit and reviewed papers on 
dyspnea. Eventually, the developmental and validation processes reduced an initial set of 
179 terms to 24 (see Appendix for these CDS items). 
There were earlier attempts to examine the language of breathlessness often using 
qualitative methods. Simon, Schwartzstein, Weiss, LaHive, Fencl, Teghtsoonian, & 
Weinberger (1989) interviewed patients with a variety of cardiac and pulmonary diseases, 
compiling a list of 19 descriptors of breathlessness. Interestingly, when the researchers 
used eight different stimuli to induce breathlessness in 30 subjects who then chose 
descriptors from the list best capturing how they felt, separate groups of descriptors 
emerged for varying stimuli. The authors surmised that the label breathlessness might 
actually apply to many different sensations. Indeed, in a follow-up study, Simon, 
Schwartzstein, Weiss, LaHive, Fencl, Teghtsoonian, & Weinberger (1990) found patients 
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were able to distinguish different sensations of breathlessness. Additionally, there was 
some association between the underlying disease and the qualitative descriptors selected. 
Elliot, Adams, Cockcroft, Macrae, Murphy, & Guz (1991) conducted a study of 
hospital staff, beginning with 18 qualitative descriptors of breathlessness discomfort from 
the Simon et al. (1989) study. They circulated the 18 descriptors among hospital staff, 
and asked for additional descriptors of the staffs respiratory sensations during exercise. 
Twelve respiratory physicians on the staff were asked to contribute descriptors used by 
patients. This generated 45 descriptors. These were then given to five senior nurses who 
recommended changes of the descriptors for greater ease of understanding by patients. 
Patients (N= 208) who described breathing troubles during walking, running, or climbing 
stairs were then given the list of descriptors and asked to rate them for agreement with 
their own sensations on two separate occasions, using response options of yes, no, or 
don't know. Some items were more consistent over time than others, but the descriptors 
did group into 12 clusters and 169 of the 208 patients were considered reliable in their 
responses over the two administrations. Again, there was an association between 
descriptors endorsed and underlying disorders. For example, chronic obstruction airway 
disease (COAD) patients were more likely to endorse distress, asthma patients to endorse 
wheeziness, restrictive airway disease patients to endorse rapid breathing, and cardiac 
patients to choose a need to sigh. A more recent study (Wilcock, Crosby, Hughs, 
Fielding, Corcoran, Tattersfield, 2002) using only 15 descriptors of breathlessness also 
found that patients with different diagnoses (six sub-groups of lung cancer diagnosis four 
sub-groups of nonmalignant cardiorespiratory disease diagnosis) were differentially 
likely to endorse the descriptors. Such relationships would support the RSMC Model in 
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that the Health and Illness domain (e.g., disease) would impact the perception of a 
symptom within the symptom experience dimension. 
It would appear that Sorenson (2001) was correct in stating, "Since this symptom 
manifests differently in each patient, it would be impossible to design a one-size-fits all 
instrument to assess dyspnea or serve as an outcome measure in dyspnea control" 
(pl331). This is echoed by Cullen & Rodak (2002) in their article assessing the clinical 
utility of breathlessness measures, which they state may have different clinical utility for 
different diagnoses. Additionally, the American Thoracic Society Consensus Guideline 
on Dyspnea (1999) directs that dyspnea assessments should be applied as related to the 
purpose for which they were designed: "Any assessment of dyspnea must take into 
consideration the question being asked. Are we trying to measure the intensity or quality 
of the sensation of respiratory discomfort or the emotional or behavioral response to the 
discomfort?" (p 322) 
An interesting qualitative methods study by Bailey (2004) was designed to 
understand the affective component of dyspnea. Their focus was on the dyspnea-anxiety-
dyspnea cycle in COPD patients' stories of breathlessness. Using 10 patient-family-nurse 
units and an ethnographic research design with in-depth interviews and narrative analysis, 
Bailey found that anxiety as manifested in a dyspnea-anxiety-dyspnea cycle for acute 
episodes was an important component of the dyspnea experience. She maintains that this 
component needs to be recognized by healthcare providers and she states that it is 
potentially measurable. Presence of anxiety related to dyspnea was also found by Bruera 
et al. (2000) who reported a correlation of .31 between dyspnea intensity and the level of 
anxiety in 135 ambulatory terminally ill patients with cancer, of whom 55% manifested 
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dyspnea. As noted below, Tanaka et al.'s (2000) Cancer Dyspnea Scale has three 
dimensions, one of which is anxiety. Also, Chiu, Hu, Lue, Yao, Chen, and Wakai (2004) 
found in their quantitative study of correlates of dyspnea in Taiwanese patients that 
anxiety again makes an appearance. This appears to be a type of convergence of findings 
between qualitative and quantitative research methods. 
Joyce (M. Joyce, personal communication, February 19, 2008; Joyce, 2006), at 
the 2006 UICC World Cancer Congress, reported her work reviewing qualitative research 
on dyspnea in search for themes regarding the experience of dyspnea beyond the simple 
description of the experience itself. She conducted a search using bibliographic 
computerized databases between 1990 and 2005. This identified nine English language 
citations for patients' experience of dyspnea being evaluated using qualitative methods. 
Joyce has not yet published this work, but she did respond to an inquiry and send 
the power point presentation that she used (M. Joyce, personal communication, February 
19,2008) wherein she stated, "Qualitative research method is primary source of 
exploring symptom experience." (2nd slide) The power point presentation also included 
the references for the nine articles (Brown, Carrieri, Janson-Bjerklie, and Dodd, 1986; 
DeVito, 1990; Roberts, Thome, and Pearson, 1993; O'Driscoll, Corner, and Bailey, 1999; 
Shih and Chu, 1999; Bailey, 2001; Bailey and Tilley, 2002; Hately, Laurence, Scott, 
Baker, and Thomas, 2003; Heinzer, Bish, and Detwiler, 2003). Using Forchuk and 
Roberts' guidelines (1993) for critiquing qualitative research, Joyce found among these 
nine articles the three qualitative methods of phenomenology, triangulation, and narrative 
ethnography. Common across these nine studies were the three themes of profound fear, 
loss of vitality, and the need to legitimize dyspnea distress. 
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RSMC Model and Dyspnea 
The use of the RSMC Model as the conceptual framework for this research is 
supported by the conceptualization of dyspnea in the research literature. The consensus 
now is that manifestations of subjective symptoms such as dyspnea are not simple 
reflections of the intensity of the mechano- and chemo-receptor level (Tanaka et al 
2002b; Ripamonti & Bruera, 1997; Bruera & Ripamonti, 1999). Moderators are thought 
to amplify or decrease perceived dyspnea intensity at the cortical level and include such 
as psychological state, cultural background, environment, and life experiences 
(Ripamonti & Bruera, 1997; Bruera & Ripamonti, 1998). These assertions are supported 
by studies that demonstrated significant relationships of dyspnea with such psychological 
states as anxiety and depression in non-cancer samples (Dales, Spitzer, Schechter, et al., 
1989; O'Connor, Rablin, & Morgan, 1996) and anxiety in cancer patients (Bruera & 
Ripamonti, 1998; Dudgeon & Lertzman, 1998). Dyspnea has also correlated with such 
demographic factors as sex and age in non-cancer patients (O'Connor, Rablin, & 
Morgan, 1996; Gijsbers Van Wijk & Kolk, 1997; Metlay, Schulz, Li YH, et al., 1997). 
Environmental factors such as exposure to asbestos, coal dust, cotton dust or grain dust 
were also related to presence of dyspnea (Dudgeon et al. 2001). 
Dyspnea is a complex symptom, from its lack of systematic reflection of 
underlying causes, to its multi-dimensionality, to its manifestation being related to the 
individual, the environment, and the health or illness status of the person. One way to 
organize this complexity and to generate strategies or guidelines for research and clinical 
practice would be to conceptualize dyspnea within the RSMC Model. 
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This RSMC model for symptom management is an evidence-based conceptual 
model that has the three basic dimensions of (1) symptom experience, (2) symptom 
management strategies, and (3) outcomes. Within the model, consistent with the 
literature on dyspnea, "a symptom is defined as a subjective experience reflecting 
changes in the biopsychosocial functioning, sensations, or cognition of an individual" 
(Dodd et al. 2001, p. 669). The model describes the interrelatedness of the three basic 
dimensions within the three domains of nursing science (1) person domain, (2) health & 
illness domain, and (3) environmental domain. Again, consistent with dyspnea literature, 
within the symptom experience dimension, there are three sub-dimensions of (1) 
perception of symptoms, (2) evaluation of symptoms, and (3) response to symptoms. See 
Figure 1 above or Appendix A for a graphic schematic of this model. 
The RSMC Model is based on five assumptions: (1) the gold standard for 
understanding and studying symptoms is the perception of the individual experiencing 
the symptom and the individual's report of the experience; (2) the symptom need not be 
experienced by an individual in order for the symptom management model to be applied, 
since the individual can be at risk for symptom development from the impact of a context 
variable such as a work hazard, and intervention strategies can be initiated before the 
symptom is experienced by the individual; (3) nonverbal patients such as infants or post-
stroke aphasic individuals may experience symptoms where the interpretation by a parent 
or caregiver is accepted as accurate for intervention purposes; (4) the target of 
management strategy can be the level of the individual, group, family, or work 
environment; (5) symptom management is a dynamic process in that it is modified by 
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individual outcomes and the influences of the three nursing domains of person, 
health/illness, and environment. 
Congruent with the RSMC Model and the dyspnea literature, Bruera and 
Ripamonti (1998) and Ripamonti (1998) recommended that a scale to measure dyspnea 
for investigating etiology and establishing therapeutic strategies should have six 
characteristics: (1) be multidimensional; (2) be self-rating since dyspnea is subjective; 
(3) be easy and simple enough to be completed by patients with dyspnea; (4) be evaluated 
not by physical effort evoking dyspnea, but by perceived dyspnea itself so that even 
bedridden patients can complete it; (5) have its reliability and validity in cancer patients 
confirmed; (6) be sensitive to clinical changes due to treatment or progression of the 
disease over time. 
Early Organizational Models of Dyspnea 
Review of dyspnea models other than the RSMC Model not only provides an 
historical perspective of the field, but also identifies the common components of a set of 
models. In addition, this review will assist the reader in understanding the RMSC Model 
itself, since it is the inheritor and improver of models developed over the last two 
decades. 
Interestingly, the first and second researcher names attached to models of dyspnea 
are names that reappear and are associated with more than one model. The first name is 
Virginia Carrieri-Kohlman, D.N.Sc, R.N. The second name is Audrey G. Gift, Ph.D., 
R.N. The field of nursing can thus lay-claim to the first models of dyspnea. 
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Carrieri-Kohlman Dyspnea Variables Model 
The model by Carrieri-Kohlman and colleagues (Carrieri-Kohlman, Janson-
Bjerklie, & Jacobs, 1984) was intended as a means to begin organizing the broad range of 
phenomena related to the complex construct of dyspnea. It was thus more a listing of 
categories of dyspnea phenomena than the more dynamic models that would emerge over 
time. Still, anyone who has attempted to grasp the literature surrounding any concept, 
including those of different clinical symptoms, can appreciate the immense step it is to 
present a way of organizing that material. The only name these researchers gave to their 
model was "Variables Related To Dyspnea" (Carrieri-Kohlman et al. 1984, p 443). 
Importantly, dimensions and components of later models can already be seen in 
this heuristic organizing of variables related to dyspnea. The three general domains of 
variable listing echo through later models: personal, health status, and situational. These 
domains were conceptualized as being related to two groupings of amelioration 
strategies: patient coping strategies and self-care behaviors, and therapeutic management 
strategies. Finally, these two strategies were organized as related to dyspnea itself with 
three areas: description, mechanisms, and measurement. The model, as do all other 
models, assumes dyspnea, like pain, to be a sensory experience of the individual. 
Although providing direction for studying dyspnea risk factors, the model is 
limited to the description and measurement of dyspnea. The grouping of some of the 
factors could be differently conceptualized. For example, some of the variables such as 
health status could be considered outcomes or consequences of dyspnea, and a bi-
directional causal path between dyspnea and such variables would better capture what 
probably does take place. Still, although dynamics were not presented in this listing of 
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phenomena, the authors were cognizant of the complex relationships among these 
variables. They ended their paper with this statement: "The obviously complex, 
multivariate relationships of all these factors and dyspnea need to be acknowledged in 
systematic study of this significant clinical symptom" (p. 443.) 
Gift Five Elements Model 
The next major model of dyspnea was that of Gift (1987, 1990a). This model, 
like that of Carrieri-Kohlman's was still a template for organizing dyspnea related 
phenomena. It was a framework with five components (Gift, 1990a), that McCarley 
(1999) has described as a kind of pie chart of elements. The five components were: (1) 
the sensation of dyspnea (physiological component), mediated or activated by sensory 
receptors and the central nervous system; (2) the perception of dyspnea (cognitive 
component) with interpretation of the sensation and affected by past experience and 
present expectation; (3) the distress of dyspnea (psychological component) characterized 
in psychoemotional terms and include the psychological correlates of dyspnea; (4) the 
response to dyspnea encompassing coping style and strategies used by the individual; (5) 
the reporting of dyspnea (social component), including the descriptors used and the 
decision to report the experience or not. 
The Gift model incorporated dimensions or domains that will be reflected later in 
more complex, dynamic models. These included such dimensions as the physiological, 
the psychological, the person (cognitive), behavioral, and social. Gift's model presented 
a holistic representation of the dyspnea experience. The model is limited in that it does 
not address risk factors for dyspnea, precipitating factors, or consequences for the 
individual. Nonetheless, as with the organizing model of Carrien-Kohlman, one can see 
the precursors of important elements of the later, more complex, dynamic models. 
Later Dynamic Models of Dyspnea 
Following Carrieri-Kohlman and Gift, there were a series of models focused on 
different aspects of dyspnea, although the aspects are usually placed within a larger 
conceptual framework. These larger frameworks were all quite similar in being multi-
dimensional, having psychological and physiological components, placing the person in 
some setting (environment, social, life context), and delineating some relationships 
among model components. 
Steele and Shaver Person-Environment Model 
For example, Steele and Shaver (1992) offered a person-environment ecological 
framework wherein they conceptualized dyspnea as a nociceptive (body part damage) 
phenomenon, and took into account biopsychosocial factors that affect dyspnea. This has 
also be labeled an ecologic model of dyspnea because the authors presented dyspnea as a 
biopsychosocial phenomenon. Although these researchers had a multi-domain model 
and they did have dynamic relationships among elements of the model (i.e., feedback 
loops), the schema and the relationships among model elements are often difficult to 
track or interpret. Also, their focus was on perceptual sensitivity, defined using 
magnitude estimation procedures. They did provide a quantifiable estimate of sensitivity 
to dyspnea generating stimluli [Mathler, Rosiello, Harver, Lentine, McGovern, & 
Daubenspeck, 1987). 
Breslin, Roy, and Robinson's Physiological Model 
Breslin, Roy, and Robinson (1992) also presented a large framework, but their 
focus was on the role of the respiratory pump and respiratory muscle function as the basic 
process contributing to dyspnea. Still, their integrated metaparadigm conceptualized 
basic nursing science as the understanding of the life processes and clinical science as 
diagnosis and treatment. This Breslin et al. metaparadigm is similar to the Carrieri-
Kohlman, Lindsey, and West (1993) general framework of selected biological and 
psychosocial life processes along with use of pathophysiological concepts. In both of 
these models, dyspnea is understood as an alteration in the normal life process of 
sensation. Indeed, Carrieri-Kohlman, Lindsey, & West (1993) used these general 
frameworks to propose a treatment of dyspnea distress based on the idea of 
desensitization, a concept also found in the model of Steele and Shaver (1992) discussed 
above. Hence, such models can lead to development of treatment possibilities. 
McCord and Cronin-Stubbs Mediation Model 
McCord and Cronin-Stubbs (1992) also presented a larger model of dyspnea with 
domains of antecedents, mediators, reactions, and consequences or outcomes. Dyspnea 
was seen as a multi-dimensional disorder where physiologic and psychogenic antecedents 
were mediated by culture, environment, perception, and psychological status to yield the 
reaction of dyspnea sensation. This model presented three areas of consequences: 
resolution (patient takes action that resolves the dyspnea sensation); adaptation (patient 
takes action that mediates dyspnea but does not completely resolve it); and no response 
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(where the action has no effect on dyspnea, either the intensity or duration). Hence, 
within this framework, coping strategies and management were seen as changing the 
degree of dyspnea instead of affecting the consequences of dyspnea on quality of life of 
the person. Most of the models developed up to when this model was presented did not 
address the impact on quality of life. 
The particular focus of the McCord and Cronin-Stubbs (1992) model was actually 
on measurement. Indeed, the authors grouped a variety of assessments of dyspnea and 
dyspnea related phenomena under the four domains of their model: antecedents, 
mediators, reactions, and consequences of dyspnea. Hence, McCord and Cronin-Stubbs 
(1992) and their model will be re-visited below in the sub-section on dyspnea assessment. 
West and Popkess-Vawter ModifiedZelechowski Action Model 
The next model of interest is that of West and Popkess-Vawter (1994), which was 
an adaptation of an earlier Zelechowski (1977) model of breathlessness that had 
physiological and psychological dimensions. The focus of the Zelechowski model was 
on the response or reaction to dyspnea, the actions taken in the presence of dyspnea. 
Individuals were conceptualized as having different actions such as anxiety, anger, and 
exercise, or having or non-action such as sleep, depression, or apathy. These actions in 
the presence of dyspnea were hypothesized to, in turn, influence dyspnea. Hence, there is 
a dynamic aspect to the Zelechowksi model, the presence of feedback loops. Although 
the focus of the model was on reactions to dyspnea, the model did also include dyspnea 
antecedent conditions such as degree of perceived threat and/or physiological changes. 
In their modification of the Zelechowski model, West and Popkess-Vawter (1994) 
expanded the list of antecedent conditions. They also added positive and negative 
adaptive responses as outcomes. The focus of the adapted model was still on the type of 
actions taken in the presence of dyspnea. 
Campbell Antecedent-Response Model for Terminal Diseases 
Campbell (1996) developed a model focused on dyspnea in patients with terminal 
diseases and offered schema for describing the relationships between antecedents of and 
response to dyspnea. Even more specifically, the focus was on those patients who 
refused intubation or ventilation. Still, even with such specific focus for a model, it had 
some of the same general features found in nearly all models developed to describe 
dyspnea. These included the elements of antecedents and reactions to dyspnea. There 
were also physiologic versus psychogenic categories for grouping dyspnea both 
antecedents and reactions. Physiologic antecedents were those conditions likely to 
increase the work or breathing (including cardiac, pulmonary, and neuromuscular 
disease) and physiologic reactions included tachypnea, tachycardia, use of accessory 
muscles, and tidal volume changes. Psychogenic antecedents included those that 
Campbell identified as having no physiologic source (including anxiety, anger, and 
depression) and psychogenic reactions included panic, fear, frustration, anger, and 
anxiety. Hence, some possible emotional states were also among possible antecedents. 
Interestingly, research has not supported the relationship between the either the 
physiologic antecedents or some of the-physiologic reactions identified in the model and 
dyspnea in patients with COPD (McCarley, 1999). Also depression is not likely to be an 
antecedent for dyspnea and is more likely a consequence. 
McCarley Chronic Dyspnea Model 
Although temporally McCarley's (1999) model of chronic dyspnea came after 
that of either the model of unpleasant symptoms described below or the initial version of 
the symptom management model (Larson et al, 1994a, 1994b) described above in its 
revised form (Dodd et al, 2001), it is basically an add on for these more general models. 
In her review of what had come before her own model, McCarley did cite and describe 
the unpleasant symptom theory, but she did not present a description of the initial version 
of the symptom management. 
As the title clearly states, McCarley's (1999) model focused on chronic dyspnea 
as opposed to acute dyspnea, and given the nature of chronic versus acute dyspnea, the 
primary focus of her model was on the consequences of chronic dyspnea.. Her primary 
criticism of other models was that they did not differentiate between acute and chronic 
dyspnea. Gift (1987), who has been involved in the development of models, did at least 
differentiate between acute dyspnea as having rapid onset, and chronic dyspnea as being 
persistent over time but with the intensity changing. McCarley did point out that within a 
model, one would want to identify differences for acute versus chronic dyspnea. For 
example, the emotional responses to chronic as opposed to chronic dyspnea might be 
expected to be quite different. 
Although McCarley states that'her purpose was to propose a new model of 
chronic dyspnea to guide care and evaluation of chronic dyspnea in patients living with 
31 
COPD, she did place her own model within the then developing concept of dyspnea as 
multi-factorial. She also delineated three components of a model of chronic dyspnea 
(physiologic, the symptom dyspnea, and consequences). Although her model did have 
three components, her interest here in chronic dyspnea led to an emphasis of the 
consequences of dyspnea rather than its antecedents. The structure of her model was is 
similar to that of Campbell's (1996), but she noted that there was only a minor focus on 
dyspnea antecedents. Also she did not use psychogenic stimuli as antecedents in her 
model but rather as sequelae of living with the persistent distress of chronic dyspnea. 
Finally, McCarley described consequences as also multi-factorial and having dimensions 
of the physical, psychological, and socio-cultural. She noted that, unlike other models of 
dyspnea McCarley did not place the sensations of fear and panic as consequences of 
acute dyspnea. Here, one can see how particular models will lead to different emphasis 
and, hence, guidelines for research and clinical practice. 
Theory of Unpleasant Symptoms Model 
Lenz, Suppe, Gift, Pugh, and Milligan (1997) offered a model that attempted to 
describe unpleasant symptoms generally. This model was briefly presented above as an 
exemplar of a middle-range theory. Labeled the "Theory of Unpleasant Symptoms," this 
model was developed from research on dyspnea in populations of COPD and asthma 
patients, and research of fatigue during intrapartum and postpartum periods. As many 
researchers of dyspnea have done, pain was used as a general analogue. Dyspnea was 
presented as having both physiological or sensory and psychological or cognitive 
dimensions. The psychological or cognitive attributes of dyspnea were seen as similar to 
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the distress components of pain. Importantly, as part of the process of identifying 
fundamental features of dyspnea, the same individuals were evaluated at times when they 
and did not have dyspnea. In a series of studies (Gift, 1990b, 1991; Gift, Plaut, & Jacox, 
1986), psychological (cognitive) or distress attributes of dyspnea were demonstrated to be 
similar to pain. These attributes of dyspnea were also found in these studies to be related 
to anxiety, somatization, and depression). 
Consistent with the emerging basic understanding of dyspnea and unpleasant 
symptoms, the Theory of Unpleasant Symptoms included three dimensions of 
antecedents of unpleasant symptoms affecting an individual's predisposition to or 
manifestation of the symptom. These three familiar dimensions were physiological, 
psychological, and situational. They were also understood to affect the characteristics of 
the symptom as well as performance variables (physical performance, functional status, 
and cognitive functioning) affected by the symptom. 
Specific to dyspnea and consistent with all other theorists, researchers and the 
general literature, Lenz et al (1996) conceived of dyspnea as a subjective symptom rather 
than an object sign. They pointed out that dyspnea could be detected only in the patient 
who reported the sensation of labored or difficult breathing. Through observation others 
could identify labored breathing, but only the patient experienced the sensation of labored 
breathing. Hence, these authors clearly stated that dyspnea must not be confused with 
rapid respiratory rate, deep breathing, or other signs of respiratory distress. Supporting 
the conceptualization of dyspnea as a sensation, Wolcove, Dajcxman, Colocone, and 
Kriesman (1989) demonstrated the lack of a consistent relationship between pulmonary 
function and dyspnea. 
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In summarizing their own synthesis of the literature and their basic concept of 
dyspnea, Lenz et al (1995) presented dyspnea as an unpleasant symptom having five 
components. These were the same five components of dyspnea explicated in Gift's 
(1990a) pie chart model for organizing dyspnea phenomena presented in more extended 
description above. In brief, these five components are: (1) the sensation of dyspnea; (2) 
the perception of dyspnea; (3) the distress of dyspnea; (4) the response to dyspnea; (5) the 
reporting of dyspnea. Lenz et al (1995) noted that one could consider these components 
as the domains of the concept of dyspnea. They also concluded that dimensions of the 
dyspnea variable would include duration, strength or intensity, degree of distress, and 
quality. 
Here, then, is a middle range theory or model of dyspnea, and unpleasant 
symptoms generally, that is based on research and a synthesis of the literature, uses 
dyspnea as one of the two unpleasant symptoms evaluated in leading to the model, 
incorporates the basic domains and dimensions identified in the literature as part of the 
concept of dyspnea, and can be heuristic in providing guidelines for research and clinical 
practice. 
It is interesting that this middle-range theory of unpleasant symptoms with its 
summary of the field, use of dyspnea as an primary example of an unpleasant symptom, 
capturing of the multi-factorial nature of symptoms including dyspnea, and ability to 
guide research and practice emerged at about the same time as the RSMC Model that also 
used literature on dyspnea as a source of information for model development. There are 
different foci within these two models that are captured by their titles. The unpleasant 
symptoms model is focused on describing unpleasant symptoms while the RSMC Model 
is focused on general symptom management. Still, although the two models also use 
some different labels for elements of the models and use some element labels differently, 
both are evidence based, both see dyspnea as a symptom as subjective and multi-
dimensional, with antecedents and outcomes that are also multi-dimensional, and both 
identify the issue of the operationalization or assessment of a symptom as being of 
primary importance. 
Conceptual Models and Measurement 
Conceptual models are touted as guiding researchers to, among other things, 
develop better assessments. It is also true that the development of measurements led to 
modification of models or the development of new models (Scott, 2004). This happens in 
all areas of science. If you can now measure something that you could not earlier, then 
you will learn new things about that which is measured. An example in the field of 
dyspnea would be the use of visual analogue scales to capture a subjective experience 
(Hayes & Patterson, 1921) and later measure "feelings" (Aitken, 1969) and pain 
(McDowell & Newell, 1996), and later still to measure dyspnea (Adams, Chronos, Lane, 
& Gjuz, 1985; Gift, 1989; Wilson & Jones, 1989; Muza, Silverman, Gilmore, Hellerstein, 
& Kelsen, 1990). Eventually, such scales were used to demonstrate that patients could 
differentiate between their experience of shortness of breath and their anxiety regarding 
that shortness of breath (Carrieri-Kohlman, Gormley, Douglas, Paul, Stulbarg, 1996). 
One could, as does Scott (2004), consider this effort of Carrieri-Kohlman et al. 
(1996) as presenting a model for management of dyspnea that considers the fear and 
panic involved and suggesting that desensitization would be an appropriate intervention. 
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Indeed, exactly this is recommended in a later Carrieri-Kohlman article (Carrieri-
Kohlman, Gormley, Eiser, Demir-Deviren, Nguyen, Paul, and Stulbarg, 2001). The 
development of tools affects the development of our perception of the phenomena that we 
find of interest. Partially because there were instruments that allowed the differential and 
independent measurement of patients' experiences of the sensation of dyspnea as 
opposed to their experiences of the affective components of dyspnea, these authors could 
hypothesize that and test whether patients could differentiate between the experience of 
the sensation versus that of the affect. This work then led to a recommended intervention 
for dyspnea, desensitization. 
It seems appropriate that this general review of models of dyspnea ends where it 
began, with the researcher and nurse, Virginia Carrieri-Kohlman. 
Assessment Instruments 
There are many instruments for measuring dyspnea. However and importantly, 
Spector and Klein (2001) state the necessity of more sensitive instruments for assessing 
dyspnea in critically and terminally ill patients. Also Bruera and Ripamonti (1998) and 
Ripamonti (1998) provided recommendations for any scale measuring dyspnea for 
investigating etiology and establishing therapeutic strategies: (1) be multidimensional; 
(2) be self-rating since dyspnea is subjective; (3) be easy and simple enough to be 
completed by patients with dyspnea; (4) be evaluated not by physical effort evoking 
dyspnea, but by perceived dyspnea itself so that even bedridden patients can complete it; 
(5) have its reliability and validity in cancer patients confirmed; (6) be sensitive to 
clinical changes due to treatment or progression of the disease over time. 
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The Cancer Dyspnea Scale 
In this research, the scale for assessing dyspnea was the Cancer Dyspnea Scale 
(CDS). It was developed using patients with cancer, has been used in studies with 
advanced lung cancer patients (Tanaka et al. 2002b), and, because of its simplicity, is 
feasible for use with hospice lung cancer patients. The CDS also meets the six criteria of 
Bruera and Ripamonti (1998) and Ripamonti (1998) stated above. In the text above, it 
was mentioned that I. Henoch (personal communication, February 11,2008) had adopted 
the same theoretical framework for her doctoral work as was here. Additionally, she also 
chose to use the CDS in her research. 
The CDS (Tanaka et al. 2000) is a brief, self-reporting scale designed to measure 
dyspnea's multidimensional nature. It assesses three dimensions: sense of effort 
(Dyspnea Effort), sense of anxiety (Dyspnea Anxiety), and sense of discomfort (Dyspnea 
Discomfort). Although the authors note that the CDS can also yield a total score 
(Dyspnea Total), the three factors are correlated with each other at only moderate levels 
(.27, .30, and .55). Hence, the factors can be interpreted as reflecting the 
multidimensional nature of dyspnea. There is no evaluation of physical function evoking 
dyspnea since the authors did not want to limit the sensitivity of the instrument when it is 
used with bedridden patients. The items can be read aloud and the patient can respond 
with a number from the 5-point scale, if the terminally ill patient cannot read the items or 
use a pencil to respond to them. 
The CDS reflects well the RSMC Model in that it is a multi-dimensional 
assessment of symptom experience. The three factors of the CDS can be conceptualized 
as capturing the RSMC Model's three dimensions of symptom experience. Sense of 
effort is recognition or perception of the presence of the symptom of dyspnea. Sense of 
discomfort is the evaluation of the symptom, including an evaluation of threat. Sense of 
anxiety is a response to the symptom. Additionally, Tanaka, Akechi, Okuyama, 
Nishiwaki, & Uchitomi (2002b) state, "The manifestations of subjective symptoms have 
recently come to be interpreted as resulting from the interaction of production, 
perception, and expression, not as a direct representative of the intensity of the 
production of the dyspnea at the mechano- and chemo-receptor level" (p 491). This is 
certainly consistent with the RMSC Model, as the study of these researchers described 
below. 
Tanaka et al. (2002b), a study looking at the correlates of dyspnea in advanced 
lung cancer patients, used the CDS to measure dyspnea. Congruent with the RMSC 
model, they not only conceptualized and measured dyspnea as a multi-dimensional 
construct, but they evaluated how dyspnea was related to a broad range of medico-
psycho-social factors. The medical factors included clinical stage, performance status, 
oxygen saturation levels, organic causes of dyspnea, and other symptoms such as cough 
and pain. The psychological factors included anxiety and depression, while the social 
factors included education, marital status, and existence of confidents. Multiple 
regression analysis demonstrated that psychological distress, presence of organic causes, 
cough, and pain were significantly related to dyspnea (R2 = .30, p < .05). The study 
confirmed that dyspnea is multi-dimensional and that the intervention for psychological 
distress and pain could be a beneficial therapeutic strategy. 
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Other researchers are now also using the CDS, including versions that are being 
translated into other languages. For example, Henoch, Bergman, and Gaston-Johansson 
(2006) translated the CDS into Swedish and evaluated its psychometric properties on a 
Swedish sample of 99 patients with advanced lung cancer. Using Cronbach's alpha, they 
reported that the CDS internal consistency was excellent with a coefficient range of .81 to 
.90. Convergent validity was evaluated through correlations of the CDS with measures 
of discomfort and both physical and emotional function (r = .34 to .57) as well as with 
other measures of dyspnea (r = .63 to .68). Interestingly, the researchers reported that the 
CDS was better at assessing dyspnea's psychological dimension than was the VAS-D 
(Visual Analog Scale for Dyspnea). Finally, the researchers report that factor analysis of 
the CDS items yielded the expected three dimensions of effort, anxiety and discomfort. 
Further they report that these CDS factors correlated as expected with specific other 
instruments as well as related-factors from other instruments. 
For evaluating effects of therapeutic interventions, an important attribute of an 
assessment of dyspnea would be responsiveness. That is, is the instrument capable of 
detecting expected changes? The CDS was used as part of a study of the effect of 
nebulized furosemide on dyspnea in end of life cancer patients. The CDS was given 
before and 60 minutes after inhalation. The researchers found that the CDS demonstrated 
a significant change in the total dyspnea score from before to after inhalation as well as 
significant changes in both sense of effort and sense of anxiety (Kohara, Ueoka, Aoe, 
Maeda, Takeyama, Saito, Shima, and Uchitomi, 2003). 
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Other Dyspnea Measuring Instruments 
At the end of the section on dyspnea models above, the relationship between 
theory and measurement was briefly discussed. This relationship is also illustrated by the 
area of work that could be labeled the language of breathlessness. This area of thought 
and research was described above in the section on models of dyspnea. It could as easily 
have been placed here under assessment. It will again be described more briefly below. 
There are four categories of mechanisms of dyspnea (Carrieri-Kohlman, Janson-
Bjerklie, & Jacobs, 1984): (1) stimulation of afferent intrapulmonary receptors; (2) 
increased sensitivity to changes in ventilation perceived via central nervous system 
mechanisms; (3) reduced ventilatory capacity or breathing reserved; (4) stimulation of 
neural receptors in the musculature of the intercostals and diaphragm and of receptors in 
skeletal joints. However, the mechanisms are not well understood and there is no general 
theory explaining dyspnea's physiologic basis completely (Carrieri-Kohlman, Janson-
Bjerklie, & Jacobs, 1984; Sassi-Dambron, Eakin, Ries, & Kaplan, 1995). 
There is also no general agreement about the appropriate method for measuring 
dyspnea (Sassi-Dambron, Eakin, Ries, & Kaplan, 1995; Eakin, Kaplan, & Ries, 1993). 
The lack of a complete understanding of the underlying causes of dyspnea and the lack of 
a consistent and systematic relationship between the assumed physiological substratum of 
dyspnea and patient reporting of dyspnea as well as the lack of consistent, observable 
signs and the subjective experience of dyspnea do raise the question of how one would go 
about measuring dyspnea. As with everything else connected to dyspnea, the attempts to 
measure it have been multi-factorial. This is not to maintain that all measurements 
assumed a multi-dimensional nature of dyspnea, but that the efforts at measurement have 
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addressed many different aspects of the phenomenon. Additionally, the aspect chosen for 
assessment depended upon the research question at the time ranging from assessing the 
breath effects of exercise in normal subjects to evaluating the multi-dimensional nature of 
dyspnea in cancer patients. 
Efforts to develop measurements for dyspnea and its different aspects have 
employed different techniques of assessment. These ranged from in-depth interviews to 
simple visual analogue scales, from retrospective reports of impact of breathlessness to 
current descriptions of a symptom being immediately experience, from listing or 
checking off descriptors of breathlessness to the use of psychophysiological magnitude 
estimation, from signal factor to multi-dimensional scales, the history of the assessment 
of dyspnea is a complex one, the number and range of attempts is enough to take one's 
breath away. Table 1 presents an alphabetic listing of instruments for measuring 
dyspnea. Such simple listings are helpful but not a complete answer. As models for 
dyspnea itself, some approach to organizing the assessments of dyspnea is needed. 
















Extensive information on antecedents 
and mediators, including respiratory 
symptoms 
0-4 scale ADL, also called 5-level SOB 
or GBS [see below]; similar to the 
MRC 
8 5-item self-report on 1 to 7 point scale 
from as active as ever to have omitted 
entirely with 4 sub-scales 
Interviewer scored 0-12 for BDI related 
to magnitude of work, activities, effort 
related to breathlessness. TDI assesses 
change scored -9 to +9 ADL 
Psychometrics & Appraisal 
Lacking documented 
psychometric rigor; does not 
assess changes over short 
time periods 
Psychometric properties not 
well established; reliability 
not documented-
No published data on 
reliability or validity 
Good reliability and validity 
with psychometrics well 
established for range of 












Hyland et al. 
1994 
CDAT 
Moody et al. 
1990 
CDS 
Tanaka et al. 
2000; Tanaka 
et al 2002a, 
2002b 
CRQ 







Tanaka et al 
2002a 
DOB 
Simon et al. 
1989 
89 item self-report checklist with 
dyspnea one of 11 categories 
0-10 scale [no dyspnea to maximal 
dyspnea]; was modified from earlier 
15-point rating version. Used to assess 
reactions during exercise. 
33 items & 13 domains such as waking, 
bending, bathing. 27 items for 
'problem score.' 
A general assessment tool that includes 
evaluation of dyspnea 
Self-report 12-item, 3 factor (effort, 
discomfort, anxiety), scale using 5-
point scale from not at all to very much 
20 items, 4 domains of dyspnea, 
fatigue, mastery, emotion with each 
scored 1-7 for severity of dyspnea 
Comprehensive & qualitative 
information on experience with living 
with dyspnea, 48 items & 2 sections: 
Shortness of breath (SOB) & impact of 
SOB on ADL 
0 ["no dyspnea"] to 10 ["as bad as can 
be imagined"] numeric scale of global 
dyspnea; the DNS is very similar to the 
NRS, but Tanaka et al 2002a do not 
reference the NRS 
19-item self-report questionnaire 
developed on pulmonary and cardiac 
patients with breathlessness and 
healthy college students with induced 
breathlessness 
patients 
Acceptable to high internal 
consistency reliability for 10 
categories, but not for 
dyspnea. 
Reasonable test-retest 
reliability and concurrent 
validity, but needs to be 
tested with larger samples; 
can discriminate between 
patients' perceived shortness 
of breath 
Good test-retest reliability 
and construct validity; 
developed for clinical trials 
Good content & concurrent 
validity; good internal 
consistency; needs testing 
applicability for clinical 
practice & research 
Good reliability, concurrent 
validity, and construct 
validity; good for clinical 
trials and sensitive to 
change; can discriminate 
between patients' perceived 
shortness of breath 
Good test-retest & internal 
consistency reliability and 
concurrent validity; needs be 
evaluated on larger samples 
No documentation of 
psychometric properties; 
long & not practical for large 
samples or for routine use 
Good test-retest reliability 
and convergent validity with 
the CDS 
Good test-retest reliability 
and construct validity; needs 
testing to determine if list of 





Stoller et al. 
1986 
ME 
















Mahler et al. 
1987 
PFSDQ 














Lareau et al. 
Same as ATS/SOB [see above] 
Interview guide with 5-point raring 
scale and 3 subscales (based on & 
similar to BDI) 
Psychophysiologic technique based on 
Steven's power law measuring subject 
magnitude of a sensation produced by 
range of physical stimulus intensities 
5-point scale grading breathlessness 
from activities that induce dyspnea to 
severe impairment ADL 
11 numbers from 0 to 10 with end 
anchors of "no shortness of breath" and 
"as bad as it can be" 
VAS 10 cm line with activities such as 
sleeping to brisk uphill walking along 
the line ADL 
164-item, intensity-related for ADLs 
33 items, self-report with 11 sections 
regarding impact on ADL [also 
reported as being a 64 items with 11 
sections (McCord & Cronin-Stubbs, 
1992). 
Interview or self-report 5-point rating 
scale from patient breath good as 
similar others to breathless on talking 
or undressing 
7-variable observation scale assessing 
respiratory distress * 
Self-report 2 section tool: [1] 6 general 
questions & a number of VAS 
Reasonable validity but 
reliability is not documented 
Like the VAS this is more a 
technique for assessment 
rather than a particular 
content assessment; reliable 
and valid but some 
questions; construct validity 
established 
Interrater reliability & 
concurrent/construct 
validity acceptable; can 
discriminate between 
patients' perceived shortness 
of breath 
Good concurrent (with VAS) 
and construct validity; in 
studies of pain NRS easier 
for patients than VAS; 
however, no reliability data 
presented in primary NRS 
article 
Reliability and validity 
acceptable; can discriminate 
between patients' perceived 
shortness of breath 
Good internal reliability and 
construct validity 
Good internal consistency, 
test-retest, and concurrent 
validity; sensitive to change 
Very little psychometric 
properties information 
available 
Good internal consistency 
and good convergent and 
discriminant validity 
Good concurrent validity, 

















1979; Gift et 
al. 1986; Gift 
1989 
measuring shortness of breath at 
different times and for different 
activities; [2] 85 activities in 4 areas 
Activities are related to dyspnea for 76 
items. Measures HRQL in 3 domains: 
symptoms, activity, impact 
Same as UCSD/SOBQ [see below] 
29 items, 4 dimensions 
Self-reported 24-item ADL related to 
breathlessness 
Horizontal or vertical 100 mm line with 
descriptive anchors at the ends [no 
breathlessness to greatest 
breathlessness]. NOTE: VAS can be 
used to assess different dimensions of 
dyspnea, e.g., intensity or affect 
information. 
Good test-retest reliability 
and criterion validity; 
developed to compare 
interventions 
Reasonable psychometrics; 
developed to compare 
interventions 
Good internal consistency 
and construct validity 
The VAS is really more an 
assessment technique than a 
content specific 
measurement; good 
reliability & validity and 
demonstrated in diverse 
samples of pulmonary 
patients; can discriminate 
between patients' perceived 
shortness of breath 
*Description of Acronyms 
ATS-DLD-78 = American Thoracic Society Standardized Questionnaire 
ATS/SOB = American Thoracic Society Shortness of Breath Scale 
ATT = Activity Assessment Tool 
BDI/TDI = Baseline Dyspnea Index/Transition Dyspnea Index 
BESC = Bronchitis-Emphysema Symptom Checklist 
BPQ = Breathing Problems Questionnaire 
BORG = Borg scale 
CD AT = Chronic Disease Assessment Tool 
CDS = Cancer Dyspnea (Dyspnoea) Scale 
CRQ = Chronic Respiratory Questionnaire 
DIS = Dyspnea Interview Schedule 
DNS = Dyspnea Numeric Scale 
DOB = Descriptors of Breathlessness 
GBS = Grades of Breathlessness Scale from American Thoracic Society 
MDI = Modified Baseline Dyspnea Index 
ME = Magnitude Estimation 
MRC = Medical Research Council Breathlessness Scale 
NRS = Numeric Rating Scale 
OCD = Oxygen Cost Diagram 
PFSDQ = Pulmonary Function Status and Dyspnea Questionnaire 
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PFSS = Pulmonary Function Status Scale 
PRUS = Pnemoconiosis Research Unit Score 
RDOS = Respiratory Distress Observation Scale 
SB AT = Shortness of Breath Assessment Tool 
SGRQ = St George's Respiratory Questionnaire 
SOBQ = same as UCSD/SOBQ 
SOLQ = Seattle Obstructive Lung Disease Questionnaire 
UCSD/SOBQ =UCSD Shortness of Breath Questionnaire 
VAS = Visual Analog Scale 
One impressive attempt to organize dyspnea assessment is found in the previously 
described model offered by McCord and Cronin-Stubbs (1992). They presented an 
overview of dyspnea assessment and used a model with the four domains of antecedents, 
mediators, reactions, and consequences or outcomes for grouping measurements. 
Nonetheless, some of the classifying was difficult to follow, although this is more due to 
the nature of the dyspnea and the instruments than any fault of the authors. For example, 
the antecedent assessments included the American Thoracic Society Standardized 
Questionnaire (ATS-DLD-78). But the ATS-DLD is an extensive questionnaire 
providing information regarding both antecedents and mediators of dyspnea. It could be 
included within both categories, and the authors so included it in both their diagram and 
text. Similarly, the Chronic Disease Assessment Test (CDAT) is an instrument based on 
a number of other tools including the Chronic Respiratory Disease Questionnaire, 
Arthritis Impact Measurement Survey, the Dyspnea Visual Analog Scale, and the ATS 
Grade of Breathlessness Scale. Hence, it winds up in all four categories of antecedents, 
mediators, reactions, and consequences. This is not to say that the McCord and Cronin-
Stubbs (1992) attempt at organizing dyspnea measures is without value. Indeed, it is an 
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excellent catalogue of measures and it helps the reader to understand what aspect or 
aspects of dyspnea each instrument assesses. 
Another approach at organizing information about dyspnea instruments is that of 
our now familiar researcher, Virginia Carrieri-Kohlman, and a colleague (Carrieri-
Kohlman & Janson, 1999). These authors did not use a model of dyspnea, and did not 
attempt to relate the many instruments to components of a model as McCord and Stubbs 
(1992) did. Instead, they simply provided four descriptive, non-dynamic categories of 
measurements of dyspnea: qualitative descriptions, intensity, affective components, and 
activities of daily living. Under qualitative descriptions, they placed much of the 
research described earlier about the language of breathlessness. This included verbal 
descriptors that may indicate types of sensations of respiration across disease states, but 
that probably reflected the pathophysiological mechanism involved (Schwartzstein & 
Cristiano, 1996). As noted earlier, different descriptors seemed to be reliably used by 
patients (Elliott et al, 1991) and used with different frequencies by patients with different 
disorders (Wilcock et al, 2002). 
Under measurement of dyspnea intensity, Carrieri-Kohlman and Janson noted the 
development of instruments that allow for the evaluation of interventions for dyspnea. 
They singled out the Visual Analogue Scale (VAS) for special consideration here. 
Originally developed for assessing subjective experiences generally (Hayes & Patterson, 
1921) and for measuring feelings (Aitken, 1969) and pain (McDowell & Newell, 1996), 
nurse researchers have validated the VAS for measuring dyspnea in chronic COPD and 
asthma patients (Gift, 1989) as well as in critically ill ventilated patients (Bouley, 
Froman, & Shah, 1999; Knebel, Janson-Bjerklie, Malley, Wilson, & Manni, 1994; Lush, 
Janson-Bjerklie, Carrieri, & Lovejoy, 1988). 
The VAS is presented as a line that varies in length with the study from 100 to 
300 mm (Carrieri-Kohlman et al, 1996; Reardon, Awad, Normandi, Vale, Clark, 
ZuWalack, 1994). The scale can be horizontal or vertical and is anchored on each end by 
descriptors. The VAS is described has having good validity and reliability (Carrieri-
Kohlman & Janson, 1999; Cullen & Rodak, 2001). It can be used to assess different 
dimensions of the same construct. 
In this grouping of intensity measures, the authors also could have included the 
modified Borg scale (1970) that was initially used to measure effects of perceived 
exertion rather than dyspnea itself. Nonetheless, the Borg scale is used to measure 
breathlessness clinically (McCord & Cronin-Stubbs, 1992). Instead of a line like the 
VAS, the modified Borg scale uses a 0 to 10 ordinal scale. Also, rather than anchor only 
the ends of the scale like the VAS does, the modified Borg scale uses verbal expressions 
of severity anchored to the numbers. The modified Borg was considered 
psychometrically superior to the original Borg since it had ratio properties and non-linear 
spacing of the descriptors (Borg, 1982). This instrument was also based on 
psychophysical principles and so was considered applicable to other areas. Hence, it is 
also used to evaluate breathlessness as well as exertion (Cullen & Rodak, 2002). Another 
scale that could be place in this same intensity category would be the Numeric Rating 
Scale (NRS) of Gift and Narsavage (1998). As reflected in its name, this scale has 
numbers (eleven of them, 0 to 10). But like the VAS, it has anchors only at the ends of 
the scale (0 = not shortness of breath and 10 = shortness of breath as bad as can be). 
Under their category of measuring affective components of dyspnea, Carrieri-
Kohlman and Janson (1999), reported the work of Steele and colleagues (Steele, Shaver, 
Hildebrandt, Schoene, Tyler, Betrus, 1991). Steele et al (1991) used the VAS for 
assessing two dimensions of dyspnea: a sensory dimension or the perceptual sensitivity to 
breathing effort and an affective dimension or the perceptual sensitivity to breathing 
discomfort. Note that these two dyspnea dimensions are among the three assessed by the 
CDS. Another study (Carrieri-Kohlman, et all, 1996) also evaluated whether patients can 
differentiate distress and anxiety associated with dyspnea. Both studies demonstrated 
that dyspnea has more than one dimension and that patients can indeed distinguish 
between them. 
The earliest clinical scale for measuring dyspnea is that Fletcher (1952) and it 
involved assessing dyspnea on a 5-point scale of grades as a function of its impact 
activities for patients with lung disease compared to age-comparable individuals without 
lung disease. A revised version of this assessment (Schilling, Hughes, & Dingwall-
Fordyce, 1955) called the Medical Research Council (MRC) scale (Fletcher CM, Elmes 
PC, & Wook CH, 1959) measured reports of dyspnea when patients were walking 
distances or climbing stairs. Although Carrieri-Kohlman and Janson (1999) do not report 
these earlier attempts, they would fall into these authors last category of dyspnea 
assessment, measuring dyspnea with activities of daily living. They do explicitly include 
in this category early work by Janson-Bjerklie, Ruma, Stolberg, and Carrieri-Kohlman 
(1987). These researchers developed the Dyspnea Interview, an open-ended 
questionnaire that included seven dimensions of dyspnea, the symptom pattern, 
management strategies used with dyspnea, family support, and education received about 
breathlessness. The focus was on activities of daily living. Other instruments that 
measure dyspnea as a function of daily activities include the University of California San 
Diego (UCSD), Shortness of Breath Scale (SOB) (Sassi_Dambron, Eakin, Ries, & 
Kaplan, 1995), the Pulmonary Functional Status and Dyspnea Questionnaire (PFSDQ) 
(Lareau, Carrieri-Kohlman, Janons-Bjerklie, & Roos, 1994), and the Pulmonary 
Functional Status Scale (PFSS) (Weaver & Narsavage, 1992). 
Another attempt at organizing assessments of dyspnea is that of Sorenson (2000). 
She ordered dyspnea instruments into three groupings: (1) activities of daily living, (2) 
exercise, and (3) health-related quality of life. She placed the MRC, UCSD/SOBQ, and 
ATS/SOB in the activities of daily living group, the Borg and VAS for the exercise 
group, and the PFSDQ for health related quality of life. Of course, including the VAS 
only under exercise, probably because that area of research was where it was initially 
developed, can be misleading. The VAS can be and is used in research that does not 
involve induction of dyspnea via exercise. 
A review of dyspnea instruments specifically regarding this use for patients with 
advanced cancer was undertaken by van der Molen (1995) and included only dyspnea 
assessment instruments covered here. She concludes that the instrument one chooses to 
use would depend on what the question is. Also, van der Molen notes that dyspnea has 
many components and is a multi-dimensional sensation, suggesting that indeed more than 
one instrument might be needed. It would also seem that the development and use of 
multi-dimensional assessments might be required. 
The last attempt to organize dyspnea assessments that will be briefly looked at 
here is that of Cullen & Rodak (2002). These authors were interested specifically in the 
clinical utility of breathlessness measures. Cullen and Rodak pointed out that dyspnea 
assessments were developed to measure breathlessness under different conditions and 
various circumstances. The choice of which instrument to use should, in part, be a 
function of the conditions and circumstances being studied. These authors grouped 
instruments under six clinical utility groupings of exercise, activities of daily living, 
benchmark, outcome, responsiveness, and clinical trials. They presented two broad 
classification dimensions of dyspnea assessments that cut across the clinical utility 
groupings, the discriminative versus the evaluative instruments. A discriminative 
instrument is one whose measures differentiate between patients, assessing individual 
differences between those who have some characteristic and those who do not. An 
evaluative instrument is one that measures change within an individual, perhaps for 
assessing change in an individual's health status or circumstances. Such instruments as 
the Borg scale and VAS are identified as discriminative while the UCSD/SOBQ and the 
PFSDQ are identified as evaluative. 
Cullen & Rodak (2002) offer an excellent overview of the issues of measurement, 
and their listing of 11 instruments is also a good resource. Additionally, the use of 
clinical utility groupings would be helpful to a researcher deciding which instrument to 
use to measure dyspnea. However, although the authors classify the VAS as a 
discriminative instrument, there is no inherent reason that the VAS could not be used for 
evaluative research purposes. Importantly, the authors report that all 11 scales have good 
validity and reliability. 
The presence of a symptom reminds us of the presence of a person. If we keep in 
mind that every time we hear of a symptom, someone, some person is telling us about 
their experience of illness. As Tenner (1996) pointed out in his book,' Whereas drugs 
and procedures target specific local problems, individual symptoms are often vague: 
headaches, fatigue, pain, digestive problems. And while X-ray and magnetic resonance 
devices at first seemed to have revealed the body's innermost secrets, now scans and tests 
all too often reveal nothing unusual. [The health care professionals] must come to grips 
with the very conception it thought it could do without: the patient as a whole system" 
(pp 47-48). 
Issues of Hospice and Palliative Care Research 
Hospice and palliative care research begins with a consideration of the unique 
patient population (Ferrell and Grant, 2001) and that, as noted by Addington-Hall (2007), 
"Palliative care is concerned with the prevention and relief of suffering . . . [and] is 
therefore by definition concerned with a sick patient group who are going to be sicker... 
[raising] concerns about whether palliative care research can ever be ethical and, if it can, 
how to conduct ethically sensitive studies." (p. 3) Terminally ill patients constitute a 
vulnerable group and research participation may be more difficult for them due to the 
presence of multi-symptoms and severe problems. 
Bruera (1994) wrote that initially palliative care programs were designed with 
only service and some teaching in mind. With the emergence of palliative care research 
has come issues of the above mentioned patient vulnerability as well as concerns about 
unstable mental status, ability to consent, response burden, measurement intrusiveness, 
dependence on health care providers, patients' limited time, use of placebos, nature of 
research design, nature of the data, subject recruitment and retention, heterogeneity of the 
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palliative care population, and involving others (hospice personnel, patients themselves, 
family caregivers) in the development of research proposals (Ferrell and Grant, 2001; 
Buss and Arnold, 2004; Ferrell, 2004; Penrod and Morrison, 2004; Storey, 2004; Wallen 
and Berger, 2004; Aoun and Kristjanson, 2005; Kaasa, Hjermstad, and Loge, 2006; 
Addington-Hall, Bruera, Higginson, and Payne, 2007). In fact, it is just such difficulties, 
particularly regarding subject recruitment (Storey, 2004) and general logistics (Buss and 
Arnold, 2004) that led, in part, to the development of this current pilot feasibility study. 
Even in the face of such concerns and challenges, both ethical and practical, 
palliative care research must be done. Indeed, given the goals of palliative care, not 
conducting research would itself be unethical. Ferrell (2004) writes, "There is no option 
to avoid research within the field of palliative care, as like all disease areas, there is a 
critical need to conduct research to advance the field. Improved care will not happen 
without inquiry." (p. 408) 
In 2007, Twaddle, Maxwell, Cassel, Liao, Coyne, Usher, Amin, and Cuny, 
reported their study on palliative care benchmarks from academic medical centers and 
noted that in the U.S., although palliative care is growing, little is still known about the 
quality of care in this area. In 1994, Bruera framed this issue as follows: " . . . one of the 
major ethical issues we must confront during the coming decade is whether we can afford 
not to make a major commitment to research in palliative care." (p 7) The coming 
decade to which Bruera referred ended in 2004, three years before the Twaddle et al. 
(2007) article. The issue of research in palliative care medicine and what forms it should 
take are still with us. 
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Although the issues in this area are still with us, there have been many calls for 
more research and a number of research approaches and responses to the challenges of 
palliative care research have been proposed and conducted. These range from the need 
for a multidisciplinary approach (Kaasa and Hjermstad, and Loge, 2006; Addington-Hall, 
2007) and the necessity of using mixed methods (Ferrell and Grant, 2001; Penrod and 
Morrison, 2004; Wallen and Berger, 2004; Aoun and Kristjanson, 2005) to designing 
studies in ways that address palliative care specific issues (e.g., use of placebos: Ferrell, 
2004; Aoun and Kristjanson, 2005; and use of skilled nurses instead of general research 
assistants: Ferrell, 2004) and close scrutiny of proposed instruments (Penrod and 
Morrison, 2004; Wallen and Berger, 2004). Regarding the recommendation for using 
skilled nurses as research assistances, Ferrell and Grant (2001) have a specific cautionary 
note about the potential conflict that nurses may have in managing their dual clinician-
researcher roles. This potential conflict should be acknowledged and the nurses helped 
with managing it. Indeed, this might be the source of productive questions for future 
research. 
It does seem that there is one area where more respect might be demonstrated 
from each side of the issue to the other side. This is the question of research methods, 
most particularly quantitative versus qualitative methodology regarding the evaluation of 
the credibility of evidence. It is unlikely that quantitative randomized control trials or 
qualitative research separately will be able to tell us all that we wish to know about 
palliative care. Krishnasamy, Corner, Bredin, Plant, and Bailey (2001), in describing 
their earlier state, "Despite including a>diverse range of instruments to measure the 
effects of the intervention, the uniqueness of individuals' experiences of breathlessness 
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were often hidden by a requirement to frame the study within a reductionist research 
approach." (p 103) Perhaps each side could become more conversant with the other 
side's frameworks and methodologies as well as recognize what each side contributes to 
the process of evaluating and understanding how we can best pursue the goals of 
palliative care. 
Regarding the general points of view in the area about appropriate methodologies, 
three studies might serve as examples of how these apparently conflicting positions can 
benefit from accepting that others might have something of value to offer as well as 
actually helping more to move the field forward. Aoun and Kristjanson (2005) make a 
strong case for the necessity of methods other than evidence-based medicine and 
randomized controlled trials. Yet they do manage to include a few straw men from the 
evidence-based side such as the studies being focused on questions that are too simple 
and using samples that are too restricted. These charges are not in and of themselves 
reasons to use other methods, since evidence-based studies should be able to ask more 
complex questions and use either a series of differentially homogenous samples or larger 
heterogeneous samples. 
Kaasa, Hjermstad, and Loge (2006) reported on their evaluation of the status of 
palliative care research in Europe over the last twenty years. Among the attributes of the 
literature that they evaluated, they listed types of methodology. They note that the vast 
majority of the studies used surveys and descriptive/observational methods and that only 
a "small fraction" of studies used randomized designs. Their response to this was to state 
that although they judged that palliative care needed to "move forward," become more 
evidence-based, and use "larger, randomized, clinical, multi-center studies on treatment, 
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treatment procedures, effects and side effects." (p. 733), they also state, "We do not 
mean, however, that other methodologies in respect to study design are of little value. On 
the contrary, we believe that palliative medicine is ideally suited for multi-disciplinary 
research with methodologies that complement each other, provided that the studies are 
conducted in a scientifically valid way." (p. 733) 
The third study here is a step in the process of addressing this last point. Bailey, 
Froggatt, Field, and Krishnasamy (2002) report on the 10-year (1990-1999) contribution 
of nursing to qualitative research in palliative care. They noted the important role that 
qualitative research plays in generating evidence for nursing practices. They also state 
that within medicine qualitative research methodologies are gaining more acceptance, 
although there are still questions about how to evaluate such research. Interestingly, the 
authors used a rigorous qualitative methodology to evaluate qualitative research. As part 
of a follow up to their large study of 138 papers from 50 journals, they used thematic 
analyses to evaluate 67 nursing papers and 29 comparison papers from areas such as 
death studies, sociology, and medical anthropology journals. In the larger earlier study, 
the authors used a procedure to assess content and quality of the papers where reviewers 
provided open-ended comments about each paper's strengths and weaknesses. These 
constituted the text that was subjected to thematic analyses in this later paper. 
The results of this study showed that 30% to 40% of the papers received positive 
comments on such dimensions as topic, quality of writing, contribution to understanding, 
and practical value. However, on the relationship between data, analysis, and findings as 
well as other methodological attributes'along with theoretical and conceptual issues, the 
papers received less than 20% positive comments. Importantly, the authors compared the 
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positive comment rates for the nursing papers to those of the comparison group. The 
comparison group papers received a higher proportion of positive comments than did the 
nursing papers: for theoretical and conceptual content the respective proportions were 
23.9% compared to 79.3%, and for contribution to understanding the respective 
proportions were 29.9% compared to 51.7%. Although these results may in part reflect 
the smaller sample for the comparison group (one is more likely to obtain larger effects in 
smaller samples), it may be that the comparison group papers were more sophisticated 
than then nursing papers. What is important here is that these authors, all nurses, were 
willing to evaluate their field and its methods in this way. 
It should be emphasized that not only is there no inherent reason not to use both 
qualitative and quantitative methods within studies, but that there have been calls for just 
this approach. This was already noted above regarding calls for mix methods (Begley, 
1996; Ferrell and Grant, 2001; Penrod and Morrison, 2004; Wallen and Berger, 2004; 
Aoun and Kristjanson, 2005; Williamson, 2005). Both Begley (1996) and Williamson 
(2005) provide overviews, summaries of the methods debates, and details about how to 
actually proceed as well as listing additional resources and literature; both are also 
directed at nursing research. Williamson (2005) also presents a specific illustration for 
guidance that is specific to nursing research. There is even a study using mixed methods 
evaluating acupuncture for people with chronic illnesses where the authors that either 
method alone would have missed information captured by the other method (Paterson and 
Britten, 2003). There seems little rationale for operating within the frame of one category 
of methods versus another category. • 
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To this point, Giacomini (2001) writes in his short, but excellent article, that 
regarding qualitative and quantitative methods, "[c]ontary to popular 
misunderstandings, both rely on systematic empirical observation, and both generate 
empirical evidence." (p 5) He notes that the two approaches complement each other 
rather than compete with each other since each addresses essentially different questions. 
"These 2 health research traditions are distinctive in what they look at, how they see it, 
and what they can learn." (p 5) He maintains that biomedical or natural causation 
questions are best addressed by quantitative methods and that questions about social 
meanings or behavior and experience to be understood as symbolically mediated social 
phenomena are best addressed by qualitative methods since these later methods are better 
suited for understanding why people do what they do. Which method one chooses 
depends on what question one wants to ask, what it is that one wants to do. These issues 
are further presented and evaluated by Mays and Pope (1995), Pope and Mays (1995), 
Green and Britten (1998), and Newman, Thompson, and Roberts (2006). 
One approach to coordinating different types of research methods, i.e., qualitative 
and quantitative methods, is that of methodological triangulation, one of four types of 
triangulation delineated by Denzin (1970). The goal of this type of research method 
combination is to better capture the phenomenon under investigation. The intent is that 
both approaches are used so that each may address the weaknesses in the other, perhaps 
producing a more accurate representation and understanding of the research results. 
Bradley (1995) offers a useable overview of the use of methodological triangulation in 
healthcare research and Murray (1999)* presents an overview while he reports on the 
results of methodological triangulation analyses including qualitative secondary data 
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from an earlier study of his (Murray, 1995). The specific triangulation methods the 
Murray used were based on those used by Connelly, Bott, Hoffart, and Taunton (1997). 
The Bradley (1995), Murray (1999), and Connelly et al. (1997) articles, and particularly 
the one by Murray, would be a good introduction to this area for any student. 
Importantly, Murray points out that methodological triangulation should be used when 
there is reason to expect that, given the nature of the research question, no one method 
would "provide a satisfactory explanation of the issue being studied," (p 196) and cites 
the Bradely 1995 article as well as Denzin and Lincoln (1994) as support for this 
position. 
As an important final comment, in spite of the potential difficulties in palliative 
care research, research participation can allow those receiving palliative care to 
experience contributing to others. Ferrell and Grant (2001) write, "Research participation 
often provides an opportunity to derive meaning from illness and to feel that one's 
suffering will provide benefit to others." (p. 702) Others have noted this as well (Fine, 
2003). Also, there has been both qualitative and quantitative research showing that many 
hospice patients want to participate in research. Indeed Addington-Hall (2007) reported 
on two such studies using hypothetically presented research projects. One study was a 
qualitative study in Australia that found that all hospice inpatients wanted to be a part of 
research with there most frequent reasons given being altruism, an increased feeling of 
personal value, continuing to feel a sense of autonomy, and the importance of research 
efforts to improve palliative care (Terry, Olson, Ravenscroft, Wilss, and Boulton-Lewis, 
2006). Another study was a quantitative study in the U.S. where close to half of the 
hospice patients were willing to be a part of interview, survey, or therapeutic research 
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(Williams, Shuster, Clay, and Burgio, 2006). Another study in the U.S. found that 
patients who had actually participated in interview research reported their experience as 
positive (Emanuel, Fairclough, Wolfe, and Emanuel, 2004). 
Chinese Medicine and Acupuncture Treatment 
Complimentary and Alternative Medicine and Human Energy Field Theory 
The National Center for Complimentary and Alternative Medicine presents a 
great deal of information about human energy field theory (NCCAM website, 2004a) as 
well as a general overview of what are termed "whole medical systems" that include 
traditional Chinese medicine (TCM), Ayurvedic medicine, naturopathy, and homeopathy 
(NCCAM website, 2004b). 
A major difference between Western medicine and TCM is that Western medicine 
takes a structural view of the human system while TCM adopts a functional approach. 
The TCM view of human physiology is based on the central concept of energy fields. 
The central tenet is that matter and energy cannot really be separated. Matter and energy, 
inner and outer, physical and mental are the same phenomena. They appear different 
only because we view them from different perspectives. Human energy theory frames 
the view of human systems through this position and its focus is on the perspective of 
energy field interpretation. Also, TCM has at its center the concept of Qi, life energy that 
flows through the body on the meridian grid that all living beings have (Xinnong, 1999; 
Freeman & Lawlis, 2001). 
Complementary and alternative, medicine (CAM) has five classifications of CAM 
therapies: alternative medical systems, mind-body interventions, biologically based 
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therapies, manipulative and body-based methods, and energy therapies (Hawks and 
Moyad, 2003; Hospice Palliative Nurse Association, 2003). Although acupuncture is 
generally classified within the alternative medical systems group, it is nonetheless based 
on a basic concept of life energy and problems related to the flow of that energy through 
the body. 
Indeed, acupuncture has been singled out as an area of special interest at the 
National Institute of Health Consensus Panel (NCCMA, 2004c), and NCCAM (2004a) 
places acupuncture under the heading of "energy medicine involving putative energy 
fields." Noting that acupuncture is the "most prominent therapy to promote Qi [life 
energy] flow among meridians," NCCAM reports that acupuncture has been extensively 
studied and that it has been demonstrated as effective in ameliorating some conditions 
including some forms of pain (Berman & Straus, 2004). Bringing together TCM and 
energy field theories in the application of acupuncture, Kloppenburg (1998) reviewed the 
anatomy of acupuncture points in the human energy field in the body and the acupuncture 
points' therapeutic consequences. 
Principles and Theories of TCM 
Chinese medicine has long and complex history that has been dated as far back as 
3,000 years. The knowledge of Chinese medicine has been organized and compiled in 
texts that go back to the first century BC. The various texts have been instrumental in the 
integration an understanding of all natural phenomena, not just health. There is a 
religious foundation in traditional Chinese medicine, which comes from Taoism and 
Confucianism (Herring & Roberts, 2002). Eastern Asian medicine has a very different 
paradigm of thinking than Western Medicine. It places an emphasis on the holistic 
patterns, relationships, cycles and processes. In Chinese medicine the healthy individual 
is "in harmony" and displays a balance among the mental, physical, and spiritual aspects. 
The goal of Chinese medicine is to change the disharmony in the mind, emotion, body, 
or behavior to a state of balance, state of harmony, and well-being. The Western 
paradigm places an emphasis on linear thinking, causality and reductionist explanations. 
This may be part of why traditional Chinese medicine has not been easily accepted in 
this country. 
Fundamental to Chinese medicine is the concept of Qi. However, as with Tao, 
there is no single English word that captures it meaning. All of the universe and 
everything in the universe is defined by and composed of Qi. The unobstructed flow of 
qi is essential to physical, emotional, and mental harmony. Qi is the life force, the vital 
energy of every cell in the body. "One can think of qi as matter on the verge of becoming 
energy or energy on the point of materializing." (Bennett, 1978, cited by Freeman & 
Lawlis, 2001). 
Another important concept is that of meridians. Meridians are of fundamental 
importance to acupuncture. Meridians are an invisible network, an energy grid, 
responsible for the circulation of the Qi, blood, and bodily fluids. They are distributed 
both on the right and left sides of the body, anterior and posterior, as well as located 
interiorly and exteriorly. They are linked to one another in a specific order. A cyclical 
flow of Qi is maintained by the meridians of the hand and foot, yin and yang, and the 
interior and exterior. There are also two main channels that are located in the center of 
the body in the anterior and posterior aspects. The twelve meridians share the following 
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features according to Xinnong (1999): (1) Its own fixed acupuncture points on fixed 
portion of the body surface; (2) Each pertains to a specific organ; (3) The meridians have 
an exterior and interior relation of mutual connection; (4) Each meridian has its own 
pathological manifestations if the Qi does not have a smooth flow. 
Auricular Acupuncture. 
Both body and auricular acupuncture originated in ancient China, but, while body 
acupuncture has not changed much over the years, auricular acupuncture changed as a 
function of work done in Europe. These changes in auricular acupuncture where initiated 
by Dr. Paul Nogier in France (Oleson, 1998). While body acupuncture assumes that 
energy lines (meridians) along the body have no obvious anatomical relationship to body 
organs represented by particular meridians, auricular acupuncture assumes a structured 
relationship between the anatomical positions of points and an inverted body image of a 
fetus on the external ear (Oleson, 1998). "A large number of sites have been identified on 
the ear which become spontaneously tender or otherwise react to the presence of disease 
or injury elsewhere in the body. Stimulation of these ear points in the turn exerts certain 
therapeutic effects on those parts of the body with which they are associated.... 
[auricular acupuncture] is relatively simple and economical, and there are few side 
effects." (O'Connor and Bensky, 1981, p. 472). 
Oleson (1998) offered a clarification of the concept of the relationship between 
points on the ears and body parts and organs labeling these relationships "somatotopic 
inversion." (p. 6) Regarding somatotopic inversion, Oleson (1998) writes, "The head 
areas are represented toward the bottom of the ear, the feet toward the top, and the body 
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in between. As with the somatotopic map in the brain, the auricular homunculus devotes 
a proportionally larger area to the head and hand than to the body. The size of a 
somatotopic area is related to the functional importance rather than its size." (p. 6) A 
caution here is noted by O'Connor and Bensky (1981). They emphasize that the 
locations of points can differ from person to person because of ear shape variation among 
individuals. 
This section has presented information regarding auricular acupuncture. It should 
be noted that one of the developments in this area is the use of auricular acupressure. The 
only difference between auricular acupuncture and acupressure is that acupressure uses 
external pressure methods instead of acupuncture needles to stimulate the designated 
points. 
Existing research evaluating effects of acupuncture 
There is evidence for the positive effect of acupuncture procedures (Manning, 
2000; Berman, 2001). However, the empirical research literature does not find clear, 
consistent support for these effects (Berman, 2001). As with much of the research done 
within CAM, there are problems of lack of use of control groups, lack of randomized 
assignment of subjects to conditions, and sample sizes that might not yield sufficient 
statistical power thus increasing the probability of Type II error (Linde, 2000; Harlan, 
2001; Berman, 2001). 
Berman (2001) presented a very good overview of research on the effects of 
acupuncture, including a set of meta-artalyses publications. Meta-analysis is the 
procedure where a search of literature generates a list of qualified studies and then the 
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results of these studies are themselves subjected to an analysis that uses their effect size 
results to combine the studies and evaluate their implications for the research area being 
examined. Most acupuncture research as been on the alleviation of pain. 
For chronic pain, three have been three systematic reviews. Patel, Gutzwiller, 
Paccaud, and Marazzi (1989) did a meta-analysis of 14 studies, ter Reit, Kleijnen, and 
Knipschild (1990) conducted a meta-analysis of 51 studies, and Ezzo, Berman, Hadhazy, 
Jadad, Lao, and Singh (2000) also conducted a meta-analysis of 51 studies The first meta-
analysis on chronic pain (Patel et al., 1989) found few significant effects among the 14 
studies included. Pooling results via meta-analysis did yield results favoring 
acupuncture, but this was only for the non-blinded effects. Similar results were found by 
the ter Reit et al. group (1990). 
In their meta-analysis for effects of acupuncture on chronic pain, Ezzo et al. 
(2000) identified four categories of control groups (waiting list, inert placebos, sham 
acupuncture, and standard care). Of the 51 studies included in this systematic review 21 
favored acupuncture. Other treatments were favored in four studies. The remaining 26 
studies had no significant findings and most of these were designs using sham 
acupuncture as the control group. Berman (2001) maintained that the risk of Type II 
error or false-negative conclusion is high. Although low quality studies were 
significantly more likely to yield positive results for acupuncture, there was still limited 
support for acupuncture being more effective than waiting lists or inert, non-acupuncture 
placebos. Importantly, the evidence for acupuncture being more effective than sham 
acupuncture or standard medical care was insufficient. Similarly, a meta-analysis of 12 
studies on back pain found that acupuncture was better than various control interventions 
but that there was insufficient evidence to demonstrate that acupuncture was superior to 
placebo (Ernst & White, 1998). An earlier meta-analysis by Ernst (1997) on 13 studies 
found seven positive for acupuncture and six with non-significant results. However, an 
examination of these 13 studies reveals design flaws including lack of randomization and 
failure to use placebos as a control condition. 
There have been two larger studies reporting positive results since these earlier 
reviews. Molsberger, Bowing, Jensen, and Lorek (1994; Molsberger & Bowing, 1997) 
conducted a clinical trial in Germany with 97 patients. They used real versus sham-
control conditions and found significant pain relief at a three-month follow up 
assessment. Berman and Ezzo (2000) used an acupuncture versus standard care design in 
73 patients and found both pain relief and improved functioning for standard outcome 
measures at a three month follow up. It may be that many of the earlier studies had 
samples too small to provide necessary statistical power, thus generating a higher 
likelihood of Type II error. 
Berman and colleagues (Berman, Ezzo, Hadhazy, & Swyers 1999) published a 
systematic review of acupuncture treatment of fibromyalgia pain. The review included 
seven studies with three using randomized control designs and four using cohort designs. 
Two of the randomized control designs demonstrated that real acupuncture was more 
effective than sham acupuncture for ameliorating pain (Deluze, Bosia, Zirbs, Chantraine, 
& Vischer, 1992; Cassisi, Roncaglione, Ceccherelli, Donolato, Gagliardi, & Todesco, 
1995). 
Although some of the studies of acupuncture treatment of pain reported above 
used randomized control designs, a review article by Pan and colleagues examined 
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complementary and alternative medicine in the management of 3 symptoms, one of 
which was pain (Pan, Morrison, Ness, Fugh-Berman, and Leipzia, 2000) and noted, 
"Acupuncture as a treatment for pain in seriously ill cancer patients has been evaluated 
only in uncontrolled studies" (p. 379). Hence, in generalizing results of acupuncture 
treatment of pain, care should be taken to note the nature of the populations studied and 
the type of designs used. Pan et al. (2000) do cite two case series studies demonstrating 
alleviation of pain in severely ill cancer patients. One such study reported acupuncture 
pain control management for at least 1 month in 72% of patients with severe abdominal 
pain resulting from locally invasive or metastatic cancer following daily treatment for one 
to two weeks (Xu, S., Lui, A., & Li, Y., 1995). Those patients with such severe pain 
were a subset of 92 patients with pain ranging from mild to moderate to severe. 
The second case series study involved cancer pain clinic patients with a sample 
size of 183 with 142 of these having pain related either directly to cancer or as a side-
effect of treatment (Filshie, J. & Redman, D., 1985). With one to four weekly manual 
acupuncture sessions of 5-15 minute duration, 70 patients (48%) reported pain relief 
and/or greater mobility for more than three days. 
Interestingly, Pan et al. (2000) also reported in their survey what they labeled a 
single-blind random controlled trial study examining acupuncture treatment (actual 
acupuncture sites versus sham acupuncture sites) for painful peripheral neuropathy in 239 
HIV-positive patients from multiple centers (Shlay, Chaloner, Max, Flaws, Reichelderfer, 
Wentworth, Hillman, Brizz, & Cohn, 1998). First, this study was not included in the Pan 
et al. (2000) review as one done with severely ill cancer patients because here the patients 
were HIV-positive patients with peripheral neuropathy. Second, although this is a 
controlled study and described by the authors as a modified double-blind study, Pan et al, 
were justified in labeling the study as single-blind one because, regarding the 
acupuncture conditions, the acupuncturist knew the condition assignment of the patients. 
Apparently Shlay et al. called their study double-blind because neither the researchers nor 
the patients knew the experimental conditions. However, they appear to have also 
labeled the study as "modified" double-blind because the acupuncturist knew the 
conditions. In any case, the study was thus open to experimenter effects from the 
acupuncturist. Nonetheless, the results showed no difference between actual versus sham 
acupuncture treatment in alleviation of pain in the patients. 
Some studies have examined the use of acupuncture with breathlessness. Jobst, 
Chen, McPherson, Arrowsmith, Brown, Efthimiou, Fletcher, Maciocia, Mole, Shifrin, 
and Lane (1986) reported a controlled study comparing actual versus placebo 
acupuncture in 24 patients with COPD and disabling breathlessness. They stated that the 
actual acupuncture group reported greater improvement in symptoms and walked a 
greater distance in six minutes. Filshie, Perm, Ashley, and Davis (1996) published a 
study regarding the effects of acupuncture on 20 patients, median age 60, with cancer-
related breathlessness. Using VAS analogue scales, the patients reported significant 
improvements in dyspnea, relaxation, and anxiety and these changes lasted up to at least 
six hours. However, this study was uncontrolled and not done blind. Hence, the results 
may have been a function of either experimenter expectations and/or a patient placebo 
effect. Still, this study was cited in the Pan et al. 2000 a review article as supporting the 
use of complementary and alternative medicine in managing dyspnea in near the end of 
life patients. 
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A well-designed study by Vickers, Feinstein, Deng, and Cassileth (2005) 
evaluated acupuncture treatment for dyspnea in advanced lung and breast cancer patients 
at Memorial Sloan-Kettering Cancer Center. They used a randomized placebo-controlled 
design for a pilot study beginning with 47 patients and 45 patients completing the study. 
They implanted acupuncture "studs" in either true or placebo acupuncture points. The 
patients self-applied pressure to these studs twice daily. Patients rated their dyspnea 
sensation on a numerical scale with a 0 to 10 point range right before and after 
acupuncture treatment daily for a week. No results were statistically significant, although 
the placebo acupuncture patients did report a small absolute improvement that was a little 
greater than that reported by the true acupuncture patients. The author concluded, "The 
acupuncture technique used in this trial is unlikely to have effects on dyspnea importantly 
larger than placebo for patients with advanced cancer." (p 1) 
Davis, Lewith, Broomfield, and Prescott (2001) conducted a pilot project 
examining methodological issues when evaluating acupuncture as a treatment for 
disabling breathlessness. Theirs was a randomized, controlled trial with three treatments: 
real acupuncture, dummy acupuncture, and mock trans-electrical nerve stimulation. The 
results showed a small, but statistically non-significant effect for acupuncture. As a pilot 
project, this study had only 12 subjects, and its statistical power was too low. The 
researchers had as one of their goals the calculation of an adequate sample size for 
necessary power. They report that their analyses indicated that 25 patients would be 
needed for power of .80 with alpha of .05. 
These same researchers then ran a larger study with 24 patients completing both 
arms of a single-blind, placebo-controlled crossover study. Still, the researchers found no 
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difference between an actual acupuncture procedure and a mock one (Lewith, Prescott, 
and Davis, 2004). Although this study had twice the number of subjects as that of Davis 
et al. (2001), again statistical power was probably insufficient. 
There have been studies examining the effects of acupressure on dyspnea. For 
example, Maa, Gauthier, & Turner (1997) evaluated the use of acupressure in decreasing 
dyspnea in COPD patients and this study was positively evaluated in the Pan et al. (2000) 
survey of research on complementary and alternative medicine in managing pain, 
dyspnea, and nausea and vomiting near the end of life. Maa's and co-authors' study had 
31 severe COPD patients daily self-administer at home acupressure for 6 weeks 
alternative with sham acupressure for 6 weeks in a single-blind, randomized crossover 
study. When patients were using acupressure as opposed to using sham acupressure, they 
reported significantly less dyspnea as assessed via VAS. A problem with the study may 
be that there was little compliance control available since the patients were self-
administering at home. Still, the results were positive. Nonetheless, a limitation of the 
study should be noted that with a single-blind design it is possible that experimenter 
effects were operating. 
Another, more recent, study by Maa evaluated the use of acupressure as well as 
acupuncture in addressing breathing difficulties evaluated relief among patients with 
chronic obstructive asthma (Maa, Sun, Hsu, Hung, Chen, Yu, Wang, & Lin, 2003). This 
was a prospective, randomized study with three conditions: eight weeks of daily self-
administered acupressure and standard care (17 patients), 20 acupuncture treatments and 
standard care (11 patients), and standafd care alone (13 patients). Both acupressure and 
acupuncture conditions showed improvement on the St George's Respiratory 
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Questionnaire. The acupressure condition demonstrated improvement in irritability 
measured by the Bronchitis Emphysema Symptom Checklist. 
A still more recent study by Wu, Lin, Wu, Lin (2007) evaluated acupressure with 
COPD patients in Taiwan employing a randomized, block experimental design, randomly 
assigning 44 patients to either a true acupressure condition using points for relaxation and 
dyspnea or a sham acupressure condition using other unrelated points. The two groups 
were also matched on a variety of characteristics including sex, age, pulmonary function, 
steroid use, and smoking. Using the Dyspnea Visual Analogue Scale, the Geriatric 
Depression Scale, as well as oxygen saturation, the study found that the true acupressure 
group statistically improved more than the sham group on all assessments. 
An interesting study evaluated the effects of acupressure for patients with 
prolonged mechanical ventilation support (Tsay, Wang, Lin, and Chung, 2005). This 
study in Taiwan compared acupressure and massage with massage and handholding for 
52 randomly assigned patients with COPD. Hence, there was no blinding to conditions. 
Still, acupressure produced statistically significantly better results for dyspnea, anxiety, 
and object physiological indicators for both heart rate and respiratory rate. 
Interestingly, as a side note, acupuncture has been demonstrated to significantly 
reduce exercise-induced asthma. Fung, Chow, and So (1986) studied breathing problems 
not in cancer patients, nor in end of life patients, not those with COPD. Rather, they 
induced asthma symptoms through motor-driven treadmill exercise in children, ages 9 to 
13.5, who had mild to moderately severe perennial bronchial asthma. Asthma symptoms 
were assessed using forced expiratory flow in the first second, forced vital capacity, and 
peak expiratory flow rate. The study used a single-blind, cross-over design where 
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children were given real and sham acupuncture in random order. The results that 
exercise-induce asthma symptoms in asthmatic children were significantly attenuated by 
real acupuncture as compared to placebo (sham) acupuncture. 
A case study (Fillmore, 1999) used acupuncture on a 45-year old male with 
reactive airway disease comparing the effects of acupuncture versus medication 
(albuterol aerosol). The outcome was assessed objectively using a simple peak flow 
meter measuring peak flow before and after each treatment. The acupuncture provided 
greater increase in peak flow than did the medication. Limitations of this study included 
neither the physician nor patient being blinded to the conditions. Although the measure 
used was an objective one, it is still possible that the patient made greater effort following 
acupuncture. The author does report that the patient appeared to make a best effort for 
each peak flow assessment. 
As discussed in earlier sections, anxiety and distress are important dimensions of 
the symptom of dyspnea. There is some research that supports acupuncture procedures as 
interventions that can reduce anxiety, including Tsay et al. (2005) reported above. 
Another blinded study treated anxiety in the mothers of children being prepared for 
surgery. Subjects were randomized to two groups: auricular acupuncture at the 
relaxation points (n = 34) versus sham acupuncture at the shoulder, wrist, and extraneous 
auricular points (n = 33) (Wang, Maranets, Weinberg, & Caldwell-Andrews, 2004). This 
was a repeated measures design where anxiety was measured by the State-Trait Anxiety 
Inventory at the three points of time: baseline, 30 minutes after the intervention, and on 
completion of the child's anesthesia induction. Analyses revealed that the group by time 
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interaction was significant for the change in mother's anxiety with the actual acupuncture 
group reporting less anxiety. 
A study that used auricular acupressure for treatment of anxiety also found 
support for such intervention (Kober, Scheck, Schubert, Strasser, Gustorff, Bertalanffy, 
Wang, Kain, & Hoerauf, 2003). Subjects in the study were patients who needed 
ambulance transport secondary to medical conditions. This was a blinded randomized 
control study. Subjects were randomized to two conditions: auricular acupressure at the 
relaxation point (n = 17) versus auricular acupressure at a sham point (n = 19). State 
anxiety and pain were assessed using visual analog scales before and after transport. The 
actual auricular acupressure group demonstrated significantly less anxiety and pain than 
did the sham auricular acupressure group. 
Studies of acupuncture and acupressure need to be done using samples and 
procedures that generate sufficient statistical power. Repeated measures designs with 
more than two time points should be used since this both allows for assessment of change 
over time and benefits from the increased power generated by multiple time points. Such 
studies should also be randomized control trials when ethical and practical with as much 
blinding to condition as possible. 
Summary Syntheses 
Dyspnea is a common and debilitating symptom that is not well understood or 
controlled even though many patients describe the experience as agonizing and worse 
than pain. Carrieri-Kohlman, Janson-Bjerklie, and Jacobs (1984) maintain that the 
documents from the 1980 policy statement by American Nurses' Association and the 
1982 Fifth National Conference on Nursing Diagnosis "provide a mandate for nurses to 
study the measurement and management of symptoms and responses to illness, dyspnea 
being an example." Although there has been research on dyspnea over the last 25 years, 
the emphasis of this research has been on chronic diseases and there has been very little 
research on dyspnea in end-of-life patients. The National Institute of Health State-of-the-
Science Conference Statement, 2004, has among its recommended future directions for 
improving end-of-life care: "Develop and test new interventions, including 
complementary and alternative medicines, to improve symptom management in diverse 
patient groups, (p. 10)" 
This proposed research will evaluate an auricular acupressure intervention for 
amelioration of dyspnea in end-of-life patients with lung cancer. This research will 
place the dyspnea construct within the theoretical framework of the Revised Symptom 
Management Conceptual Model (RSMC Model) that has three basic dimensions of (1) 
symptom experience, (2) symptom management strategies, and (3) outcomes. The 
RSMC Model also has three sub-dimensions of the symptom experience consisting on (1) 
perception of symptoms, (2) evaluation of symptoms, and (3) response to symptoms. 
These three sub-dimensions will be captured by the multi-dimensional assessment 
instrument, the Cancer Dyspnea Scale, which was developed on lung cancer patients. 
Finally, another important contribution of this research will be the use of a true 
experimental design with random assignment of subjects to experimental conditions in 
the testing of a complementary alternative intervention. 
73 
Chapter 3. Methods 
Research Design 
This study used both quantitative and qualitative methodologies. Hence, in 
addition to the quantitative methods described below, this study also employed 
qualitative questions and analysis. Following the quantitative analyses, the qualitative 
results are presented. In the Discussion section, the quantitative analyses are reviewed 
within the context of the qualitative results. This approach extended the researcher's 
understanding of the phenomenon under investigation. 
For the quantitative methodology, this feasibility study employed a true 
experimental design where group membership was determined through random 
assignment. Although the sample was essentially one of convenience, an experimental 
design is not a function of the source of a sample. A true experiment is defined by the 
subjects being randomly assigned to condition and by the condition or the independent 
variable being under the control of the researcher. The basic research design for this 
study was a 3 (group: standard care [SC], standard care plus acupressure placebo [SC + 
AP] with use of seed adhesive not on lung or anxiety points, standard care plus 
experimental auricular acupressure using seed adhesive on lung and anxiety points [SC + 
AE]) by 8 (time: 2 assessments for each of 4 days — day 1 baseline, day 2, day 3, day4) 
mixed design analysis of variance (ANOVA) with time as the repeated measure (see 
Table 2). The auricular acupressure treatment was administered on the morning of Day 2 
following the Day 1 baseline assessments. All early and late assessments took place at 
the same time each day. 
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These three conditions were designed to help differentiate between different 
sources of effects. For example, SC versus SC + AP and SC + AE would enable the 
determination of any effect due to simple change in procedure, additional attention to the 
patient, and general placebo effects. Also, SC + AP versus SC + AE allowed for the 
differentiation between effects due to placebo auricular procedures versus those due to 
actual auricular therapy. Additionally, a baseline assessment allowed for evaluation of 
any differences between the subjects in the three conditions before any treatment begins. 
Table 2. 3 (Condition/Group) by 8 (Time) ANOVA with Time as the repeated measure 
Condition* 
SC 
SC + AP 








S T # 
Day 2 post-tx 
Early Late 
Day 3 post-tx 
Early Late 
Day 4 post-tx 
Early Late 
SC = standard care 
SC + AP = SC & seed adhesive not on lung or anxiety points (placebo condition) 
SC + AE = SC with seed adhesive auricular acupressure on lung and anxiety 
(experimental condition) 
#ST = Start Treatment of Auricular acupressure or Placebo Auricular acupressure 
The major advantage of the basic research design is that it is a true experimental 
design that allows for direct manipulation of the primary independent variable. In turn, 
this allows for greater confidence in interpretation of results and for making causal 
inferences. An additional advantage of a mixed design ANOVA is that with repeated 
measures statistical power is increased in that each time a subject is assessed, the power 
increases as if an additional subject had been enrolled in the study. The major 
disadvantage of this type of design in this study is that each research participant had to be 
individually run including repeated follow up assessments rather than subjects being run 
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in groups. A limitation of this design because of the source of this sample is that of 
generalizability. 
The quantitative independent variable in this study was an experimentally 
manipulated one, and consisted of treatment condition (SC group versus SC with 
inappropriate seed point adhesive placebo group versus SC plus acupuncture with 
appropriate seed adhesive experimental group). The quantitative dependent variables 
were self-reported dyspnea (total score as well as three subscales), oxygen saturation, and 
use of respiratory treatments. 
The two non-SC conditions (SC with seed adhesive placebo group and the SC 
plus acupressure with seed adhesive experimental group) were blinded for both the 
subjects and the research assistants administering the dyspnea and pulse-oximeter 
assessments. Subjects in both conditions had adhesive on their ears. 
Additionally, although there was random assignment to condition, there were still 
two issues regarding individual differences among subjects. First, even random 
assignment does not guarantee lack of differences between the subjects in different 
conditions. This is particularly the case with relatively small samples. Second, even if 
there were no differences between subjects in different conditions, individual differences 
within conditions still contribute to the error terms in statistical analyses. Hence, 
statistically controlling for such individual differences can reduce the error terms and, 
hence, increase the effect size. Of course, repeated analyses does control for such 
individual differences within each condition over time since the same subjects are used 
over time. Still, analysis of covariance (ANCOVA) was used in order to ensure control 
of differences between conditions because of the relatively small sample in this study. 
For the qualitative data, five questions were asked of the subjects. Three 
questions were asked on Day 1 baseline. On Day 4, these three questions were asked 
again, but specifically regarding the subject's experienced at that time only, along with 
two additional questions. 
Finally, subjects were told that at the end of their research participation they 
would have the opportunity to make a decision about any continued treatment. They 
were told that they would be able to continue receiving acupressure if they were in the 
experimental group or to begin receiving acupressure if they were in either of the two 
other groups. 
Sample 
The 11 research participants consisted of lung cancer inpatients and homecare 
patients at a Southern California hospice. Inclusion criteria consisted of a primary 
diagnosis of end stage lung cancer, dyspnea, no lesions in the ears, no allergies to 
adhesive materials, at least 45 years old, English speaking, ability to comprehend and 
understand consent, and ability to communicate with the researcher. Research 
participants were assigned randomly to one of three groups. The first group received 
current standard of care. The second group received current standard of care plus sham 
Auricular acupressure. The third group received current standard of care plus Auricular 
acupressure. 
The target sample consisted of 15 subjects in each of the three groups for a total 
of 45 research participants. Since this research was being conducted on end-of-life stage 
hospice patients, it was expected that some patients might die during the study. Hence, 
the plan was that subjects would continue to be recruited until the sample size of 45 was 
achieved. This target sample size was chosen as a function of formal statistical power 
analyses for quantitative data with power set to at least .80, the conventional cut off level 
for sufficient power (Cohen, 1988,1992). The power analyses were conducted using the 
SOLO Power Analysis software (Hintze, 1992). For both research and clinical purposes, 
the decision was to be able to detect down to at least a medium effect size (f= .25, Cohen 
1988,1992) if the full sample were recruited for this feasibility study. For detecting such 
medium effects, power analysis demonstrated that originally planned total sample size of 
45, there would be more than sufficient power for both the main effect of time (power = 
.90) and for the interaction of group by time (power = .81). It is the group by time 
interaction that would be used to determine the presence of group effects. That is, the 
focus here was on whether the change over time depends on group membership. 
Although there would have been insufficient power to detect such an effect size for the 
main effect of group (power = .28), the group main effects were neither the focus of this 
research nor necessary to demonstrate the efficacy of acupressure in these patients. 
For this feasibility study, the target sample of 45 participants was not achieved. 
The sample size at the time of data analyses was 11 with two subjects in the control 
condition, five in the placebo condition, and four in the experimental condition. Issues 
and difficulties regarding participant recruitment are covered in the Discussion Section. 
Data collection procedures 
There were three general methods of quantitative data collection. First, self-
report was used for both demographic Information and for rating of dyspnea. Second, a 
medical assessment of oxygen saturation was conducted. Third, patient charts were used 
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for determining use of respiratory treatment as well as a source of other data, e.g., 
diagnosis of small cell versus non-small cell lung cancer. Self-report of demographic 
data is a frequently used procedure for assessing such data. The self-report scales for 
dyspnea are commonly used in treatment facilities and appear to provide both reliable 
and valid information. Patient charts are another frequently used source for research 
data. As mentioned above, for qualitative data collection five questions were asked of the 
subjects: Three questions on Day 1 repeated on Day 4 but asked regarding current 
experience and also on Day 4 two additional questions. 
Measures 
A short demographic questionnaire was used that asked for self-report of sex, age, 
marital status, number of children, and support which is the number of family or close 
friends within a 50-mile radius. Although much of this information could have been 
obtained from medical records, the taking of such information can also help establish a 
research rapport with the patient and research participant. 
The CDS (Tanaka et al, 2000) was used to measure dyspnea. This 12-item scale 
assesses three dimensions of dyspnea: sense of effort [Dyspnea Effort], sense of anxiety 
[Dyspnea Anxiety], and sense of discomfort [Dyspnea Discomfort] using a 5-point Likert 
scale for responding to each item from 'not at all' to 'very much'. Also, a total score can 
be used. Bruera and Ripamonti (1998) recommended that a scale to measure dyspnea for 
investigating etiology and establishing therapeutic strategies should have six 
characteristics: (1) be multidimensional, (2) be self-rating since dyspnea is subjective, 
(3) be easy and simple enough to be completed by patients with dyspnea, (4) be evaluated 
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not by physical effort evoking dyspnea, but by perceived dyspnea itself so that even 
bedridden patients can complete it, (5) have its reliability and validity in cancer patients 
confirmed, and (6) be sensitive to clinical changes due to treatment or progression of the 
disease over time. Tanaka and colleagues stated that they had followed these 
requirements in their development of the CDS. Additionally, the Oncology Nursing 
Society (2008) formally listed this scale on their web site. 
The CDS is best suited for use in this study because its average time required for 
completion was 140 seconds. Also if terminally ill patients cannot read the items and/or 
use a pencil to respond to them, the items can be read aloud and the patient can respond 
with a number from the five-point scale. Construct validity was confirmed through the 
use of repeated factor analysis, once in the developmental phase of the research and once 
in the validation phase. Both factor analyses yielded the expected three factors. 
Convergent validity with both the Visual Analogue Scale and a modified Borg scale was 
good (average r = .57 and .52 respectively with both having p < .001). Reliability as 
assessed by internal consistency was also good (average Cronbach's alpha = .86). Also 
test-retest reliability was good (r = .66, p< .005). It is important to keep in mind that one 
might expect dyspnea itself to change over time in a patient. Hence, this level of 
obtained test-retest reliability is quite good. Pulse-oximeters are well established, 
reliable, and valid medical instruments (Tanaka et al., 2002a, 2002b). 
Oxygen saturation was assessed with the Welch-Allyn Sure-Temp Pulse 
Oximeter. The pulse-oximeter in this study is manufactured by Welch-Allyn Sure-Temp 
Technology and is already available at "the research site. The use of patient charts is also 
a well-established procedure. 
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For the qualitative data, the three questions on Day 1 were as follows: (1) 
Describe what the experience of breathlessness has been for you; (2) Describe how the 
experience of breathlessness has affected your quality of life; and (3) Describe any 
suffering that you associate with breathlessness. On Day 4, the 5 questions were as 
follows: (1) Describe what the experience of breathlessness has been for you at this time; 
(2) Describe how the experience of breathlessness has affected your quality of life at this 
time; (3) Describe any suffering that you associate with breathlessness at this time; (4) 
Describe your experiences of receiving auricular acupressure; and (5) Would you 
recommend acupressure to other people with breathlessness? If so, what would you tell 
them? If not, why not? 
Experimental Procedure 
Each new admission to the inpatient hospice center or homecare that had a 
primary diagnosis of lung cancer was approached and asked whether the researcher could 
give them an overview of the research participation opportunity. If permission was 
given, then the subject was provided with such an overview while clearly emphasizing 
that the research participation was completely voluntary and that declining participation 
or withdrawing from participation once enrolled in the study would have no effect on the 
course of the subject's treatment while at the inpatient hospice center or in homecare. 
Once the overview was provided and if the potential subject wished to participate, he or 
she was given a copy of the Experimental Human Subjects Bill of Rights and asked to 
sign a consent form. 
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Before allowing the subject to sign the consent form, the researcher asked 
whether the subject understood the research, knew what would happen if he or she 
consented, understood that he or she could decline or withdraw at any time, and 
understood the nature of any risks of participation. After the subject signed the consent 
form, he or she was asked to complete the brief demographic form. For each subject, the 
same individual researcher followed the patient through to the end of the study. 
On Day 1, once in the morning (about 9 AM ±1.5 hour) and once in the evening 
(about 6 PM ±1.5 hour), the subject was administered the Cancer Dyspnea Scale and had 
oxygen saturation assessed. Both of these assessments were conducted one-on-one. The 
Cancer Dyspnea Scale and the oximeter were used twice a day (morning and evening) for 
the next three days (Day 2, Day 3, Day 4). The first three qualitative questions were 
asked during the early Day 1 assessment period and the subject responses were tape 
recorded. 
On the morning of Day 2 and before the early Day 2 assessments, the treatment 
intervention began. Application of acupressure seed adhesives were carried out by a 
licensed acupuncturist. The experimental acupressure condition (SC + AE) consisted of 
placing small seeds (botanical name: vaccaria segetalis; English name: vaccaria seeds 
obtained from the company Heilo) with an adhesive material that allowed the seed to be 
held in place over the appropriate acupressure point on both ears. The placebo 
acupressure condition (SC + AP) also included the use of seed adhesive but not placed on 
lung or anxiety points. Before the adhesive with seeds was put in place, the auricular 
points were mildly stimulated for 3 seconds with a surface, non-invasive probe, making a 
slight indentation on the points, then cleansed with an alcohol applicator stick. Subjects 
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were asked whether they had any known allergies for adhesives or tape. Additionally, the 
site of the adhesive used was monitored for any allergic reaction. Skin integrity was 
monitored during both the application and removal of the adhesive to prevent and 
ameliorate skin tear. Fatigue was monitored during the subjects' participation in the four-
day protocol. The subject was both directly asked about experience of fatigue and 
observed for any evidence of increasing fatigue over the course of the protocol. The seed 
adhesives were placed on the ears of the subject the morning of Day 2. Then, within two 
hours before each morning and evening assessment, research personnel visited the 
subject, asked how he or she were doing, and reminded the subject that assessments 
would happen at a specified time. For those subjects in the two-acupressure conditions, 
pressure was applied to the seeds. 
Day 3 and Day 4 involved the morning and evening pre-visits and, for the 
acupressure groups pressure being applied to the seeds followed two hours later by the 
assessments. On Day 4, the 5 qualitative questions were asked and the subject responses 
were tape recorded. On this last day, the subjects were also engaged in conversation 
where they were asked whether they had any questions regarding the study. Subjects 
were told that if they had not received the auricular acupressure treatment, they would be 
offered the treatment when the study was completed. The subjects were thanked for their 
participation, told that the researcher greatly appreciated their help, and that this research 
may help others. 
The site of this research, the San Diego Hospice Inpatient Care Center, is also a 
clinical site for the Pacific College of Oriental Medicine. The acupuncturist was licensed 
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in California. As covered in the Human Subjects Research section below, all research 
personnel were trained in the ethics and procedures of human subjects research. 











3) Lung Lower 
4) Chest 
5) Relaxation 
AKA St Jerome point, 
Jerome point, 
sexual compulsion | 
Rationale for Selection 
Chosen for ease of access, similar physical location as 
experimental points, but very little likelihood of impacting 
patients' respiration. 
One of most commonly used auricular points; calms the 
spirit, promoting sense of relaxation, helps with coughing. 
Role in respiration. In TMC, the 'Kidney' (TCM organ) 
assists the 'Lung' (TCM organ) in grasping the clear 'Air 
Qi' that the Lungs send downward to the absorbed by the 
Kidney. If inhalation is difficult, it indicates deficiency in 
the 'Kidney.' 
Role in respiration. In TCM, the 'Lung' Governs Qi, 
manages respiration, regulates the water pathways, 
Governs diffusions of Qi and body fluids. When there is a 
pathology in the body and phlegm is accumulating it can 
sometimes it can sometimes be stored in the "Lung.' 
This point as two purposes: (1) The Lung and Kidney's 
relationship in TCM goes beyond simple respiration. The 
use of this point focuses the action of these two organ 
systems directly on breathing. (2) The intention of this 
point is to keep the Qui moving in the chest. Hence, 
breathlessness is not created by the congestion of Qi in the 
chest. 
Anxiety seems to be a significant component of dyspnea. 
This point along with the Shenmen point above (#1) can 
work synergistically to promote a sense of relaxation. This 
point also helps with insomnia. Also ease of placement. 
* Jeffrey Smith, LAc, the Licensed Acupuncturist who conducted the acupressure 
procedures in this study, helped prepare this information. 
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The acupuncturist performed the customary pre-assessment procedures for auricular 
acupressure for the condition of breathlessness. This was done the morning of the second 
day of the protocol. The placebo or sham acupressure points were chosen for ease of 
access, similar physical location as experimental points, but very little likelihood of 
impacting patients' respiration. The experimental acupressure points were chosen for 
relationships to dyspnea and respiratory distress based upon the Chinese Diagnosis and 
disease concept of "breathlessness." (See Table 3 for details. Note that Table 4 describes 
possible points that were not used.) This concept is based on rapid difficult continuous 
Table 4. Auricular Acupressure Points Not Used (Oleson, 1998; Bensky, xxxx)* 
Point/Representation 
1) Stop wheezing 
2) Adrenal 
3) Allergy point 
4) Master Cerebral 
5) Wheezing 
Emphysema 
Rationale for Non-Selection 
Very close to border of antitragus and other points. 
Concern about loss of seed through poor adhesion and also 
seed could migrate to another point. 
While easy to activate with a needle, it still had the same 
issues as above, but on the traqus. 
Just hard to get to. 
Could be issue with hair growth. 
Too close to ShenMen and not as well rounded for the 
treatment 
Too hare to get for good seed placement 
* Jeffrey Smith, LAc, the Licensed Acupuncturist who conducted the acupressure 
procedures in this study, helped prepare this information. 
breathing with the mouth open and an inability to lie down because of breathing 
difficulties. With dyspnea, one of the main problems for the patient is anxiety due to 
drowning feelings. Hence, points were chosen so as to focus on anxiety. If anxiety is 
controlled then maybe the breathing will become more even and more efficient. So the 
points were chosen using three criteria:* breathlessness treatment, anxiety reducing, ease 
and retention of seed placement. All placements also followed three axis lines in the ear: 
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ShenMen, Kidney and Lower Lung. For detail graphic illustration of these points, see 
Appendix F. 
As mentioned earlier, the SC versus the SC + AP versus SC + AE conditions used 
SC with no adhesive, SC with seed adhesive not on lung or anxiety points, and Auricular 
acupressure seed adhesive on lung and anxiety points, respectively. The placement of the 
seeds on or not on lung or anxiety points was not easily discernable without very close 
inspection by a knowledgeable acupuncturist of the ears. Hence, the subjects and those 
who conduct the dependent variable assessments were blind to the SC + AP versus SC + 
AE conditions. 
While blind to subject assigned condition, the researcher asked the qualitative 
questions at the two designated times and administered the CDS and the pulse-oximeter 
testing. These quantitative assessments were carried at the eight time points of the 
protocol. 
Data Analysis 
Although as a feasibility study this research enrolled only 11 subjects, generally 
the data were analyzed as if the target sample of 45 had been obtained. The analyses 
were carried out as part of determining feasibility in that both the researcher tested his 
ability in this area and the analyses yielded estimated effect sizes that can be used in 
power analyses for planning continued and future research in this area. 
The distributional properties of the dependent variables were evaluated to 
determine whether they met the assumptions for parametric statistics other than the 
assumption of independence. The presence of independence was supported by random 
assignment and by running subjects one at a time in this study. Other than independence, 
there are two other assumptions: normality and homogeneity of variance (Keppel, 1991). 
The initial plan was that in the case where there were violations of these assumptions, 
data transformations would be used, e.g., logarithmic transformations for highly right-
skewed data. Additionally, for repeated measures designs such as this one, there is the 
assumption of sphericity, which can be thought of as the dependent variable having a 
similar correlation between any two time points. The original plan was that if this 
assumption were violated in the data set, Geisser-Greenhouse corrections for the level of 
violation would be used (Keppel, 1991). A final assumption would apply when analyses 
of covariance (ANCOVA) were run. That assumption is that the relationship between 
covariates and the dependent variable is a linear one. However, since the sample size that 
was generated consisted of only 11 participants, such evaluation of these last two 
assumptions was not warranted. 
Even though random assignment was used, it was always possible for research 
participant characteristics to differ between conditions. That is the subjects in the three 
conditions could still have been different on important variables at baseline. This was 
especially the case with the relatively small target sample size of 45. Since there was the 
even smaller sample size of 11 generated in this study, evaluations of such differences 
across groups would not be meaningful. Still, for the sake of the protocol, some tests 
were run on baseline differences between groups using ANOVA for continuous variables 
such as age and chi-squares for categorical variables such as sex. In the case of such 
differences in variables central to the study being present, the original plan called for the 
basic design to be modified as an ANCOVA where variables that differ between the two 
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groups at baseline would have been used as covariates in order to take such differences 
into account. Although there were no such statistically significant differences that could 
be used here, two such analyses were run as demonstrations of the procedure. 
The primary quantitative data analysis that was used in this study was ANOVA 
for the 3 (group) by 8 (time) mixed ANOVA design. Additionally, besides the 
demonstration ANCOVA used for taking into account a baseline difference between the 
groups, a demonstration ANCOVA was also used to test for the effects of controlling 
sources of individual differences, thus reducing the error term and increasing statistical 
power. Such potential variables included sex, age, ethnicity, marital status, number of 
relatives and close friends within a 50-mile radius, number of complementary treatments 
used, and medications,. For demonstration purposes some of these possible differences 
among groups at baseline were tested using one-way ANOVA for continuous variables 
and chi-square for categorical variables. Part of the original plan include considering 
some variables such as sex as an additional factor in a 2 (sex) by 3 (group) by 8 (time) 
mixed design ANOVA. Because of the final sample size, this was not done. 
The relationships among the dependent variables were evaluated. Pearson 
product moment correlations were used for these evaluations. 
Alpha was set at .05 for evaluating statistical significance. In the original plan, an 
alpha of .05 was to be used even though there were a number of tests being run in this 
study. The greater concern for error here was for a Type II error (saying that an effect is 
not present when it is) than for a Type I error (saying that an effect is present when it is 
not). It should be kept in mind that replication would be the best way to control for error. 
Although the original plan was that the significance of the group by time interaction term 
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for each of the primary dependent variables (dyspnea ratings and oxygen saturation) 
would be used to evaluate whether each of the three hypotheses was supported, in this 
pilot feasibility analyses, these tests were used to generate estimates of effect size for 
each hypothesis. 
For the qualitative data, the subjects' tape-recorded responses were transcribed. 
The qualitative method employed in this study was Simple Thematic Analysis [Braun and 
Clarke, 2008]. The process here was similar to that used by Jackson, Melvin, and Downe 
(2007). The procedure was conducted by two people, the author and by a consultant 
trained in qualitative research and nursing. The interactive procedure was conducted 
through debate and consensus. The initially identified themes were then reevaluated with 
an examination for discontinuing data. Thus the transcriptions were evaluated for the 
presence of themes, there was an agreement on the final themes, and the results were 
used to inform the understanding of the quantitative results. 
Chapter 4 Results 
Sample 
The data analyzed here came from a sample of 11 subjects enrolled and randomly 
assigned among three conditions: two in Control, five in Placebo, and four in 
Experimental. Subjects all had a primary diagnosis of lung cancer and were drawn from 
the San Diego Hospice and Palliative Care Center with four (36.4%) coming from the 
Inpatient Care Center (ICC) and seven (63.6%) from Home Care (HC). These 11 were 
enrolled from a total of 74 approached from July 2007 through March 2008; 11 were in 
the ICC and 63 were in HC. Of those approached, two in the ICC and 10 in HC died 
before they could be enrolled in the study. One subject in HC was discharged from San 
Diego Hospice and Palliative Care Services because he was doing better and began 
looking for curative interventions. The most common reasons provided for not enrolling 
were time involvement, appointments for doctors and treatments, and fatigue. For 
characteristics of those eligible subjects who were approached but did not enroll in the 
study can be found in Appendix K. 
Characteristics of the sample included 54.5% female, 72.7% Caucasian, 63.6% 
married, and 45.5% with a high school degree. The average age was 68.7 (14.21) with a 
range from 49 to 89. Support, the mean number of friends and family living within 50 
miles of either the San Diego Hospice and Palliative Care Center or the place of Home 
Care on whom the individual could count, was 3.6 (3.59) with a range from 1 to 13. A 
little over a third (36.4%) of the subjects had only one person on whom they could count. 
The average number of eight different types of complementary medical treatments that 
the individual had had was 1.5 (1.51) with a range from 0 to 4. Those who had had at 
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least one type of complementary treatment comprised 54.5% of the sample. Also, the 
time between eight of the subjects' enrolling in the study and death averaged 64.6 days 
with a standard deviation of 47.39 and a range from 6 to 141 days. Three subjects had 
not died as of May 9, 2008. See Appendix L for details. 
Table 5 presents the sample characteristics with more detail and compares the 
attributes of the subjects across the three conditions. Because of the small sample it was 
Table 5. Subject Characteristics Across 3 Experimental Conditions 
Condition 
Variables 
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not expected that the conditions would be statistically significantly different on sample 
characteristics. Still, the statistics were run as part of the feasibility study, using chi-
square for nominal variables and one-way ANOVA for continuous (interval or ratio) 
variables. In general the differences across the three conditions were not significant. The 
one exception was for the number of the eight types of complementary medical treatment. 
Here the difference across the three conditions was significant (F(2,10) = 4.50, p < .05), 
with Control subjects reporting an average of 3.5 (0.71) types of treatments, Placebo 
subjects reporting 1.4 (1.34), and Experimental subjects reporting 0.5 (1.00). Even with a 
small sample size, it is possible to obtain significant results if the estimated effect size is 
large. For the ANOVA analyses in this study, partial eta square (r|p ) was used to 
represent effect sizes. This effect size estimate is available as part of the ANOVA 
programs within SPSS. For r\p
2, effect sizes are as follows: small ~ .01, medium ~ .06, 
large ~ .20 (Cohen, 1988). For the significant result for number of complementary 
treatments across the three conditions, the T|P
2 = .53, a very large effect. 
Hypotheses Testing 
A 3 (condition) by 8 (time) mixed design ANOVA with time as the repeated 
measure was used for testing the two hypotheses predicting change in dyspnea and 
oxygen saturation as a function of assigned experimental condition (Control, Placebo, 
Experimental). 
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Hypothesis 1: Dyspnea Change 
Four statistical analyses were conducted to test this hypothesis about the change 
in dyspnea being a function of the experimental condition. These analyses were run for 
four different dependent variables: Dyspnea Total, Dyspnea Effort, Dyspnea Anxiety, 
and Dyspnea Discomfort. The means and standard deviations for these dependent 
variables over eight time points within each of the three experimental conditions are 
presented in Tables 6 through 9. The effect that was of interest for each of these analyses 
was that of the condition by time interaction. Condition by time interactions are reported 
below for the general overall effect and for the type of interaction: linear where the 
change is generally in the same direction over time or quadratic where the change shifts 
directions at least once over time. The type or form of interaction tests have more 
statistical power since they test for a specific shape of a change rather than testing for 
whether there is any type of change present. The results of these analyses are presented 
below and the plots of the results of the changes over time in dyspnea for the three 
conditions are presented in Figures 2 through 5. Figures 6 and 7 are presented for 
demonstration purposes to show how possible covariates would be used in an ANCOVA. 
Dyspnea Total. For Dyspnea Total, there appears to be a general change in 
alleviation of dyspnea over time for all subjects, as can be seen in Table 6 and Figure 2. 
This is reflected in the significant ANOVA main effect for time (F(7,56) = 2.33, p < .04) 
with a large effect size (np
2 = .23). The form of this time effect appears to be a simple 
linear one (F(2,8) = 9.22, p < .02) with a very large effect size (t|p
2 = .54). It should be 
noted that main effects are best not interpreted if there is a disordinal interaction effect 
present, and the effect interest here is that of the condition by time interaction. 
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Regarding this interaction effect, the plot in Figure 2 suggests that the Experimental 
condition has a general overall trend of improvement through time point 6 while the other 
two conditions bounce around a bit, thus reflecting an interaction. However, the ANOVA is 
not significant for the overall test of condition by time interaction (F(14,56) = 0.62, p = .84), 
although it does have a large size effect (np
2 = .23). A better result is reflected by the test for 
a linear condition by time interaction with an F-value at least greater than 1, a p-value that is 
much better than the overall interaction test (F(2,8) = 2.34, p = .16), and a fairly large effect 
size (rjp
2 = .37). 
Dyspnea Effort. For the dependent variable Dyspnea Effort, the results are a little 
clearer (see Figure 3). Here, neither the overall main effect for time (F(7,56) = 2.15, p = 
.053) nor condition by time effect (F(14,56) = 0.86, p = .62) were significant. However, the 
effects were of reasonable sizes for both the time main effect and the condition by interaction 
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effect (large with r|p
2 = .21 and medium with np
2 = .17 respectively). Importantly, the tests 
for the form of the changes were significant with large effects for both the main effect of 















time(F(l,8) = 11.63, p < .01; large np
2 = .59) and the condition by time interaction (F(2,8) = 
4.69, p < .05, rip2 = .54). It appears that the Experimental condition changes more over time, 
more steeply, will the other two conditions are flatter over time as well as becoming worse 
and better at different time points. Because of concerns regarding the use of such parametric 
statistics as ANOVA with a small sample size, these data for Dyspnea Effort were re-run via 
the nonparametric statistic Friedman two-way ANOVA by ranks (Siegel and Castellan, 
1988). The nature of the Friedman is such that the three conditions could not be 
simultaneously run. Hence, the Friedman was run once for each of the three conditions. The 
only condition that resulted in a statistically significant change over time was auricular 
acupressure experimental condition (control condition: *£tf=n - 7.0, p = .43; placebo: % dM = 
3.3, p = .86; experimental: x 2 ^ = 21.4, p < .01). These nonparametric results support those 
generated by the parametric test. A final step here was an example exploration of possible 
confounding effects using the dependent variable Dyspnea Effort. These results are 
presented below following the results for Dyspnea Anxiety and Dyspnea Discomfort. 
Dyspnea Anxiety. The dependent variable Dyspnea Anxiety has dramatic plots (see 
Figure 4) that look like they would yield a significant condition by time effect. However, 
although both the overall main effect for time and the overall condition by time interaction 
are large effects (t|p = .26 and np = .22, respectively), the main effect for time is significant 
(F(7,56) = 2.82, p < .02) while the condition by time interaction is not (F(14,56) = 1.10, p = 
.38). The same pattern was found for the test of the linear form of the effects with a 
Figure 4. Plot of Condition by Time for Dyspnea Anxiety. 
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significant time main effect (F(l,8) = 5.64, p < .05, np
2 = .41) and a non-significant condition 
by time interaction (F(2,8) = 1.81, p = .23, np
2 = .31). 
Dyspnea Discomfort. The dependent variable Dyspnea Discomfort yielded neither 
significant effects nor any easily discernable patterns (see Figure 5). For the time main 
effect, neither the overall test (F(7,56) = 1.15, p = .35) nor the test for linear form (F(l,8) = 
0.16) were significant and the effects were medium for the overall test (r|p
2 = .13) and small 
for the test for linear form (r|p
2 = .02). As well, for the condition by time interaction, neither 
the overall test (F(14,56) = 0.59, p = .86) nor the test for linear form (F(2,8) = 0.20) were 
significant and the effects were medium for the overall test (np
2 = .13) and small to medium 
for the test for linear form (np = .05). 
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Demonstrating Use ofCovariates. To present a demonstration regarding the issue of 
possible confounding variables, the dependent variable Dyspnea Effort is revisited here. For 
examples of possible confounding variables, age and the number of family and friends living 
within 50 miles of the subject's location on whom the subject could count were chosen. The 
problem with using other possible confounding variables can be seen in Table 5. Note that 
sex is completely confounded for the Control condition with only females in this intervention 
and hence 0.00% males. Also, the variables ethnicity, marital status, and education degree 
have some cells with 0.00%, indicating some complete confounding. If confounding is 
complete, then the separate effects for the experimental independent variable and the 
complete confounding variable are impossible to parse. With a larger sample, it would be 
expected that these 0.00% cells would have some entries and, thus, no variable would be 
completely confounded with condition interventions. 
The first example used age as the possibly confounding variable, where the potential 
confounding effects were evaluated through the use of age as a covariate. Figure 6 presents 
the plots for Dyspnea Effort across the three conditions. If Figure 6 is compared to Figure 3, 
where it is obvious that age as a covariate had little effect. This lack of effect was also 
reflected in the statistical results. The overall age by time interaction was not significant 
(F(7,49) = 2.68, p = . 14) although it was nearly a large effect (np
2 = . 19). Neither was the test 
of the linear form of the age by time interaction significant (F(l,7) = 1.37, p = .28) and this 
effect size was medium to large (r|p2 = .26). On the other hand, the overall condition by time 
interaction was still large (rip2 = .22), although, as it was without age as a covariate, not 
significant (F(14,49) = 0.98, p = .49); and the test of the linear form of the condition by time 
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Figure 6. Plot of Condition by Time for Dyspnea Effort with Age as Covariate. 
experimental condition 




interaction was still significant (F(2,7) = 5.15, p < .05) and the effect size was still large (riP 
= .59), as was the case when this analysis was run without age as a covariate. 
In the example of testing for possible confounding variables using as the potential 
covariate support which is the number of family or close friends living within 50 miles and 
on whom the subject can depend (see Figure 7 for plots). In this case, for the overall support 
by time interaction, the covariate did have a significant large effect (F(7,49) = 6.79, p < .001, 
x\v = .49). For the test of the form of the interaction, support did have a significant large 
effect that was not linear, but rather was for a high order shape that is not easily interpreted 
(F(l,7) = 8.26, p < .03, rip2 = .54). Importantly, even with such large effects, and significant 
in the case of the overall interaction, the condition by time interaction effect was still large 
(r|p
2 = .32), although still, as it was initially, not significant (F(14,49) = 1.61, p = .11). Also 
importantly, the test of the linear form of the condition by time interaction was still large and 
about the same size as in the initial analysis (np
2 = .52) and, although not significant as it was 
Figure 7. Plot of Condition by Time for Dyspnea Effort with Support as Covariate. 
experimental condition 




initially the significance level is still notable (F(2,7) = 3.86, p = .074). If Figure 7 is 
compared with the original Figure 3, the effects of controlling for support can be identified, 
although the general patterns of the plots remain quite similar reflecting the near significant 
condition by time interaction. 
Hypothesis 2: Oxygen Saturation Change 
Two statistical analyses were conducted to test this hypothesis about the change in 
oxygen saturation being a function of the experimental condition. The first analysis uses as 
the dependent variable simple percent oxygen saturation. However, as Winer, Brown, and 
Michels (1991) point out, conducting ANOVAs with a dependent variable using percent or 
proportion metrics is a problem. The problem is that given the nature of upper and lower 
limits of such metrics, having values close to the upper or lower limits makes it difficult to 
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detect the presence of interactions. A remedy for this problem is to use an arcsin data 
transformation on the percentages or proportions. Given that interaction effects are the 
effects of interest in this study, a second analysis was run on oxygen saturation using an 
arcsin data transformation. Tables 10 and 11 present the oxygen saturation means and 
standard deviations for the eight time points across the three conditions. Table 10 presents 
the raw percentage values and Table 11 presents the arcsin transformed variables. 
Oxygen Saturation Percent Values. See Figure 8 for plotting of the condition by time 
interaction effect. The ANOVA for the dependent variable using percent values yielded no 
significant effects for either the overall time main effect (F(7,56) = 0.19, p = .99) or the 
overall condition by time interaction (F(14,56) = 0.66, p = .81). The effect size for the 
overall time main effect was small (t|p
2 = .02), while that for the condition by time interaction 
was medium (riP
2 = .14). The testing of the linear form of the main effect for time yielded 
non-significant results (F(l,8) = 0.13, p = .73) for a small effect (r|p
2 = .02). Testing for the 
linear form of the condition by time interaction also yielded non-significant results (F(2,8) = 
1.33, p = .32), but it did have a large effect size ((rjp
2 = .25). 





























































































































Figure 8. Plot of Condition by Time for Oxygen Saturation as Percent. 
experimental condition 
- - • control 
placebo 
experimental 
1 2 3 4 5 6 7 8 
Time 
Oxygen Saturation Arcsin Transformed Values. See Figure 9 for plotting of the condition by 
time interaction effect. The results here were essentially the same as for the oxygen 
saturation percent values dependent variable. 
The ANOVA for the dependent variable using arsin transformed values did not have 
significant effects for the overall time main effect (F(7,56) = 0.32, p = .94) nor for the overall 
condition by time interaction (F(14,56) = 0.86, p = .61). The effect size for the overall time 
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main effect was small (np
2 = .04), while that for the condition by time interaction was 
medium (np
2 = .18). The analysis regarding the linear form of the main effect for time also 
yielded non-significant results (F(l,8) = 0.24, p = .64) for a small effect (np
2 = .03). As well, 
the testing for the linear form of the condition by time interaction yielded non-significant 
results (F(2,8) = 1.95, p = .21), although it did have a large effect size (np
2 = .33). It is 
interesting that although the results of both of the oxygen saturation analyses were similar, 
the arcsin transformation did result in larger F-values, smaller p-values, and large effect 
sizes. 






Correlations Between Dyspnea Assessments and Oxygen Saturation 
The correlations between the four measures of dyspnea over the eight time points and 
the two variables used to assess oxygen saturation were evaluated. See Tables 12 and 13. 
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Although there is reported in the literature some disconnect between a patient's report of 
dyspnea and physical measures of functioning, the correlation here suggested that there 
might be some relationship between the four dyspnea measures and the two oxygen 
saturation variables. This relationship was not consistent across time or measures. However, 
some of the correlations were quite large. Effect sizes for correlations are as follows: small 
= .10, medium = .30, and large = .50. Some correlations here exceeded .80. This may have 
been due to the small sample and, hence unreliable estimations of effect size. As an example 
of testing for this, the correlation of Dyspnea Anxiety and arcsin transformed oxygen 















































p-values a = .05, b = .01 c = .001 
















































p-values a = .05, b = .01 c = .001 


















































*Note: Because of the nature of Spearman rho coefficients, they are the same for both 
oxygen saturation variables. Hence, only a single table needs to be presented. 
saturation (See Table 13, r = .83, p < .01) was evaluated further via the use of a scatter plot 
(see Figure 10). A visual examination of the scatter plot identified one outlying subject with 
a Dyspnea Anxiety score of 10 and an arcsin transformed oxygen saturation level of 1.57 
(corresponding to 100 percent oxygen saturation). When this subject was removed from the 
analysis, the correlation dropped to .33 (p = .36). If there are relationships between dyspnea 
scores and oxygen saturation, the effects may be more medium than large. 
Again, because of the small sample size, a nonparametric statistic was also used to 
check the parametric results. Here, Spearman rho coefficients (Table 14) were used to 
compare with the results of the Pearson product moment correlations (Tables 12 and 13). 
The general pattern of results was remarkably the same. Only the relationships within Time 
3 appeared to be much at variance. 
Figure 10. Scatter Plot of Relationship Between Time 2 Dyspnea Anxiety andArcsin 




















Dypsnea Anxiety Time 2 
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Evaluation of Parametric Assumptions 
As stated in the Methods Section, the assumption of independence is likely to have 
been met here since random assignment was used and by subjects were run one at a time. 
The assumption of homogeneity of variance could not be tested within the 3 (condition) by 8 
(time) mixed design ANOVA due to the small sample size. The SPSS general linear model 
program use to run the ANOVAs was unable to compute Box's Test of Equality of 
Covariance Matrices because of sample size. Also, as stated in the Methods Section, due to 
the small sample size, evaluating the assumption of sphericity and ANCOVA linearity 
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assumption of the relationship between covariates and dependent variables across conditions 
was not warranted. 
Regarding the assumption of normality, again the small sample size limits the 
usefulness of evaluation this assumption. However, for illustrative purposes, the evaluations 
of the normality assumption for two dependent variables are presented here. The Dyspnea 
Effort score at Time 1 had z-scores of less than 1 for both the test of skewness (z = 0.20) and 
kurtosis (z = -0.82) strongly supporting the assumption of normality. Yet, an examination of 
the histogram for this variable strongly suggests that the distribution was not actually normal 
(see Figure 11). The second dependent variable used as an example here was that of arcsin 
transformed oxygen saturation at time 1. Again, neither of the z-scores for skewness (z = 
1.58) and kurtosis (z = 1.22) were significant and thus provided support for the assumption of 
normality. And, again, however, a visual examination of the histogram for this variable 
suggests that the distribution was not actually normal (see Figure 12). 
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Figure 11. Histogram Evaluating Normality Assumption for Dyspnea Effort Time 1 
Histogram 
2 4 6 8 
Cancer Dyspnea Scale Effort Time 1 
Mean =4.82^ 
Std. Dev. =3.25 
N=11 
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Figure 12. Histogram Evaluating Normality Assumption for Arcsin Transformed Oxygen 
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Qualitative Analysis of Themes 
Qualitative data were collected, transcribed, and analyzed for themes. Subjects all 
had a primary diagnosis of end-stage lung cancer. They received palliative care in a hospice 
setting at the time of data collection. Subjects were interviewed twice, pre-treatment and 
post-treatment. All subjects were willing to give answers to qualitative questions but at times 
struggled to communicate due to medical problems, medication effects, and fatigue. Some 
subjects declined to answer the first three questions of the post interview questions because 
they had no additional information to share. Simple thematic analysis was performed with 
the goal of identifying cogent themes that were pertinent to most subjects. There was little if 
any change in themes from pre-treatment to post-treatment. The following is a discussion of 
the six themes that emerged along with one global theme most frequently present outside of 
the formal taping sessions. 
Breathlessness 
Subjects were asked to describe their experience of breathlessness. All subjects had 
at least mild or intermittent bouts of breathlessness and were able to describe these 
experiences vividly. Some descriptions included smothering, drowning, or being buried 
alive. Subjects noted "It was horrible, sheer fright, that is it", and "Terrible, because you feel 
like your gonna die." One description characterized it as "Breathlessness is not panting. It is 
just short breaths without the speed." 
Breathlessness was noted to be associated with fatigue and was seen as a part of 
everyday life: "I am worn out. I still keep trying to walk." and "It's kinda wrapped around 
everything else, I am worn out." Some subjects injected humor into their discussion: "It's an 
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interesting experience. I wouldn't wish it on anybody," "It is like being one of those puffer 
fish," and "I am enjoying the breath I'm getting." Finally, subjects felt that it was a symptom 
that evidenced a great mortality: It's a consequence of something that's life-threatening. It's a 
reminder of how close the end is." 
Suffering 
Most subjects denied that they experienced suffering even with repeated questions 
related to the concept of suffering. Subjects were prompted with possible aspects of 
suffering that included physical, spiritual, and psychological suffering. One subject stated "I 
can't relate to that at all." Another gave the vague response "I can't live my life normal." 
Several subjects gave responses that indicated discomfort at being cared for by others 
to the questions about suffering. Some examples of these responses were: "It is watching 
what my wife has to go through j ust to take care of me... waiting on me hand and feet and 
this hurts me deeply." And "Suffering is irritating. Irritating is having people being bothered, 
paying too much attention to me." 
Finally, several subjects reported anger and sadness at the loss of ability to work and 
the need to accept help from others. One noted also that the future was a "wait and see 
game" of unknown further changes. 
These responses may indicate that suffering was a difficult concept for subjects to 
understand within the context of dyspnea; possibly they associated suffering with extreme 
pain only. Alternately, subjects who self-selected for this study may have experienced less 
suffering. Most subjects seemed to be accentuating the positives in their lives and 
minimizing the negatives. This may have inhibited their discussion of suffering. 
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Quality of Life 
Quality of life questions elicited the biggest response from subjects. These responses 
fell into two general subcategories: loss of abilities and changes in relationships. 
Loss of abilities encompassed the areas of loss of power and energy, loss of ability to 
work, and loss of ability to care for themselves. Subjects spoke about the process of adapting 
to these losses while accepting some loss in the pursuit of maintaining their independence. 
Losses included inability to work outside of home, accomplish activities of daily living, or 
travel. 
Subjects shared their experiences of loss of ability: "I can't do anything. If I could do 
something I know I'd feel better, but I can't do it today." and "(activities) they are very 
curtailed. The center of your life seems to be on breathing rather than on enjoying the things 
in life," and "It's very much slowed me down, my ability to do normal activities has changed 
incredibly." 
They also shared ideas about how they adapted: "I know how to equip myself and I 
go." and "I'm not doing a lot of things I used to, but you can adapt." They accepted some 
losses: "It prevents me from traveling so my family has to travel without me. So it's harder 
for them and not as much fun for me," and "I can't visit like I used to, talk on the phone or 
any of that (for long periods)." 
Changes in relationships were profound. Subjects reported the discomfort of having 
their wives/partners waiting on them, of having other caring for them, the loss of socializing, 
role-reversal, and loss of sex life. "I do have a babysitter.. .my daughter, she is my caretaker 
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now," "Independence, it's everything, everything," "All of my independence has been taken 
away," and "It seems like day by day, its using up your energy and your intelligence." 
One subject spoke of changes in her relationship with her husband and said, "We 
have no sex life. That's sad. God, I could cry. It's because I have no desire, that's the main 
thing, I'm done with that." 
Other subjects reported positive changes in their relationships due to illness: "It has 
brought us closer together in a way that is almost impossible to imagine, a really deep way," 
and "I am more (emotionally) mature than I was when I came into the ICC (in-patient 
center)." 
Experience of Acupressure Therapy 
All subjects found the experience to be pleasant, not noticeable, or minimally 
uncomfortable at times. None experienced significant discomfort or stopped treatment early. 
Subjects were happy with their decision to participate, even without noticeable benefits. 
Two subjects noticed a significant result, one in the reduction of breathlessness and another 
in the reduction of pain and use of pain medication. The subject who reported a decrease in 
breathlessness was in the placebo acupressure group. Still, his qualitative reports of 
breathing more easily are also reflected in his CDS ratings for dyspnea effort across the eight 
time points. His eight dyspnea effort scores for the eight time points were 3, 3, 5, 5, 0,0, 3, 
4, 1. For the subject who reported less breathlessness, this was also noted by interviewer and 
family members. However, the subject did not attribute this change to the acupressure. The 
subject who reported using less pain medication said, "It's beneficial. I think that it might 
have me not needing my Dilaudid." It should be noted this subject was in the placebo 
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condition and that, although the subject attributes the lower pain and less use of medications 
to the acupressure, she stopped taking the medication on the baseline day. Hence, per 
experimental protocol, she did not receive placebo intervention before she stopped taking 
pain medication. 
Some subjects described the experience as pleasant. "Interesting and curious. It felt 
very pleasant," "It's been fun, I enjoyed it," "It works out fine," "Very easy," and "I found 
the whole thing interesting and I was very skeptical". Others noticed nothing during the 
treatment: "It was sort of not an experience," and "It was nothing." Many subjects noted 
their satisfaction in deciding to participate even if they did not notice a benefit: "I'm glad that 
I participated," and "I was hopeful last time but didn't derive much benefit." 
The subject who described the experience as fun and enjoyable was in the 
experimental acupressure condition and on his CDS dyspnea ratings went from 10 to 3 on 
effort and 15 to 8 for the total score. He is also the subject who stated that he would 
recommend the treatment to others: as reported below, "Of course I would, I would 
recommend it 100%." The subject who reported that the experience as being "Interesting 
and curious. It felt very pleasant" was in the placebo acupressure condition and rated dyspnea 
effort and total as quite high across all eight time points. The subject who reported "It was 
sort of not an experience," was in the placebo acupressure group and gave very low ratings (0 
and 1 's) on the CDS for all eight time points across the four days. Given his low ratings 
from the first time point, he could not have shown improvement on the scales. 
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Awareness of Mortality 
Subjects spoke indirectly about the process of death and about fears of discomfort 
during the dying process. They had an awareness that time was limited. Many mentioned 
similar thoughts, of time being short, making the day count, and making the best of your time 
and energy. A few subjects' comments included: "I'm half afraid of something happening," 
"I don't know what will happen at the next stage," "Things mean a lot more and I notice 
things," and "I was too far gone for immediate help." 
Recommendation of Acupressure for Others with Lung Cancer 
Subjects generally were positive in recommending it to others in similar situations. 
Some noted that it was not clearly proven to work. Others noted that it would do no harm 
and there was little risk associated with trying it. Others noted that cancer put them in a 
precarious position and that they would try almost anything. 
The positive comments included, "Of course I would, I would recommend it 100%" 
and "Absolutely, I would recommend it highly." More cautious comments included, "I 
haven't seen any advantage and I haven't seen any disadvantage," and "I don't know, I really 
don't know." Harm was a big component in recommending acupressure for others with lung 
cancer, as evidenced by the comments such as "It didn't do me any harm " and "It didn't hurt 
me any." Cancer-related comments included, "When you are in my position, you really try 
anything as long as it doesn't interfere with your traditional treatment." 
Finally, there was a sense of hopefulness in one subject who said, "I would 
recommend anybody try it. It is something new and different, and that is where the promise 
is, in something new and different I think, so yes, I would recommend it." Another subject 
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said "I hope if it don't help me, it will help others with their breathing and their quality of 
life." Other subjects also spoke of the possibility that the treatment might help someone else 
more that it helped them. 
Global Theme: Helping Others and Meaning 
Subjects spoke outside of actual taping about their desire to help others with similar 
health challenges and to leave something positive behind. They were looking beyond 
themselves with a positive view of life, wanting to be involved with something bigger than 
themselves. Many had hopeful attitudes about their own illness, and positive attitudes about 
growing and maintaining relationships. They chose freely to participate in the study even 
though they were experiencing fatigue and breathlessness at times during the study, and were 
at the end of life. These comments and behaviors point to a desire for connection with others 
and a wish to contribute to the well being of others and continuing to have meaning in their 
own lives. 
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Chapter 5 Discussion 
Purpose of the Study and Preliminary Overview of Results 
The primary purpose of this research was to conduct a pilot feasibility study for 
evaluation of the effects of auricular acupressure on dyspnea in hospice patients with a 
primary lung cancer diagnosis. The general conclusion regarding feasibility is that this type 
of study can be done, although it is quite difficult, as has been previously reported (Storey, 
2004). Of the 74 patients approached, 11 (14.9%) were enrolled as subjects. Twelve 
additional patients did accept the invitation to be in the study, but before they could be 
enrolled, their condition quickly deteriorated and they began the active dying process. This 
emphasized the general fragility of this population. Had these 12 additional patients lived to 
participate in th& study, the enrollment rate would have been 31.1%. Storey (2004) reported 
that, in the hospice where he was conducting the research, there was a steadily decreasing 
average length of stay that, "By the time patients were admitted they were usually too ill to 
participate." (p. 393) 
Importantly and similar to what is found in the literature (Ferrell and Grant, 2001; 
Fine, 2003; Emanuel, et al., 2004), the subjects in this study generally stated that they liked 
and valued participating in this study. It has also been reported in the literature that from half 
(Williams et al., 2006) to all (Terry, et al., 2006) hospice patients said that they would like to 
be in some research. As is discussed below in the sub-section on implications for future 
research, it might be helpful in the initial recruitment stage to tell potential subjects that most 
patients find attractive the idea of participating in research and those who have actually been 
in such research state that they liked the experience. 
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As part of the feasibility assessment, the planed quantitative and qualitative analyses 
were carried out. The statistical analyses were used to determine whether effects were 
present and to estimate effect sizes that might be used in planning future research. There was 
a statistically significant effect for the auricular acupressure with the general effect sizes 
being from medium to large. Even the non-significant results generally had the expected 
pattern of changes over time as a function of experimental condition. The qualitative results 
yielded six themes and one global theme. 
Testing of Hypotheses and Estimating Effect Sizes 
The experimental effects of primary interest in this study were those of treatment 
condition by time interactions with the expectation that the interaction effects would be linear 
in form. Linear in form means that the changes over time would have the general shape of 
change in one direction. In general, estimation of these effect sizes yielded medium to large 
effects with the larger effects being for linear shapes. For the dependent variable of Dyspnea 
Effort, this interaction was statistically significant and linear with the effects of actual 
auricular acupressure being greater than those of either the control or the placebo acupressure 
conditions. It is surprising that the Dyspnea Effort was significant given the small sample 
size, but it was carried by the very large effect size. Dyspnea Anxiety and Dyspnea Total 
both had large condition by time interaction effects as well, although they were not 
significant. Dyspnea Discomfort had much smaller effect sizes and no overall linear pattern. 
ANCOVA was used to test for the effects of possible covariates when the dependent 
variable was Dyspnea Effort. Dyspnea Effort was used in these examples because it had the 
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only statistically significant condition by time interaction. Age and support were used as 
example covariates. 
Age was not related to the dependent variable and the ANCOVA results reflected this 
in that the condition by time interaction was still significant and large. Given the absence of 
any substantial relationship between age and the dependent variable, this was expected. For 
the second example, the level of support was used because it was related to Dyspnea Effort. 
Here the ANCOVA still yielded a large condition by time interaction effect, but the effect 
was not significant, neither for the overall interaction nor the test of the linear form (although 
the p-value for linear form was .074). 
This same pattern of change was also found for the dependent variable oxygen 
saturation. Here for both the raw percent and arcsin transformed variables, the condition by 
time interaction effects were large ones, although neither was statistically significant. That 
the same pattern of change over time was present for oxygen saturation as for dyspnea was 
also reflected in the presence of some correlations between oxygen saturation and self-
reported dyspnea. This is interesting because often the experience of dyspnea is not directly 
related to physical assessments. Even with oxygen therapy as a treatment for dyspnea, there 
is some lack of clarity as to its effectiveness. 
Some research has been shown oxygen therapy to be helpful in ameliorating dyspnea 
(Bruera, Stoutz, Velasco-Leiva, Schoeller, and Hanson, 1993). Other research has shown 
that oxygen is not more helpful than administration of air, although both do help (Booth, 
Kelly, Cox, Adams, and Guz, 1996). Sadly, a recent review of literature on oxygen and 
airflow effects for treatment of dyspnea found that there were no earlier systematic reviews 
of this literature and that most published studies, both case studies and case control studies, 
had small samples without matched or cohort controls (Gallagher and Roberts, 2004). These 
authors concluded that there is little solid high-grade scientific evidence for oxygen or 
airflow improving dyspnea. 
Statistical assumptions were evaluated and were technically met. However, for 
example, the distributions did not look normal. Still, lack of their both not looking normal 
and not being found different from normality may itself be due to the small sample size. 
Larger sample sizes may indeed yield data distributions that both look reasonable and meet 
assumptions. The perils of small a sample size was also apparent in the example of scatter 
plots that was run (see Figure 10). Arcsin transformed oxygen saturation was highly 
correlated with Dyspnea Anxiety at Time 2. However, this relationship was carried by a 
single subject. When that subject was removed from the analysis, the correlation became 
much smaller. 
Qualitative Results 
For the simple thematic analysis of qualitative data, six themes emerged along with 
one global theme. The presence of six themes was surely partly due to the questions that 
were asked. The six themes were breathlessness, suffering, quality of life, experience of 
acupressure therapy, awareness of mortality, and recommendation of acupressure to others 
with lung cancer. Strikingly, the content across these six themes was similar to that listed by 
Ferrell and Coyle (2001). These included the four dimensions of quality of life: physical, 
psychological, social, and spiritual, although there was not much regarding the latter (see 
below). Some specific content areas listed'by these authors were also found here: social 
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relationships, sexual intimacy, visiting family and friends, being a burden to others, concern 
about the suffering of others because of oneself, and working and employment. 
The global theme that emerged was that the subjects enjoyed and/or valued their 
participation in the study. They spoke of the experience as being one of still being useful, 
potentially helping others, and providing a sense of continued purpose. It may be that the 
process of gathering the qualitative data was itself part of why every subject communicated 
that they enjoyed and/or valued being a part of this research. The qualitative process allowed 
a specific opportunity for the subjects and researcher to engage in a conversation. It is also 
of note that there were some relationships between what an individual said during the 
qualitative assessments and what he or she reported on the CDS. 
It is also interesting that only one subject mentioned much about spirituality, and her 
comment was that she did not feel that she was being punished by God. This general lack of 
response may have been a function of how the question was asked or that the qualitative 
questions specifically addressed the experience of dyspnea. Even the quality of life question 
was focused on dyspnea. There is research that supports the important role of spirituality in 
the well-being of patients with lung cancer (Meraviglia, 2004). 
Regarding changes over time, many subjects reported no such major changes. This is 
reflected in many subjects also not responding much to the first three qualitative questions at 
the end of the study what were asked at the beginning. Notably there were some 
relationships between the qualitative and quantitative analyses. For example, the one subject 
who spoke of her experiences of general anxiety was also the subject who scored the highest 
on Dyspnea Anxiety. 
Study Limitations 
Although as a feasibility study, it was expected that the sample size would not be 
large, the sample size of 11 that was gathered did pose problems not only of issues of 
statistical power, but for the confidence that one could have in the reliability of the estimates 
of effect size. For example, this can be clearly seen in the scatter plot of Figure 10 were a 
single subject can be understood as having a disproportionate affect on the estimation of the 
effect size of the relationship between Dyspnea Anxiety and the arcsin transformed oxygen 
saturation. 
Beside sample size there is the issue of sample recruitment not reflecting 
characteristics and attributes of the population being sampled. For example, there is little 
ethnic or racial diversity. This means that any generalizations one might wish to make, even 
based on such a small sample, would necessarily be limited. Of course, even if the sample 
were large and representative of those at San Diego Hospice and Palliative Care, the 
population at the San Diego Hospice and Palliative Care may not be the same as other 
hospice and palliative care centers elsewhere in the country. 
The researcher read the CDS out loud for nine of the 11 subjects. It is unknown what 
effects this may have had on the responses of the subjects. In future research, having the 
instrument read to the subjects versus the subjects being able to read the instrument 
themselves would need to be evaluated. Since in this study it was the subject who 
determined whether to have the researcher read the CDS, those who were having more 
difficulty may have made such a request. Regarding the issue of reading effects, see the 
discussion in the future research implications above. 
123 
Although the CDS is a multi-dimensional, it is still a single instrument. Results using 
other assessments may be different. This is one reason to use more than a single instrument, 
even with the increase in subject research burden. 
An important limitation and a possible explanation for the effects that were found in 
this study is that not all personnel were blind to the experimental conditions. Although the 
primary researcher and the subjects in the two acupressure conditions were blind to their 
treatment, the acupuncturist was not. This could have produced a form of experimenter 
expectation effect. However, the presence of such an effect here is not supported by the 
pattern of results across the dependent variables. Why would such an effect affect Dyspnea 
Effort, Dyspnea Anxiety, and oxygen saturation while not affecting Dyspnea Discomfort? 
Nonetheless, the general issue of blindness in such research needs careful consideration. 
Nursing Profession Implications 
Dyspnea, a leading symptom among lung cancer patients as well as among end-of-life 
patients, can create a feeling of suffocation. Further, Ferrell and Coyle (2001) report, 
"Studies tell us that most people fear a protracted, painful death; unfortunately, this is what 
many experience. Palliative nursing care seeks to change this" (p. 26). Ferrell and Coyle 
(2001) also note, "Nurses spend more time with patients and families facing advanced illness 
than do any other health care professionals and are intimately involved in all aspects of end-
of-life care" (p. 29). Hence, it is important that nurses understand dyspnea, its treatment, and 
treatment alternatives. 
It is important to keep in mind thata person can have high oxygen saturation and still 
be experiencing extreme dyspnea. It is the patient's experience, not the observation of others 
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that is central. Additionally, dyspnea does appear to be multi-dimensional. In this study, 
using a multi-dimensional assessment of dyspnea, dyspnea related effort and anxiety 
appeared to change over time due to auricular acupressure while discomfort did not. Also, 
total dyspnea did not significantly change over time as a function of condition, although 
some of its sub-scales did. This general point is reinforced by the previously cited research 
by Carrieri-Kohlman et al. (1996) who used a visual analog scale that subjects employed to 
rate components of dyspnea. The four components of dyspnea were effort in breathing, 
shortness of breath, distress associated with dyspnea, and dyspnea associated anxiety. They 
found that the subjects could and did differentiate among these four components. These four 
components are quite similar to the three sub-scales of the CDS: effort, anxiety, discomfort. 
If such procedures as auricular acupressure are shown to be helpful with symptoms 
like dyspnea, it may be possible to incorporate them into the hospice and palliative care 
settings. For example, Johnstone, Polston, Niemtzow, and Martin (2002) report on the 
integration of acupuncture into the oncology clinic of the Naval Medical Center in San 
Diego, California. 
Other implications for nursing would include the education of nurses, nursing staff 
faculty, and hospice staff regarding CAM and regarding research generally. Specifically, it 
might be reasonable to provide information on how to complement Western Medicine with 
the use of CAM in symptom management. Additionally, it might be beneficial to both end of 
life patients and to the field to educate nurses regarding the potential experience of end of life 
patients when they participate in research. Specifically, as reflected in this study, end of life 
patient participants expressed that this experience added purpose to their lives through 
potentially helping others. This might lead to nurses being appropriately less protective of 
such patients when being approached by researchers seeking end of life patient participation 
in research. 
Future Research Implications 
This feasibility study certainly demonstrated that researchers should expect such 
research to take long periods of time to complete if designed as this study was. One way of 
shortening the time required would be to have more than one experimenter and more than 
one source of potential subjects. A possible positive implication of this study is that the 
effects involved may be quite large. If so, then the required sample sizes would be smaller 
than if the effects generally medium or even small. However, see the limitations of the study 
section above regarding concerns about the estimation of effect sizes in this study. 
Related to issues of time for recruitment and low recruitment rates, reducing subject 
research burden might help. One way of reducing some potential subject burden might be to 
use ratings by nursing staff and/or caregivers. Moody and McMillian (2003) found, 
"Patients' and caregivers' ratings of the patient's dyspnea intensity revealed no significant 
differences in ratings thus verifying that caregivers can assess dyspnea severity accurately" 
(p. 1). However, if such an approach is used, there should be careful consideration of the 
general issue that dyspnea is a symptom experienced by the patient. In the Moody and 
McMillan (2003) study, the measurement of dyspnea was done using the Memorial Symptom 
Assessment Scale (MS AS). Perhaps the results of this study are specific to this instrument. 
Perhaps involvement of hospice patients, their caregivers, and hospice nurses would 
be helpful in the development of research protocols that would lead to better recruitment of 
subjects and a better experience for all involved, including the identification of other ways to 
lessen as much as possible subject research burden. Moody, Webb, Cheung, and Lowell 
(2004) report on the use of a focus group of caregivers of hospice patients with severe 
dyspnea to gather information that might help in research and treatment. 
Although it may add to subject research burden, thought should be given using 
another dyspnea instrument in addition to the CDS. Because of its general utility, its use in a 
great deal of successful previous research, its psychometric properties, and its low subject 
research burden, the visual analogue scale might be considered. It was a set of such scales 
that was used by Carrieri-Kohlman et al. (1996) cited above. It might be interesting and of 
value to use four such scales, one for each the scores that can be derived from the CDS: 
effort, anxiety, discomfort, and total. 
An important design addition to future research would be not only larger samples, but 
more diverse samples. Although the sample in this study was too small and had too little 
diversity regarding ethnicity and race to evaluate the effects of such variables, still it would 
be important in future research to assess the effects of such variables as age, sex, ethnicity, 
race, education, etc., since such characteristics may be related to response to auricular 
acupressure as well as to the experience of dyspnea. This would be the case for both 
quantitative and qualitative methodologies. For example, Hardie, Janson, Gold, Carrieri-
Kohlman, and Boushey (2000) found that African-Americans as compared to white patients 
with asthma were different in their perception of breathlessness and in the words that they 
used to describe their breathlessness during induced airflow obstruction. 
Generally, it appears that the best type of research approach would seem to involve 
both quantitative and qualitative methodologies. Not only for the arguments made in the 
earlier section on issue of hospice and palliative care research, but because use of at least 
127 
some qualitative methodology may be helpful in ensuring that the subjects value more being 
in research and are more willing to continue in a project. It is also an opportunity for the 
subjects and researchers to have conversations and exchanges that are not limited to 
structured instruments. Additionally, even if there were no benefits to the researcher and the 
study, use of such methodology could be considered part of what the researcher does for the 
subjects and their end-of-life experience. 
In the current study, most subjects requested that the researcher read the CDS to 
them. Having the instrument read to a subject versus the subject reading the instrument may 
have effects on subject responses. This is particularly the case since those subjects who are 
having more difficulty may be more likely make such a request. For future research to 
evaluate possible effects here, researchers might take all those subjects who can read the 
instrument themselves and randomly assign them to one of two conditions: being read to 
versus reading themselves. 
Regarding qualitative open-ended questions, it is interesting to note that the dyspnea 
measures showed an increase in dyspnea assessments at time 7. This was the morning of the 
last day of the study. The subjects were aware that the study was then ending. It may be that 
this increase in dyspnea experience reflected a more general distress response to the end of 
the study, the loss of twice daily visits from the acupuncturist and the researcher, and the loss 
of any perceived benefit of the acupressure. Future research might include a question about 
the subjects' response to the study ending, their interest in the study continuing, their interest 
in continuing acupressure, and any distress that they are experiencing at study's ending. 
In the current study, the researcher,was blind to the placebo versus experimental 
auricular acupressure, but the acupuncturist was not. This could have allowed for some 
experimental expectation effect (see limitations of study section below). This is a common 
problem for such complementary treatment studies as those involving acupuncture or 
acupressure. Still, in future research, since auricular acupressure points are specific to 
individuals and are thus individually placed, it may be possible to have an acupuncturist 
place the seeds, but have the patient, a caregiver, a nurse, or a research assistant do the 
stimulation of the seeded areas. This might be one way to reduce the opportunities for an 
experimenter expectancy effect. 
Finally, this study did find medium to large effect sizes for the impact of one form of 
CAM on one important symptom, dyspnea. It might be reasonable for future research to 
exam different CAM approaches and/or the effects of CAM on other important symptoms. 
More generally, it might be of interest to evaluate the impact on general quality of life when 
a patient participates in CAM approaches to the management of symptoms. 
Conclusions 
The primary conclusion here is that such a study is feasible. It may take longer than 
initially expected, but it can be done. The experience with this study highlighted the 
importance of paying attention to and attempting to improve subject recruitment. 
Another conclusion would be that the results of this study suggest that there may be 
medium to large effects of auricular acupressure on the experience of dyspnea. The likeliest 
outcome is that the effects are probably medium, since any confidence placed in these results 
should be made with caution because of the small sample size. 
The CDS performed well and the importance of the multi-dimensionality of the CDS 
was highlighted by the differential pattern of results across the CDS sub-scales. Still other 
instruments should also be used in future research so that the results will be more 
generalizable. Also, other instruments may define additional components of dyspnea. 
Using both qualitative and quantitative methodology was important. In fact, the use 
of both qualitative and quantitative methods might be the best way to advance the field. 
Within quantitative methods, the use of both randomized control trials and quasi-
experimental designs may be helpful given the difficulties of developing reasonable control 
or sham conditions. Even in the face of important concerns and challenges, both ethical and 
practical, palliative care research must continue to be carried out. Such research should 
include compliments to Western medicine such as auricular acupressure. As stated earlier, 
given the goals of palliative care, not conducting research would itself be unethical. Ferrell 
(2004) writes, "There is no option to avoid research within the field of palliative care, as like 
all disease areas, there is a critical need to conduct research to advance the field. Improved 
care will not happen without inquiry." (p. 408) 
In the end, there are two basic points. One, there is a continued need for symptom 
control at end of the life (National Institutes of Health, 2005). Two, the role of nursing is 
central to end of life care. 
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APPENDIX A 
REVISED SYMPTOM MANAGEMENT CONCEPTUAL MODEL (RSMC MODEL) 
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APPENDIX B 
BACKGROUND INFORMATION FORM 
BACKGROUND INFORMATION 
Instructions: 
Please check or provide the most accurate response in each question. 
Please answer every question. 
The information that you give will be held in the strictest confidence and your 





What is your sex? 
1. Female 
2. _ Male 
What is your age? 
What is your marital status? 
1. single 
2. married 




What is your ethnic/racial background? 
This has two parts. Please answer both. 
A. 
1. Not Hispanic or Latino 
2. Hispanic or Latino 
B. 
l . _ White 
2. Native Hawaiian or Other Pacific Islander 
3. Black or African American 
4. Asian 
5. American Indian or Alaska Native 
5. What is the highest educational degree you obtained? 
1. none 
2. high school diploma 




7. other If other, please specify 
6. What is your approximate current yearly salary? 
7. How many family members and friends do you have that you can count on and that 
live within 50 miles of the inpatient care center? 
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THE CANCER DYSPNEA SCALE 
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The Cancer Dyspnea Scale (Tanaka, et al. 2000) 
We would like to ask you about your breathlessness or difficulty in breathing. Please answer 
each question by circling only the numbers that best describe the breathing difficulty that you 
felt during the past few days* Base your response on your first impressions. 
Use the scale of 
1= Not at all 
2 = A little 
3 = Somewhat 
4 = Considerably 
5 = Very much 
1 2 3 4 5 1. Can you inhale easily? 
1.2 3 4 5 2 . Can you exhale easily? 
1 2 3 4 5 3. Can you breathe easily? 
1 2 3 4 5 4. Do you feel short of breath? 
1 2 3 4 5 5. Do you feel breathing difficulty accompanied by palpitations and 
sweating? 
1 2 3 4 5 6. Do you feel as if you are panting? 
1 2 3 4 5 7. Do you feel such breathing difficulty that you don't know what to do 
about it? 
1 2 3 4 5 8. Do you feel your breath is shallow? 
1 2 3 4 5 9. Do you feel your breathing may stop? 
1 2 3 4 5 10. Do you feel your airway has become narrower? 
1 2 3 4 5 1 1 . Do you feel as if you are drowning? 
1 2 3 4 5 12. Do you feel as if something is sticking in your airway? 
*For this research, on the first administration these instructions will read, "that you felt in the 
last 12 hours," and on subsequent administration will read, "that you felt since the last time 
you completed this scale." 
Computation of three factors [subtractions adjust for 0 as state of absence of dyspnea]: 
Factor 1 [sense of effort] = (items 4 + 6 + 8+10+12) -5 
Factor 2 [sense of anxiety] = (items 5 + 7 + 9 + l l ) - 4 
Factor 3 [sense of discomfort] = 15 - (items 1 + 2 + 3) 
For total scores add the three factors together. 
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APPENDIX D 
HUMAN SUBJECTS RESEARCH 
Human Subjects Research 
An Overview of Subject Selection and Characteristics. 
The composition of the sample being studied was established by the requirements of 
subject selection per the purpose, aims, and hypotheses of the study. Subjects were recruited 
over the course of 2007 to 2008. These volunteer subjects were end stage lung cancer 
patients hospitalized in a free-standing inpatient care center that was within a hospice. 
Inclusion criteria consisted of lung cancer diagnosis, English speaking, and ability to 
communicate with the researcher. There were no sex or ethnicity criteria for enrollment, 
although there was an age inclusion criteria of 45 or older. It is also important to note that 
none of these subjects were selected because of any present mental illness, and there were no 
subpopulations chosen because of pregnancy, prisoner status, institutionalization, or for any 
specific characteristic other than their being lung cancer patients enrolled in a hospice 
program. 
Inclusion of Women. Given the nature of the populations within hospice settings, there were 
women as well as men enrolled in the study. Therefore, we believe that this investigation 
adequately gathered information relevant to females and males. 
Inclusion of Minorities. Minorities were present in the current study population. These 
groups could have include Latino, Native American, African American, Asian (South East, 
Chinese, Korean, Japanese), and Ethiopian, but only Latino and Native American enrolled. 
Inclusion of Children. Due to the nature of the research question, there were no children in 
the study's sample. 
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Sources of Research Material. 
The materials gathered were generated from patient charts, questionnaires, a pulse-
oximeter, and up to five open-ended questions for qualitative data that were tape recorded 
and then transcribed. There were two questionnaires: a demographic survey asking for basic 
descriptive information and the Cancer Dyspnea Scale (CDS). All materials were limited to 
specific research purposes that were outlined in the proposal. 
Potential Risks. 
There were no significant risks known to be associated with the protocol. As described in 
the proposal, the subjects responded to a brief demographic questionnaire, one 
psychometrically sound instrument used to assess dyspnea (the CDS), and up to five open-
ended questions that were tape recorded and transcribed. Subjects were free not to 
participate and free to refuse any questions or testing they would like. No medications or 
similar materials were administered to subjects, and no blood draws or invasive procedures 
were included in this protocol. The treatment intervention consisted of a non-invasive 
auricular acupressure procedure that involved the use of small seeds with an adhesive 
backing that were applied to the ear at designated breath and anxiety related points. A 
placebo condition consisted of non-invasive use of small seeds with an adhesive backing that 
were applied to the ear at points other than those designated for breath and anxiety. There 
were no needles used and the skin was not broken. However, there was some risk regarding 
any allergic reaction to the adhesive used fpr the auricular acupuncture, although no were 
present Additionally, given the age and medical conditions of these research participants, it 
was possible that skin tears could take place, although, this did not happen. Finally, 
participating in this protocol could have produced fatigue in the subjects over and above that 
which would be found in this population generally. However, there was no more fatigue 
present than they would normally have. 
There was a minimal risk for psychological harm through responding to the CDS. Again 
however, this scale had been used in previous research with similar populations without 
reports of such harm and no such harm was reported here. 
The pulse-oximeter was simply placed on the finger of the patient. This procedure was 
also non-invasive involving no broken skin. 
Procedures for Protecting Subjects and Minimizing Risks. 
In this study, the protection of human subjects was an important consideration. The 
following briefly describes the steps taken: 
Informed Consent. Consent was obtained from each subject using IRB approved consent 
forms. The consent form was presented to the subject along with a written description of the 
study and a copy of the Medical Research Patient's Bill of Rights. The consent process, the 
use of demographic questionnaire, the CDS, the pulse-oximeter, and the protocols for 
managing the data were evaluated by two IRBs. One IRB was from USD and the other was 
from San Diego Hospice and Palliative Care. An additional consideration for this informed 
consent in this research was the enrollment of hospice patients. The National Hospice and 
Palliative Care Organization (NHPCO) (Casarett, Ferrell, Kirschling, Leveton, Merriman, 
Ramey, & Silverman 2001) procedures regarding the ethics of hospice participation in 
research were used. 
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Procedures to Protect Confidentiality. Careful procedures were instituted to protect 
confidentiality. These included having all research material identified only by code numbers, 
keeping any information that connects codes with specific names in a locked file cabinet with 
access limited only to the research personnel working on this protocol, and keeping access to 
the computer storage of information only to those individuals directly involved in this study. 
Special considerations were taken regarding maintaining security of computerized 
data. These include using complex passwords for access; avoiding any easily guessed 
password for any of the datasets; working with computer experts; data were stored and 
analyzed on a computer system isolated from the internet; and with steps taken to build a 
wall against Trojan-horse-like programs. All data will be kept for 4 years before being 
destroyed. 
Pledges of Confidentiality were signed by the acupuncturist, statistical consultant, 
transcriber, and qualitative data analyst expert. Copies of these signed Pledges of 
Confidentiality can be found in Appendix H. 
Risk Reduction. Subjects were asked whether they have any known allergies for adhesives or 
tape. Additionally, the site of the adhesive use was monitored for any allergic reaction. Skin 
integrity was monitored during both the application and removal of the adhesive to prevent 
and ameliorate skin tear. Regarding fatigue, this too was monitored during the subjects' 
participation in the four-day protocol. The subject were both directly asked about experience 
of fatigue and observed for any evidence of increasing fatigue over the course of the 
protocol. 
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All Personnel Were Well Trained and Were Monitored Regarding Maintenance of 
Confidentiality and Other Human Subjects Protection Issues. 
The person administering auricular acupuncture was an acupuncturist (LAc) licensed 
by the state of California. This individual was trained at and a graduate of the Pacific 
College of Oriental Medicine. 
All research staff was trained regarding confidentiality procedures. All consent forms 
were in accordance with HIP A A regulations and were reviewed by two IRBs. All project 
staff working on the study complied with HIPAA regulations by taking online training, 
including: 1) Research Aspects of HIPAA Tutorial, 2) Basic principles of Human Research 
Subjects Protection, and 3) Basic HIPAA 1021: Workforce Training. All individuals 
working on the study also complied with HIPAA regulations by signing a Healthcare 
Confidentiality Agreement [see Pledges of Confidentiality in Appendix H). Part of this 
training and ongoing supervision involved reminders regarding the need to never put 
identifying information inappropriately into the computer or onto any of the research 
instruments. Once the demographic questionnaire and the CDS had been completed, no 
identifying information was kept in the same database as the completed forms. Identifying 
data were kept in a locked file cabinet with access limited to the doctoral student and the 
specific research assistants for whom such information was essential. Furthermore, a series 
of safety measures were developed and limited access to information stored in password-
protected computers. 
Use of Control Groups with Option for Treatment Procedure. Although a control group and 
a placebo group were used in this study, the control group was a standard care condition and 
the placebo group was a standard care condition and were also administered the same non-
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invasive auricular acupressure seed adhesives but not on breath or anxiety points. Subjects 
who were randomly assigned to these conditions were given the option of receiving the 
auricular acupressure seed adhesive procedure immediately following completing their 
participation in the study. 
Potential Benefits of the Proposed Research and the Safety Ratio. 
This research helped evaluate the effectiveness of auricular acupressure in reducing 
dyspnea in end of life hospice patients with lung cancer. This is a common symptom and one 
that is not generally well managed. Also, the results supported the relevance of the UCSF 
School of Nursing Symptom Management Faculty Group's Model for Symptom 
Management to the symptom of dyspnea. 
Benefits to the individual subject included the possibility of having some relief from 
the experience of dyspnea. Benefits also included the possibility of having a sense of 
purpose, the ability to contribute to helping other individuals who are or will be facing the 
same problem. Such a sense of being useful and of value has been anecdotally reported by 
end of life patients even for participating in rounds and teaching of medical students. Indeed 
this experience of meaning and purpose has been reported in research literature (see Chapter 
1, section Hospice and Palliative Care) and it was also reported by all but one subject in this 
research study. 
When one considered the low level of risk involved in this research that used only 
non-invasive procedures, the careful steps to optimize confidentiality, and the potential 
benefits of the research including that to the participating subjects, the ratio of risks to 
potential benefits appeared to be extremely low. 
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APPENDIX E 
HUMAN SUBJECTS TRAINING DOCUMENTS 
Human Participant Protection' "Education for Research Teams Page 
Completion Certificate 
This is to certify that 
Roger Strong 
has completed the Human Participants Protection Education for Research Teams online course, 
sponsored by the National Institutes of Health (NIH), on 06/18/2005. 
This course included the following: 
• key. historical events and current issues that impact guidelines andlegislation on human participant 
protection in research. 
• ethical principles and guidelines that should assist in resolving the ethical issues inherent in the 
conduct of research with human participants. 
• the use of key ethical principles and federal regulations to protecthuman participants at various stage 
in the research process. 
• a description of guidelines for the protection of special populations in research. 
• a definition of informed consent and components necessary for a validconsent. 
• a description of the role of the IRB in the research process. 
• the roles, responsibilities, and interactions of federal agencies, institutions, and researchers in 
conducting research with human participants. 
National Institutes c 
http://www 
Home | Contact Us | Policies | Accessibility | Site Help | Site Map 
A Service of the National Cancer Institute 
4 "FmsTGov 




This is to certify that 
Jeffrey Smith 
has completed the Human Participants Protection Education for Research Teams online course, 
sponsored by die National Institutes of Health (NIH), on 08/16/2007. 
This course included the following: 
• key historical events and current issues that impact guidelines and legislation on human participant 
protection in research. 
• ethical principles and guidelines mat should assist in resolving the ethical issues inherent in the 
conduct of research with human participants. 
• ore use of key ethical principles and federal regulations to protect human participants at various stages 
in the research process. 
• a description of guidelines for the protection of special populations in research. 
• a definition Of informed consent and components necessary for a valid consent 
• a description of the role ofthelRB in the research process. 
« die roles, responsibilities, and interactions of federal agencies, institutions, and researchers in 
conducting research with human participants. 
National Institutes of H 
http://www.nir. 
Home | Contact Us [ Policies [ Accessibility [ Site Help [ Site Map 
A Service of the National Cancer Institute 
0& l%s'rcx>v 
Completion Report P 
CITI Course in The Protection of Human Research Subjects 
Human Research Curriculum Completion Report 
Printed on Thursday, February 1, 2007 
Learner: Tom Smith (username: thurber6) 
Institution: San Diego, CA-664 
Contact 9326 Twin Trails Dr. #205 
Information: San Diego, CA 92129 USA 
Department: Psychiatry Research 
Phone: 858-642-3883 
Email: dtomr@aol.com 
2006 VA PRIDE Curriculum: 
Stage 2. Refresher 1 Course Passed on 02/01/07 (Ref # 873056) 
Required Modules 
101 Refresher Course - History and Ethics 
101 Refresher Course - Regulations and Process 
101 Refresher Course - Informed Consent 
101 Refresher Course - Social and Behavioral Research 
101 Refresher Course - Records Based Research 
101 Refresher Course - Genetics Research 
101 Refresher Course - An Overview of Research with Vulnerable 
Subjects 
101 Refresher Course - FDA Regulated Research and Conference on 
Harmonization 
101 Refresher Course - Conducting human subjects Reserch at the 
VA 
GCP Update Course: Module 1, Good Clinical Practices for VA Staff 
GCP Update Course: Module 2, Accountability 
GCP Update Course: Module 3, Informed Consent 
GCP Update Course: Module 4, Safety Reporting 
GCP Update Course: Module 5, Documentation 
GCP Update Course: Module 6, Privacy and Confidentiality 



















For this Completion Report to be valid, the learner listed above must be 
affiliated with a CITI participating institution. Falsified information and 
unauthorized use of the CITI course site is unethical, and may be considered 
scientific misconduct by your institution. 
Paul Braunschweiger Ph.D. 
Professor, University of Miami 
Director Office of Research Education 
CITI Course Coordinator 
Q a t n r n 
Certificate: VA Research Data Security And Privacy 
Employee Education System 
Certificate of Completion 
This is to certify that 
Thomas Smith 
has completed the course entitled 
VA Research Data Security And Privacy 
The Employee Education System has presented this 
Continuing Education Activity for 1 contact hour(s) 
The Employee Education System maintains responsibility for the program. 
This On-Line Course was completed on Tue May 15 11:23:32 PDT 2007 
Joy W. Hunter 
Dean, VA Learning University 
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AURICULAR ACUPRESSURE POINTS 
Accupressure point 














SAN Dieqo Hospk* IRB 
CENTER ton PAUIATIVE Studies 
HUMAN Sutfccra tomtom 
AppnovEd by-. ^ = » 0 
E . T f w f r - > - K ? - ' * . o g > B CPS STUDY #: 03-01 ( 
SPONSOR STUDY # 
CENTER FOR PALLIATIVE STUDIES 
PATIENT INFORMATION AND CONSENT FORM 
PROTOCOL TITLE: 
CPS SUTUDY NUMBER: 
SPONSOR PROTCOL NO.: 
SPONSOR: 
INVESTIGATOR: 
Dyspnea: Effect of Auricular Acupressure in End Stage Lur 
Cancer Patients 
CPS Study: 03-010-ED 
Not Applicable 
Not Applicable 
Roger Strong, APRN, BC-PCM 
San Diego Hospice & Palliative Care 
4311 Third Avenue 
San Diego, CA 92103 
This consent form may contain words you do not know. Please ask the study nurse 
the study staff to explain any words or procedures that are not clear to you. 
INTRODUCTION 
We are asking you to take part in a research study. The nurse in charge of the study has ft 
that you meet what is required to take part in this study. Please read this consent form befi 
you agree to take part in this study. 
This consent form contains facts to help you decide if it is in your best interest to take part i 
study. Study staff members will help with any questions that are not answered for you in th 
consent form. 
The Principal Investigator is a student in the Doctoral Program in the School of Nursing at t 
University of San Diego. San Diego Hospice in combination with University of San Diego r 
approved this study. 
PURPOSE OF THE STUDY 
The purpose of this research study is to evaluate the use of pressure on parts of the exterr 
ear in helping control the experience of shortness of breath in lung cancer patients. 
DESCRIPTION OF THE RESEARCH STUDY 
This study will involve about 45 patients at one center in the United States. 
Your participation will last S days. 
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Screening: 
• Researchers will explain the study to you and obtain informed consent. 
• You will be asked to be part of the formal study for 5 days. 
• If you agree, you will complete one brief background information form at the beginni 
(takes about 3 minutes). 
• If you participate, you will agree that the researchers can look at your medical recon 
record your receiving oxygen, respiratory treatments, or medications for pain or to h 
you breath. 
• If you participate, you will be assigned to 1 of 3 usual care groups. 
Randomization: 
If, based upon the results of the screening tests, you continue to qualify for the study; you \ 
randomly assigned by chance (like a flip of a coin) into one of three treatment groups: 
• Standard care (SC). 
• Standard care plus auricular acupressure with points for lung and anxiety (SC + AE 
• Standard care plus auricular acupressure with placebo points (SC + AP). 
You will have a 33-1/3% chance of receiving standard care, standard care plus auricular 
acupressure with points for lung and anxiety, or standard care plus auricular acupressure \ 
placebo points. 
The statistician will randomly assign you into one of three groups. Neither you nor your sh 
nurse will know which of the treatments you are receiving. The acupuncturist, student inte 
and statistician only will be aware of who is receiving the auricular acupressure (SC +AE), 
auricular acupressure (SC +AP). 
Audiotape Recording: 
At two times you will be asked for verbal responses to some short questions. We will audi 
record what you tell us. You may ask us not to record certain things, and we'll turn off the 
recorder for that part. Anything you tell the researcher or assistant will be kept confidentia 
the extent permitted by law. We are required by state law to report any abuse and the ide 
of the alleged offender if you should tell us that information. Everything you tell us on tape 
be typed without using your name. The actual tape recording of your voice will not be hes 
anyone other than the investigator, research assistant, and the person typing the informat 
from the tape. Following the completion of the study the tape will be erased. All of the typ 
information will only use a number to identify you. Even this typed information will be desti 
after 5 years. During the study the tape, and any coded information will be kept in a locke 
accessible only to the researcher or assistant. You are protected by federal regulations w 
require a subpoena from a court for the release of information from research studies. 
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If you agree to be in this study the following will occur: 
Day 1 
• Once in the morning (between 7:30 and 10:30 AM) and once in the evening (betwe 
4:30 and 7:30 PM), you will be administered the Cancer Dyspnea Scale, will have 
oxygen level in your body assessed, and be asked a series of questions. It may be 
necessary to wake you up. 
• Oxygen level in your body will be assessed with a small finger device that will place 
over the tip of your finger This device reads your oxygen level without going throu 
the skin. 
• Both of these will be conducted one-on-one. 
• All three groups will receive standard care on this day that has been ordered by th< 
physician. 
• Each visit will take from 5 to 10 minutes. 
Day 2 
• On the morning of Day 2 and before the early Day 2 assessments, the treatment 
intervention will begin. Application of acupressure seed adhesives will be carried * 
a student intern under the supervision of a licensed acupuncturist. It may be nece 
to wake you up. 
• You will be asked whether you have any known allergies for adhesives or tape. 
• The experimental acupressure condition consists of placing small seeds with an 
adhesive material that allows the seed to be held in place over the appropriate 
acupressure point on both ears. 
• Before the adhesive with seeds is put in place, the auricular points are mildly stim 
for 3 seconds with a surface, non-invasive probe, making a slight indentation on ti 
points, then cleansed with an alcohol applicator stick. 
• Additionally, the site of the adhesive use will be monitored for any allergic reactior 
condition will be monitored during both the application and removal of the adhesiv 
prevent and treat skin tear. 
• Fatigue will be monitored during your participation in the four-day protocol. You v 
both directly asked about experience of fatigue and observed for any evidence of 
increasing fatigue over the course of the protocol. 
• Then, within two hours before each morning and evening assessment, research 
personnel will visit you, ask a series of questions, and remind you that assessmei 
happen at a specified time. If you are in one of the two-acupressure conditions, 
pressure will be applied to the seeds. 
• Once in the morning (between 7:30 and 10:30 AM) and once in the evening (betv 
4:30 and 7:30 PM), you will be administered the Cancer Dyspnea Scale and will I 
oxygen levels in your body assessed. 
• Oxygen level in your body will be assessed with a small finger device that will be 
over the tip of your finger. This device reads your oxygen level without going thrc 
the skin. 
• Each visit will take from 5 to 10 minutes. 
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Day 3 and 4 
Then, about two hours before each morning and evening, research personnel will visit 
you, ask you a series of questions, and remind you that assessments will happen at a 
specified time. If you are in one of the two-acupressure conditions, pressure will be 
applied to the seeds. It may be necessary to wake you up. 
Fatigue will be monitored during your participation in the four-day protocol. You will be 
both directly asked about experience of fatigue and observed for any evidence of 
increasing fatigue over the course of the protocol. 
Additionally, the site of the adhesive use will be monitored for any allergic reaction. Skii 
integrity will be monitored during both the application and removal of the adhesive to 
prevent and ameliorate skin tear. 
Once in the morning (between 7:30 and 10:30 AM) and once in the evening (between 
4:30 and 7:30 PM), you will be administered the Cancer Dyspnea Scale and will have 
oxygen levels in your body assessed. 
Oxygen level in your body will be assessed with a small finger device that will placed 
over the tip of your finger.. This device reads your oxygen level without going through 
the skin. 
Each visit will take from 5 to 10 minutes. 
Day 5 
• You will be approached and told that you have finished your participation in the study. 
You will be asked a series of questions, a short debriefing will take place and the 
researcher will express his or her appreciation for your participation. 
RISKS / DISCOMFORTS 
As with all studies there are some added risks (or discomforts) to you. There may be other ris! 
or discomforts we do not now know about besides those listed here. 
• If you have adhesive (tape) placed on your ear, it is like a small band-aid, you may hav 
an allergic reaction to the adhesive or your skin may tear like when you take off a band 
aid 
• Some mild discomfort when mild pressure is applied to the seeds 
• Participation in this study may lead to some fatigue 
• Some people may feel anxious when being part of a study, when they know that 
research personnel are looking at some of their medical records or when they are fillini 
out forms asking about their background information or how they are doing 
Some people may find that this added amount of time and energy required during their 
participation in a study to be a burden. However, it is also true, that some people find t 
extra time and attention provided to them through additional appointments and attentic 
from the research team to be a real benefit to them. 
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NEW FINDINGS 
Your research nurse will tell you in a timely manner of any new facts he or she learns that mig 
cause you to change your mind about taking part in the study. We may be able to give you th 
final study results. We will tell you how to learn more about the results at the end of the study 
POSSIBLE BENEFITS 
You may get no direct benefit from being a part of this study. We hope you may be helped b\ 
• Being able to breathe more easily 
• Feeling less anxious 
• Feel good about helping with research that aims to help those in similar situations to 
yours 
Also, information that we learn from this study may help future patients. It is possible, howev 
that you may not be helped during or after this study. 
PAYMENT FOR PARTICIPATION 
We will not be giving you any payment for taking part in this research study. This is not a wa 
or release of any of your legal rights. 
ALTERNATIVE TREATMENTS 
If you decide not to take part in this study, there are other treatments that you may discuss w 
the study doctor or your Primary Care Physician. These other treatments are already avaiiab 
to you here at the inpatient care center and you are eligible to receive whether you are in the 
study or not. These would consist of receiving oxygen, respiratory treatments, and medicati< 
for pain or difficulty in breathing. 
CONFIDENTIALITY AND RELEASE OF MEDICAL RECORDS 
What we talk about in this study will be kept private to the extent allowed by law. We will kei 
the records under a code number rather than by name to protect your privacy. We will keep 
records in locked files. Only study staff will be allowed to look at them. Your name and othe 
facts that might point to you will not appear when we present this study or publish its results. 
Certain persons or institutions may sometimes look at your study records and those of other 
like you who take part in the study. They include: 
• Your study nurse and study staff 
• Your Primary Care Physician 
• San Diego Hospice & Palliative Care 
• San Diego Hospice Institutional Review Board (IRB) 
The tape recorded and transcribed short questions will be identified by a code number, not j 
name. The tape and transcription will be stored in a locked file cabinet. The results of this 
research may be presented at meetings or in published articles. However, your name will b 
kept private. You have already signed a separate authorization form. This form explained wl 
will have access to your protected health information. 
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A court of law could order study records shown to other people, but this is unlikely. 
COMPENSATION FOR RESEARCH RELATED INJURY 
Mishaps can occur in any study. We may or may not expect them. They may be no one's fa 
San Diego Hospice will provide any medical and supportive care for any harm that happens t 
you from being in the study. San Diego Hospice has not set aside funds to pay you for 
other costs if you are injured. You may call the San Diego Hospice, Center for Palliative 
Studies at 1-619-278-6296 to learn more about this or to report problems you have with bein< 
the study. 
LEGAL RIGHTS 
The above section does not restrict your right to seek legal assistance. 
RISK MANAGEMENT 
Report any unusual symptoms or side effects at once to your study nurse. If you have any 
question regarding: 
• Your adhesives and seeds attached to your ear 
• Your reaction to adhesives and seeds attached to your ear 
• Any possible study related injury 
• Your participation in the study 
Contact your study nurse, Roger Strong, at his work number [619-688-1600 x6280], voice n 
number [619-688-1600 x6913], or cell number [619-922-4058]. 
CONTACT FOR QUESTIONS 
If you have general questions or questions about your rights as a research subject you may 
contact: 
Eugene Grimshaw 
Coordinator, Research Programs 
San Diego Hospice 
San Diego, CA 92103 
Telephone: 1-619-278-6296 
If you would like to speak to someone not associated with the study about your rights as a 
participant, or any other matter related to the study contact: 
Vice PresidemVCIO/Compliance Officer 
San Diego Hospice 
San Diego, CA 92103 
Telephone: 1-619-278-6309 
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VOLUNTARY NATURE OF PARTICIPATION 
You are free to join the study or not. You are also free to join the study and later decide to I© 
for any reason. Please tell your study nurse if you wish to leave. This will allow the nurse to 
you of any medical risk to your decision to leave. 
WITHDRAWAL 
Your study nurse has the right to stop the study at any time. He or she can stop the study wi 
or without your consent for any of the following reasons: 
• If you have an adverse effect from the study treatment 
• If you need a treatment not allowed in this study 
• If you do not take keep the treatment adhesive on your ear. 
Please note that the San Diego Hospice Institutional Review Board (IRB) has signified by the 
Committee's stamp that it has approved this consent form. The IRB will review the consent 
form each year. The form expires on the date that is on the stamp. 
An IRB is a group of doctors and nurses and laypersons that review a research plan with the 
aim of protecting each study's subjects from harm. 
THIS SPACE INTENTIONALLY LEFT BLANK 
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SUBJECT CONSENT 
I know that if I qualify and would like to take part in this research study, the study nurse ma 
enroll me in the study. I know that my taking part in this research study is my choice. I kn( 
that I may decide not to take part or to withdraw from the study at any time. I know that I c 
this without penalty or loss of benefits or treatment to which I am entitled. I also know that 
study nurse or the study Sponsor may stop the study without my consent. 
I have had a chance to ask the study nurse and study staff member's questions about this 
study. They have answered those questions to my satisfaction. 
I state by my signature below that I have read the information above 
I know the conditions and procedures of the study 
I know what the possible risks and benefits are from taking part in this research sti 
I know that I do not give up my legal rights by signing this form 
I know that I will receive a signed and dated copy of this consent form as well as a 
signed and dated copy of "The Patient's Bill of Rights" 
Printed Subject's Name 
Subject's Signature Date/Time 
Printed Name of Legally Authorized Representative 
(If applicable) 
Signature of Legally Authorized Representative 
(If applicable) 
Date/Time 
Printed Name of Person Obtaining Consent 
Signature of Person Obtaining Consent Date/Time 
IRB APPROVAUEXPIF 
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CPS STUDY #: 03-01 
SPONSOR STUDY # 
Medical Research Patient's Bill of Rights 
California law and our policy requires that any person asked to take part as a subject in 
research involving a medical experiment, or any person asked to consent to such participal 
on behalf of another, is entitled to receive the following list of rights written in a language in 
which the person is fluent. This list includes the right to: 
1. Be informed of the nature and purpose of the research. 
2. Be given an explanation of the procedures to be followed in the medical experiment 
any drug or device to be used. 
3. Be given a description of any attendant discomforts and risks reasonably to be exp 
from the experiment. 
4. Be given an explanation of any benefits to the subject reasonably to be expected fr 
the experiment, if applicable. 
5. Be given a disclosure of any appropriate alternatives procedures, drugs or devices 
might be advantageous to the subject, and their relative risks and benefits. 
6. Be informed of the avenues of medical treatment, if any, available to the subject af 
experiment if complications should arise. 
7. Be given an opportunity to ask any questions concerning the experiment or the 
procedures involved. 
8. Be instructed that consent to participate in the medical experiment may be withdra 
any time and the subject may discontinue participation in the experiment without 
prejudice. 
9. Be given a copy of the signed and dated written consent form. 
10. Be given the opportunity to decide to consent or not to consent to a medical exper 
without the intervention of any element of force, fraud, deceit, duress, coercion or 
influence on your decision. 
Signature of Subject Date/Time 
Signature of Witness Date/Time 
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CENTER FOR PALLIATIVE STUDIES 
AUTHORIZATION TO USE YOUR PRIVATE HEALTH INFORMATION 
PROTOCOL TITLE: Dyspnea: Effect of Auricular Acupressure in End Stage Lung Cane 
CPS STUDY NUMBER: 03-010-ED 
SPONSOR PROTCOL NO.: Not applicable 
SPONSOR: Not Applicable 
INVESTIGATOR: Roger Strong, APRN, BC-PCM 
San Diego Hospice & Palliative Care 
4311 Third Avenue 
San Diego, CA 92103 
What is private health information? Private health information is any information that can be 
to you. We need your authorization (permission) to use your private health information in this res< 
The private health information that we will use and share for this study includes: 
* Your past and present health information, 
* Information that can be used to contact you, 
s Results of your medical tests 
• 
Who else will see my information? This information may be shared with: 
s Your study nurse and study staff, 
* Your primary care physician, 
• Institutional committees that review research to help protect people who join research studi 
Once we have shared your information, we cannot be sure that it will stay private. If you share y 
information with people outside the research team, it will no longer be private. Your name will not 
any report that is written. 
How long will the institution use and share my information? Your information will be used i 
until the research is completed. If you are participating in a clinical drug study, your records will be 
maintained at the institution for no more than two (2) years after FDA approval/decline of the stuch 
your study is not a clinical drug study, any records will be retained for up to but no more than four 
You may not participate in this study unless you sign this approval. 
What if I change my mind about sharing my research information? If you decide not to sr 
informatfon anymore: 
Vprcinn Oatp: Da/ia 1 rtf O Dr&K/M** T » * : M ^ I « » I 
• The research team may continue to use the private information that they have already colli 
• You will no longer be a part of the research study, 
• You will still get the same medical care that you've always had at San Diego Hospice & Pall 
s You must write to the study doctor and tell him or her that you no longer want to share yo 
information. Write to the study nurse at: 
Principal Investigator. 
Complete mailing address: 
Street Address 
City/State/Zip 
Roger Strong, APRN, BC-PCM 
San Diego Hospice & Palliative Care 
4311 Third Avenue 
San Diego, CA 92103 
v If you do not withdraw your consent, this form will expire 25 years after the date of study < 
Do I have the right to see and copy my research information? No, you may not see your r 
information unless it is also being used for your health care. 
If you agree to share your information you should sign this form below. You will be given a copy c 
I agree to share my information as described in this form: 
Printed Subject's Name 
Subject's Signature Date/Time 
Printed Name of Legally Authorized Representative 
(If applicable) 
Signature of Legally Authorized Representative 
(If applicable) 
Date/Time 
Printed Name of Person Obtaining Consent 
Signature of Person Obtaining Consent Date/Time 
Version Date: Page 2 of 2 Patient Initials: 
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Thomas Herrinton [herrinton@sandiego.edu] 
Thursday, May 11, 2006 10:44 AM 
Roger Strong; Jane Georges 
Bernadette Maidonado; Sally Hardin 




Dear Mr. Strong and Dr. Georges, 
Your request for IRB authorization of your human subjects research 
proposal entitled "Dyspnea: Effect of Auricular Acupressure in End 
Stage Lung Cancer Patients" has been approved. Please see the 
attached Project Action Summary form for your project number and action date. 
Sincerely, 
Dr. Thomas R. Herrinton 
IRB Administrator 
Associate Provost 
University of San Diego 
*** eSafe scanned this email for malicious content *** 
*** IMPORTANT: Do not open attachments from unrecognized senders *** 
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14 November 2005 
Roger Strong, APRN, BC-PCM 
San Diego Hospice & Palliative Care 
4311 Third Avenue 
San Diego, CA 92103 
RE: CPS Study 03-010-gD; "Dyspnea: Effects of Auricular 
Acupressure in End Stage Lung Cancer Patients." 
Dear Mr. Strong: 
The Chair of the San Diego Hospice IRB has reviewed the changes as 
requested in our letter dated, July 21,2005: 
Your protocol dated 28-June-200S is approved. 
Your consent form dated 28-June-2005 is approved. Please find 
enclosed an original, stamped, and approved consent. Please use this 
copy to generate copies for consenting subjects. 
Approval for this study expires on 13-July-2006 
As a reminder, any modifications to the protocol or consent forms must be 
approved by the IRB prior to their implementation. Any forms, except 
Case Report Forms, to be used during the study, or any advertisements 
must be approved by the IRB prior to their implementation. If you are 
unsure as to what needs review contact this office directly at 619-278-
6296. 
All Serious or Unexpected Adverse Events must be reported in a timely 
manner. If you are unsure as to what constitutes a Serious or 
Unexpected Adverse Event please contact this office directly at 619-278-
6296. 
You will be required to complete a quarterly report indicating the status of 
your research. This office utilizes the following as its quarterly reporting 
requirement (January/February/March - 1 * Quarter), (April/May/June -
2nd Quarter), (July/August/September-3"1 Quarter), 
(October/November/December - 4th Quarter). 
Along with quarterly reporting, federal regulations state, "An IRB shall 
conduct continuing review of research covered by these regulations at 
intervals appropriate to the degree of risk, but not less than once per 
year. TJitle 21 Part 56, Section 56.109(f)] 
."==?3" 
4311 TWrd Avenue, San Diego, CA 92103-1407 619-688-1600 
www.sdhospice.org 
14 November 2005 
Page 2 
When your study has completed you will be required to complete a Study Summary. 
The San Diego Hospice is in compliance with Good Clinical Practices, the Common Rule [Title 
45 CFR Part 46], the Declaration of Helsinki, the Belmont Report and the regulations set fort by 
the Food and Drug Administration and all amendments thereto, contained in Title 21 of the 
Code of Federal Regulations, Parts 50,56 and 312. 
Please contact this office for any matters that you are unsure of by calling direct at 619-278-
6296. 
Sincerely, 




San Diego Hospice 
& Palliative Care 
Caring for Our Community 
Snce1977 
July 14, 2006 
Roger Strong, APRN, BC-PCM 
San Diego Hospice & Palliative Care 
4311 Third Avenue 
San Diego, CA 92103 
RE: CPS Study 03-010-CM: Dyspnea: Effect of Auricular Acupressure in End Stage 
Dyspnea 
Dear Mr. Strong: 
Your application for Continuing Review was addressed at the San Diego Hospice IRB meeting 
held on July 13, 2006. 
The protocol dated June 28, 2005 is approved. Your consent form dated June 28, 2005 is also 
approved. Your HIPAA Consent remains in effect unless amended. As a reminder, if your 
consent form has been modified at this review or at any time during the study duration you are 
required to re-consent all subject currently enrolled or in follow-up. 
Approval for this site expires on July 12, 2007. 
As a reminder, any modifications to the protocol or consent forms must be approved by the IRB 
prior to their implementation. All forms to be used during the study, or any advertisements must 
be approved by the IRB prior to their implementation. Contact this office at 619-278-6296 should 
you have any questions. 
All Serious or Unexpected Adverse Events must be reported in a timely manner. If you are 
unsure as to what constitutes a Serious or Unexpected Adverse Event please contact this office 
directly at 619-278-6296. 
All protocol deviations or exceptions should be reported to the IRB in a timely manner: 
Deviation is defined as: An incident involving noncompliance with the protocol, but one 
that typically does not have a significant effect on the subject's rights, safety, welfare, 
and/or integrity of the resultant data. Deviations may result from the action of the 
participant, Investigator, or staff. 
Exception is defined as: Accidental or unintentional changes to the IRB approved 
protocol procedures without prior sponsor or IRB approval. Violations generally affect 
the subject's rights, safety, welfare, and/or the integrity of the resultant data. 
4311 Third Avenue • San Diego, CA 92103-1407 
619-688-1600 • 866-688-1600 (toll free) • www.sdhospice.org 
July 24, 2006 
Continuing Review Approval 
Page 2 
Per federal regulations, "An IRB shall conduct continuing review of research covered by the: 
regulations at intervals appropriate to the degree of risk, but not less than once per year." [T 
21 Part 56, Section 56.109(f)] 
When you have completed your study, you will be required to complete a Final Report 
Summary. 
The San Diego Hospice is in compliance with the regulations Food and Drug Administration 
all amendments thereto, contained in Title 21 of the Code of Federal Regulations, Parts 50, 
and 312. The IRB is also compliant with ICH guidelines. 









San Diego Hospice 
& Palliative Care 
APPLICATION FOR AMENDMENT REVIEW 
Investigator Name: Roger Strang APRN, BC-PCM IRB #: 03-010-ED 
PI Phone: 619-922-4058 PI Fax: 619-688-6599 
PI Email Address: rstrong@sdhospice.Ofg 
Sponsor Name: NA Sponsor ID #: 
Protocol Title Dyspnea: Effect of Auricular Acupressure in End Stage Lung Cancer 
Patients 
REVISION OR ADDITIONS: 
1. Revision or Addition Description [check all that apply] 
Ex] Revision to currently approved protocol: Amendment # : 
Original Version Date: 06-28-05 
New Version Date: 3-18-07 
Revision to currently approved consent: 
Current Version Date: 06-28-05 
New Version Date: 3-18-07 
2. Check ail that apply: 
13 This revision involves minor changes only. [Administrative or having no direct impact 
or intervention pertaining to research subject] 
13 This revision does not increase risks to participants enrolled in the study. 
D This revision does increase risks to participants enrolled in the study. [Include 
explanation in revision description.] 
3. Protocol: Submit a strikeout copy or a summary of changes to the protocol electronically. 
3A. Consent From: Submit a strikeout version electronically. 
4. If requesting Expedited Review, complete the IRB Request for Expedited Revie 
Application. 
Certification and Assurances: 
I certify that this form is complete and is correct. 
I accept ultimate responsibility for the conduct of this study, the ethical performance 
the project, and the protection of the rights and welfare of the human subjects who; 
directly or indirectly involved in this project. 
I will comply with all SHDIRB policies and procedures as well as with all applicable 
federal, state and local laws regarding this project. 
I acknowledge that if this activity changes or extends beyond the expiration date, th< 
certificate is voided. 
In the event of any legal action the applicant will hold SDH IRB harmless. 
Signature of Principal Investigator:  Date s>V3oy 
APPROVAL STATUS 
f Approved • Conditionally Approved • Not Approved Q Rejected ElA  
IRB Signature: jjljC^' 
Steve Oppeflneirri, MD Date 
Chair, San Diego Hospice & Palliative Care IRB 
9 
San Diego Hospice 
& Palliative Care 
REQUEST FOR EXPEDITED REVIEW 
Investigator Name: Roger Strong APRN, BC-PCM 
PI Phone: 619-922-4058 
IRB#: 03-010-ED 
PI Fax: 619-688-6599 
PI Email Address: 
Sponsor Name: 
rstrong@sdhospice.org 
NA Sponsor 10 #: 
Protocol Title | Dyspnea: Effect of Auricular Acupressure in End Stage Lung Cancer Patients 
JUSTIFICATION FOR EXPEDITED REVIEW: (Also choose one of the criteria below) 
Title 21 CFR Part 56 Sec 56,110 /Title 45 CFR Part 46 Sag 46.110 - Expedited review procedures for certain 
kinds of research involving no more than minimal risk, Please give a brief description for your request and for mine 
changes in approved research. 
The risks to the subjects in this research are minimal. The only 
change in the protocol and the consent form consists of adding detail 
regarding the first qualitative question and noting that the response 
to the four qualitative questions will be audio taped. Subjects will 
be informed about the audio taping, that they may choose to not have 
taped part or all of their responses, that the audiotapes and 
transcripts of the tapes will be securely stored, and that the 
audiotapes will be destroyed after the completion of the study. 
If in your judgment your research project fails In one of the categories below, please check the appropriate box: 
• CATEGORY 1: Clinical studies of drugs and devices only when condition (a) or (b) Is met (a) Research on drugs 
for which an Investigational new drug application (21 CFR Part 312) is not required, (b) Research on medical devices 
for which (i) an Investigational device exemption application (21 CFR Part 812) is not require; or (II) the medical 
devices Is cleared/approved for marketing and the medical device Is being used in accordance with its 
cleared/approved labeling. 
• CATEGORY 2: Collection of blood samples by finger stick, heel stick, ear stick, or venipuncture as follows: (a) 
from healthy, non-pregnant adults who weigh at least 110 pounds. For these subjects, the amounts drawn may not 
Page 1 of 3 
exceed 550 ml In an 8 week period and collection may not occur more frequently than 2 times per week; 
other adults and children, considering the age, weight, and health of the subjects, the collection procedui 
amount of blood to be collected, and the frequency with which It will be collected. For these subjects, the 
drawn may not exceed the lesser of 50 ml or 2 ml per kg in an 8 week period and collection may not occ 
frequently than 2 times per week. 
• CATEGORY 3: Prospective collection of biological specimens for research purposes by non-Invasive 
Examples: (a) Hair and nail clippings in a non-disfiguring manner; (b) Deciduous teeth at time of exfoliati 
routine patient care Indicates a need for extraction; (c) Permanent teeth if routine patient care indicates s 
extraction; (d) Excreta and external secretions (including sweat); and (e) uncannulated saliva collected e 
unstimulated fashion or stimulated by chewing gumbase or wax or by applying a dilute citric solution to tr 
Placenta removal at delivery; (g) Amniotic fluid obtained at the time of rupture of the membrane prior to c 
labor; (h) Supra- and subgingival dental plaque and calculus, provided trie collection procedure is not mi 
than routine prophylactic scaling of the teeth and the process is accomplished in accordance with accept 
prophylactic techniques; (i) Mucosal and skin cells collected by buccal scraping or swab, skin swab, or rr 
washings; (j) Sputum collected after saline mist nebulization. 
• CATEGORY 4: Collection of data through noninvasive procedures (not including general anesthesia 
routinely employed in clinical practice, excluding procedures Involving x-rays or microwaves. Where mei 
are employed, they must be cleared/approved for marketing. (Studies intended to evaluate the safety ar 
effectiveness of the medical device are not generally eligible for expedited review, including studies of cl( 
medical devices for new indications.) Examples: (a) physical sensors that are applied either to the surfac 
or at a distance and do not involve input of significant amounts of energy into the subject or an invasion c 
subject's privacy, (b) weighing or testing sensory acuity; (c) magnetic resonance imaging; (d) electrocart 
electroencephalography, thermography, detection of naturally occurring radioactivity, electroretinoraphy, 
diagnostic infrared imaging, doppler blood flow, and echocardiography; (e) moderate exercise, muscular 
testing, body composition assessment, and flexibility testing where appropriate given the age, weight anc 
the individual. 
D CATEGORY 5: Research involving materials (data, documents, records, or specimens) that have be 
for any reason or will be collected solely for nonresearch purposes (such as medical treatment or diagno 
FJ3 CATEGORY 6: Collection of data from voice, video, digital or Image recordings made for research DL 
• CATEGORY 7: Research on group characteristics or behavior (including, but not limited to, research 
perception, cognition, motivation, identity, language, communication, cultural beliefs or practices, and soc 
or research employing survey, interview, oral history, focus group, program evaluation, human factors ev 
quality assurance methodologies. 
D CATEGORY 8: Continuing review of research previously approved by a convened IRB as follows: (a) 
research is permanently closed to the enrollment of new subjects; (ii) all subjects have completed all rest 
interventions; and (ill) the research remains active only for the long term follow-up of subjects; or (b) whei 
subjects have been enrolled and no additional risks have been identified or (c) where the remaining rese: 
activities are limited to data analysis. 
• CATEGORY 9: Continuing review of research not conducted under an investigational new drug applic 
investigational drug exemption where categories 2 through 8 do not apply but the IRB has determined an 
documented at a convened meeting that the research involves not greater than minimal risk and no addit 
have been Identified. 
Expedited review Is NOT allowed for research involving persons under the age of 18 years except 
collections, which are part of the usual diagnostic or therapeutic regimen of children. A full review is requ 
these projects. 
Certification and Assurances: 
• I certify that this form is complete and is correct. 
• I accept ultimate responsibility for the conduct of this study, the ethical performance of the project, 
protection of the rights and welfare of the human subjects who are directly or indirectly involved in 
• I will comply with all SHO IRB policies and procedures as well as with all applicable federal, state a 
laws regarding this project. 
• I acknowledge that if this activity changes or extends beyond the expiration date, the certificate is v 
• In the event of any legal action the applicant will hold SDH IRB harmless. 
Signature of Principal mVestlgator 
ZVAL STATUS •oved • Conditionally Approved • Not Approved • Rejected 
IRB Signature: 
Steve Oppenheim, MD 
Chair, San Diego Hospice & Palliative Care IRB 
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San Diego Hospice 
& Palliative Care 
REQUEST FOR EXPEDITED REVIEW 
Investigator Name: Roger Strong APRN, BC-PCM IRB #: 03-010-ED 
PI Phone: 619-922-4058 pi Fax: 619-688-6599 
PI Email Address: rstrong@sdhospice.org 
Sponsor Name: NA Sponsor ID #: 
Protocol Title i Dyspnea: Effect of Auricular Acupressure in End Stage lung Cancer Patients 
JUSTIFICATION FOR EXPEDITED REVIEW: (Also choose one of the criteria below) 
Title 21 CFR Part 56 Sec 56.110 /Title 45 CFR Part 46 Sec. 46.110 - Expedited review procedures for c« 
kinds of research involving no more than minimal risk, Please give a brief description for your request and f 
changes in approved research. 
The risks to the subjects in this research are minimal. The onlj 
change in the protocol and the consent form consists expanding tr 
source of potential research participants to include those in the 
hospice homecare program. 
If in your judgment your research project falls in one of the categories below, please check the appropriate bo 
• CATEGORY 1 : Clinical studies of drugs and devices only when condition (a) or (b) is met (a) Research c 
for which an investigational new drug application (21 CFR Part 312) is not required, (b) Research on medical 
for which (i) an investigational device exemption application (21 CFR Part 812) is not require; or (ii) the medic 
devices is cleared/approved for marketing and the medical device is being used in accordance with its 
cleared/approved labeling. 
D CATEGORY 2: Collection of blood samples by finger stick, heel stick, ear stick, or venipuncture as follows 
from healthy, non-pregnant adults who weigh at least 110 pounds. For these subjects, the amounts drawn m. 
exceed 550 ml in an 8 week period and collection may not occur more frequently than 2 times per week; or (b 
other adults and children, considering the age, weight and health of the subjects, the collection procedure, tin 
amount of blood to be collected, and the frequency with which it will be collected. For these subjects, the amc 
Page 1 of 3 
drawn may not exceed the lesser of 50 ml or 2 ml per kg in an 8 week period and collection may nc 
frequently than 2 times per week. 
D CATEGORY 3: Prospective collection of biological specimens for research purposes by non-im 
Examples: (a) Hair and nail clippings in a non-disfiguring manner; (b) Deciduous teeth at time of ex 
routine patient care indicates a need for extraction; (c) Permanent teeth if routine patient care indie 
extraction; (d) Excreta and external secretions (including sweat); and (e) uncannulated saliva collec 
unstimulated fashion or stimulated by chewing gumbase or wax or by applying a dilute citric solutJoi 
Placenta removal at delivery; (g) Amniotic fluid obtained at the time of rupture of the membrane pri< 
labor; (h) Supra- and subgingival dental plaque and calculus, provided the collection procedure is n 
than routine prophylactic scaling of the teeth and the process is accomplished in accordance with s 
prophylactic techniques; (i) Mucosal and skin cells collected by buccal scraping or swab, skin swab 
washings; (j) Sputum collected after saline mist nebulization. 
• CATEGORY 4: Collection of data through noninvasive procedures (not including general anestl 
routinely employed in clinical practice, excluding procedures involving x-rays or microwaves. Wher 
are employed, they must be cleared/approved for marketing. (Studies intended to evaluate the saf 
effectiveness of the medical device are not generally eligible for expedited review, including studies 
medical devices for new indications.) Examples: (a) physical sensors that are applied either to thes 
or at a distance and do not involve input of significant amounts of energy into the subject or an inva 
subject's privacy, (b) weighing or testing sensory acuity; (c) magnetic resonance imaging; (d) elect 
electroencephalography, thermography, detection of naturally occurring radioactivity, electroretinor; 
diagnostic infrared imaging, doppler blood flow, and echocardiography; (e) moderate exercise, mus 
testing, body composition assessment, and flexibility testing where appropriate given the age, weigl 
the individual. 
D CATEGORY 5: Research involving materials (data, documents, records, or specimens) that hs 
for any reason or will be collected solely for nonresearch purposes (such as medical treatment or d 
Kl CATEGORY 6: Collection of data from voice, video, digital or image recordings made for reseat 
• CATEGORY 7: Research on group characteristics or behavior (including, but not limited to, rese 
perception, cognition, motivation, identity, language, communication, cultural beliefs or practices, ar 
or research employing survey, interview, oral history, focus group, program evaluation, human facte 
quality assurance methodologies. 
• CATEGORY 8: Continuing review of research previously approved by a convened IRB as follow 
research is permanently closed to the enrollment of new subjects; (ii) all subjects have completed a 
interventions; and (iii) the research remains active only for the long term follow-up of subjects; or (b; 
subjects have been enrolled and no additional risks have been identified or (c) where the remaining 
activities are limited to data analysis. 
• CATEGORY 9: Continuing review of research not conducted under an investigational new drug 
investigational drug exemption where categories 2 through 8 do not apply but the IRB has determin 
documented at a convened meeting that the research involves not greater than minimal risk and no 
have been identified. 
Expedited review is NOT allowed for research involving persons under the age of 18 years e 
collections, which are part of the usual diagnostic or therapeutic regimen of children. A full review is 
these projects. 
Certification and Assurances: 
• i certify that this form is complete and is correct. 
• I accept ultimate responsibility for the conduct of this study, the ethical performance of the pn 
protection of the rights and welfare of the human subjects who are directly or indirectly involv 
• I will comply with all SHD IRB policies and procedures as well as with all applicable federal, s 
laws regarding this project 
• I acknowledge that if this activity changes or extends beyond the expiration date, the certifica 
• In the event of any legal action the applicant will hold SDH IRB harmless. 
PanR 7 of 3 
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Signature of Principal Investigator Date 
APPROVAL STATUS 
H'Approved • Conditionally Approved • Not Approved D Rejected 
IRB Signature: 
—Undo C, StrotttB, PhD— 7Di 
Chair, San Diego Hospice IRB 
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San Diego Hospice 
& Palliative Care 
Caring for Our Community 
3nce 1977 
July 10, 2007 
Roger Strong, APRN, BC-PCM 
San Diego Hospice & Palliative Care 
4311 Third Avenue 
San Diego, CA 92103 
RE: CPS Study: 03-010-ED 
Study Title: Dyspnea: effect of Auricular Acupressure in End Stage Lung 
Patients. 
Dear Mr. Strong: 
The IRB Chair has had the opportunity to review your request for Expedited review on 0' 
1. The protocol dated 06/23/07 is approved. 
Approval for this site expires on 07/12/07. 
As a reminder, any modifications to the protocol or consent forms must be approved by t 
prior to their implementation. All forms to be used during the study or any advertisemen 
be approved by the IRB prior to their implementation. Contact this office at 619-278-629) 
you have any questions. 
All Serious or Unexpected Adverse Events must be reported in a timely manner. Shoulc 
unsure as to what constitutes a Serious or Unexpected Adverse Event, please contact tr 
directly at 619-278-6296. 
All protocol deviations or exceptions should be reported to the IRB in a timely manner: 
Deviation is defined as: An incident involving noncompliance with the protocol, bi 
that typically does not have a significant effect on the subject's rights, safety, wei 
and/or integrity of the resultant data. Deviations may result from the action of the 
participant, Investigator, or staff. 
Exception is defined as: Accidental or unintentional changes to the IRB approved 
protocol procedures without prior sponsor or IRB approval. Violations generally i 
the subject's rights, safety, welfare, and/or the integrity of the resultant data. 
4311 Third Avenue • San Diego, CA 92103-1407 
619-688-1600 • 866-688-1600 (toll free) • www.scihospice .org 
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July 10,2007] 
Continuing Review Approval 
Page 2 
Per federal regulations, "An IRB shall conduct continuing review of research covered by 
regulations at intervals appropriate to the degree of risk, but not less than once per year 
21 Part 56, Section 56.109(f)] 
When you have completed your study, you will be required to submit a close-out letter ai 
complete a Final Summary Report. 
The San Diego Hospice is in compliance with the regulations Food and Drug Administra 
all amendments thereto, contained in Title 21 of the Code of Federal Regulations, Parts 
and 312. The IRB is also compliant with ICH guidelines. 









San D i e g o Hospice 
& Palliative Care 
Caring for Our Community 
3nce 1977 
July 11, 2007 
Roger Strong, APRN, BC-PCM 
San Diego Hospice & Palliative Care 
4311 Third Avenue 
San Diego, CA 92103 
RE: CPS Study: 03-010-ED 
Study Title: Dyspnea: Effect of Auricular Acupressure in End Stage Lung Cane 
Patients 
Dear Mr. Strong: 
Your application for Continuing Review was addressed at the San Diego Hospice IRB n 
held on July 11, 2007. 
1. The protocol dated 06/23/07 is approved. 
2. Your consent form dated 03/18/07 is approved. 
3. Your HIPAA Consent meets the requirements as set forth in Privacy Rule and s1 
If your consent was modified, you are required to re-consent those subjects currently or 
or in follow-up. 
Approval for this site expires on July 10, 2008. 
As a reminder, any modifications to the protocol or consent forms must be approved by 
prior to their implementation. All forms to be used during the study or any advertisemer 
be approved by the IRB prior to their implementation. Contact this office at 619-278-62$ 
you have any questions. 
All Serious or Unexpected Adverse Events must be reported in a timely manner. If you 
unsure as to what constitutes a Serious or Unexpected Adverse Event please contact tr 
directly at 619-278-6296. 
All protocol deviations or exceptions should be reported to the IRB in a timely manner: 
Deviation is defined as: An incident involving noncompliance with the protocol, b 
that typically does not have a significant effect on the subject's rights, safety, we 
and/or integrity of the resultant data. Deviations may result from the action of th< 
participant, Investigator, or staff. 
4311 Third Avenue • San Diego, CA 92103-1407 
619-688-1600 • 866-688-1600 (toll free) • www.sdh0spice.0r9 
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July 11, 2007 
Continuing Review Approval 
Page 2 
Exception is defined as: Accidental or unintentional changes to the IRB approv 
protocol procedures without prior sponsor or IRB approval. Violations generall 
the subject's rights, safety, welfare, and/or the integrity of the resultant data. 
Per federal regulations, "An IRB shall conduct continuing review of research covered I 
regulations at intervals appropriate to the degree of risk, but not less than once per ye 
21 Part 56, Section 56.109(f)] 
When you have completed your study, you will be required to submit a close-out letter 
complete a Final Summary Report. 
The San Diego Hospice is in compliance with the regulations Food and Drug Administ 
ail amendments thereto, contained in Title 21 of the Code of Federal Regulations, Par 
and 312. The IRB is also compliant with ICH guidelines. 








San D i e g o Hospice 
& Palliative Care 
Caring for Our Community 
Snce1977 
July 11, 2007 
Roger Strong, APRN, BC-PCM 
San Diego Hospice & Palliative Care 
4311 Third Avenue 
San Diego, CA 92103 
RE: CPS Study: 03-010-ED 
Study Title: Dyspnea: Effect of Auricular Acupressure in End Stage Lung Cane 
Patients 
Dear Mr. Strong: 
Your application for Continuing Review was addressed at the San Diego Hospice IRB i 
held on July 11, 2007. 
1. The protocol dated 06/23/07 is approved. 
2. Your consent form dated 03/18/07 is approved. 
3. Your HIPAA Consent meets the requirements as set forth in Privacy Rule and s 
If your consent was modified, you are required to re-consent those subjects currently oi 
or in follow-up. 
Approval for this site expires on July 10, 2008. 
As a reminder, any modifications to the protocol or consent forms must be approved by 
prior to their implementation. All forms to be used during the study or any advertisemei 
be approved by the IRB prior to their implementation. Contact this office at 619-278-62! 
you have any questions. 
All Serious or Unexpected Adverse Events must be reported in a timely manner. If you 
unsure as to what constitutes a Serious or Unexpected Adverse Event please contact tl 
directly at 619-278-6296. 
All protocol deviations or exceptions should be reported to the IRB in a timely manner: 
Deviation is defined as: An incident involving noncompliance with the protocol, t 
that typically does not have a significant effect on the subject's rights, safety, we 
and/or integrity of the resultant data. Deviations may result from the action of th 
participant, Investigator, or staff. 
4311 Third Avenue • San Diego, CA 92103-1407 
619-688-1600 • 866-688-1600 (toll free) • www.sdhospice.org 
July 11, 2007 
Continuing Review Approval 
Page 2 
Exception is defined as: Accidental or unintentional changes to the IRB approve 
protocol procedures without prior sponsor or IRB approval. Violations generally 
the subject's rights, safety, welfare, and/or the integrity of the resultant data. 
Per federal regulations, "An IRB shall conduct continuing review of research covered b 
regulations at intervals appropriate to the degree of risk, but not less than once peryei 
21 Part 56, Section 56.109(f)] 
When you have completed your study, you will be required to submit a close-out letter 
complete a Final Summary Report. 
The San Diego Hospice is in compliance with the regulations Food and Drug Administi 
all amendments thereto, contained in Title 21 of the Code of Federal Regulations, Pari 
and 312. The IRB is also compliant with ICH guidelines. 










PLEDEGES OF CONFIDENTIALITY 
Acupuncturist's Pledge of Confidentiality 
I will be participating in this research project as a licensed Acupuncturist administering 
auricular acupressure. Although I will know the names of the participants, I will not 
purposefully acquire other identifying information. In any case, I agree to maintain the 
confidentiality of the participants. I will maintain confidentiality by not discussing anything 
that I learn about the participants with anyone for any reason and by not identifying the 
participants to others in any way. I understand that if I do not maintain confidentiality that 
the participants' right to privacy will be seriously violated and that this will constitute 
unethical behavior that will jeopardize this research project. 
Jefferv S. Smith. L.Ac.. MSTOM. National Diplomat of OM 
Name of Acupuncturist Ŝ gn̂ tjfre of Acupuncturist 
Date: <4~ L~Ql 
215 
Transcriber's Pledge of Confidentiality 
I will be participating in the transcription of audio taped research interviews to typed 1 
will not purposively know the names of the participants being interviewed. However, 
inadvertently obtain information that would give me clues to participants' identity. I i 
maintain the confidentiality of the participants. I will maintain confidentiality by not 
discussing the information that I transcribe with anyone for any reason and by not ide 
the participants to others in any way. I understand that if I do not maintain confidenti 
that the participants' right to privacy will be seriously violated and that this will const 
unethical behavior that will jeopardize this research project. 
Jennifer Mitch. RN.BSN  
Name of transcriber signature of'transcriber 
Statistical Consultant's Pledge of Confidentiality 
I will be participating in this research project as a statistical consultant. I will not know th 
names of the participants. I will not purposefully acquire other identifying information. Ii 
any case, I agree to maintain the confidentiality of the participants. I will maintain 
confidentiality by not discussing anything that I learn about the participants with anyone f 
any reason and by not identifying the participants to others in any way. I understand that i 
do not maintain confidentiality that the participants' right to privacy will be seriously 
violated and that this will constitute unethical behavior that will jeopardize this research 
project. 
Tom L. Smith. Ph.D. 
Name of statistical consultant 
Date:<p6>/~(9f— 
:ghature of stat^tic^ri-eorisultant 
Qualitative Data Analyst Expert's Pledge of Confidentiality 
I will assist in the qualitative analysis of transcribed audio taped research interviews, 
not purposively know the names of the participants being interviewed. However, I m 
inadvertently obtain information that would give me clues to participants' identity. I 
maintain the confidentiality of the participants. I will maintain confidentiality by not 
discussing the information that I help analyze with anyone for any reason and by not 
identifying the participants to others in any way. I understand that if I do not maintai: 
confidentiality that the participants' right to privacy will be seriously violated and tha 
will constitute unethical behavior that will jeopardize this research project. 
Rhoberta J. Haley. Ph.D.. RN 




NON-ENROLLED SUBJECT CHARACTERISTICS 
















Declined no specific reason 
Declined fatigue 
Declined fatigue/appointments 
Declined by family/spouse 














* moved to Skilled Nursing Facility 
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APPENDIX L 
TIME TO DEATH OF SUBJECTS ENROLLED 
Enrolled Subjects: Characteristics and Number of Days Between End of Study 



























































































= skilled nursing facility 
= homecare 
= board & care 
= inpatient care center 





,w. »j . 
From: "' j " -, K-.'KfikoTANAKA [k.tanaka@scchr.jp] 
Sent: ,' * '-' Thursday, July 07,2005 4:18 AM 
To: <{' ' R o g e r Stfepinu 
Subject: / ,' Cancjr,Dysprrea Scale 
•: <. 
Dear Strong*1. . ..- <' 
I'm Dr. Tanak^,, a physician in Palliative Care Unit, who developed the 
Cancer Dyspnea Scale. Dr. Uchitomi sent your mail to me. 
It is our pleasure1.that you are planing the study using the CDS. 
Acupuncture and accupressure are used to alleviate symptoms also in cancer 
patients. But they are not regarded as "medicine". They are delivered not 
.in Jssspltal nor even in PCU. There is few reports showing how it works, and 
few or no scientific studies on it. 
I suppose CAM like acupuncture and accupressure is perhaps more widely 
applied to patients in USA than in Japan. 
Sincerely, 
********************** 
Keiko TANAKA M.D., Ph.D. 
Division of Palliative Medicine, 
Shizuoka Cancer Center Hospital 
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From: Roger Strong 
Sent: Tuesday, April 01, 2008 8:34 PM 
To: 1oumalsriQht5@oxon.blaclwellpublisinq.com 




To Whom This May Concern: 
I am a doctoral student at the University of San Diego in the School of Nursing. I am in the 
process of completing my dissertation. I am requesting permission to use the Revised Symptom 
Management Conceptual Figure in my dissertation. This is found in the following reference: 
DoddrM.1Janson,S.,Facione>N.>Froelicher,E.S.,Humphreys,J.1Lee,K.,MiaskowskilC, Puntillo, K., 
Rankin, S..& Taylor ,D .(2001). Advancing the science of symptom management. Journal of 
Advanced Nursing, 33 (5), 668-676 
Thank you, 
Roger A. Strong ,RN, PhD(c) 
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From: Byers, Sally - Oxford rmailto:sally.byers@wiley,com] 
Sent: Friday, April 18, 2008 6:41 AM 
To: Roger Strong 
Subject: RE: Request for Permission to Use Figure for Doctoral Dissertation 
Dear Roger Strong, 
Thank you for your email request. Permission is granted for you to use the material below for 
your thesis/dissertation, subject to the usual acknowledgements and on the understanding that you 
will reapply for permission if you wish to distribute or publish your thesis/dissertation 
commercially. 





PO Box 805 
9600 Garsington Road 
Oxford OX4 2DQ 
UK 
Tel.01865 476149 
Fax. 01865 471149 
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From: Eastland Press fmallto:info@eastlandpress.com] 
Sent: Thursday, April 17, 2008 5:43 PM 
To: Roger Strong 
Subject: RE: Request For Permission to Use Diagram and Table 
Hello Roger, 
You have our permission to reproduce this illustration and diagram for the limited purpose 






From: Roger Strong rmailto:rstrona@SDHospice.ora1 
Sent: Sunday, April 06, 2008 10:15 AM 
To: info@eastlandpress.oom 
Subject: Request For Permission to Use Diagram and Table 
Eastland Press,INC 
Po Box 99749 
Seattle,WA08139 
TO WHOM IT MAY CONCERN: 
My name is Roger Strong, doctoral student, in the School of Nursing, at the University of San 
Diego. I am completing my dissertation currently and going to defend it this month. I am 
requesting permission to use Diagram 3-54 on page 478 and Table 3-5 on pages 479-490. 
This is located in the following book: O'Connor ,J.& Bensky ,D.(1981).Acupuncture: A 
comprehensive text .Seattle: Eastland Press Inc. My dissertation is Titled: Dyspnea :Effect of 
Auricular Acupressure on Lung Cancer End Stage Patients 
Thank you for your help, 
Roger A. Strong,PhD(c), RN 
